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In this thesis, mutualistic and pathogenic relationships between Galleria 
mellonella, Steinernema carpocapsae, and Xenorhabdus nematophila were studied. 
Using Ultra Performance Liquid Chromatography in tandem with High Resolution Mass 
Spectrometry (UPLC-HRMS), metabolite intensities were measured. In the first 
experiment, Galleria mellonella was infected with entomopathogenic Steinernema 
carpocapsae nematodes and the progress of infection was analyzed using metabolomics. 
In a mutualistic relationship, Steinernema carpocapsae nematodes transport Xenorhabdus 
nematophila bacteria into the host and kill the insect for nematode development. 
Metabolomics analysis of Galleria mellonella showed statistical significant differences in 
metabolite intensities as infection progressed in both known and unknown spectral 
features.  
In the second experiment, the metabolic profile of two strains of Xenorhabdus 
nematophila were studied for differences in colonization abilities induced by the 
nematode intestinal location (nil) locus. The nil locus was deleted in both strains, but the 
control strain was complemented for the deletion. Metabolomics analysis using UPLC-
HRMS was performed on both whole cell samples and supernatant samples with an 
interest in known and unknown spectral features. Of metabolites detected, 18 more were 
detected in the whole cell samples verses the supernatant samples. Unknown spectral 
features were analyzed with 1301 more spectral features being detected in the whole cell 
samples. After reduction by statistical significance, unknown spectral features were 
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INTRODUCTION TO METABOLOMICS AND MASS 
SPECTROMETRY TECHNIQUES  
Metabolomics  
Metabolomics is the comprehensive analysis of small molecules, referred to as 
metabolites, in a biological system with a mass of less than 1 kDa.1,2 By studying 
metabolites in a biological system, the biochemistry of cellular responses can be related 
to phenotype.3 Metabolomics is a vital tool for studying the cause of biological effects in 
a system by providing a snapshot of cellular regulation and control.4 By gaining an 
understanding of cellular phenotype, we can begin to understand how a system interacts 
with its surrounding environment.5  
The amount and type of metabolites synthesized represent the metabolome of an 
organism.4 The metabolome consists of a wide variety of compound classes such as 
organic acids, amino acids, nucleotides, and amino acids, which all have diverse 
properties and occur in a wide range of concentrations.3 These small molecules 
participate in general metabolic reactions and are required for maintenance, growth, and 
normal functions of a cell.6 Metabolomics is at the bottom of the omics cascade (Figure 
1) below gene expression and amplifies changes in the transcriptome and proteome. This 
type of analysis reflects the activities of the cell at a functional level.6,7 
The two main types of metabolomics analysis are targeted and untargeted 
metabolomics. Targeted metabolomics is known as a hypothesis-driven technique. 
Targeted metabolomics focuses on quantifying and identifying specific metabolites 
within the biological system.1 The metabolites analyzed are usually part of a specific 
group related to a pathway or class of compounds.8 In this technique, the chemical 
properties of compounds are known meaning sample preparation can be changed to 
reduce interference from other compounds or reduce matrix effects.1 
 Untargeted metabolomics aims to detect as many mass spectral features from a 
sample as possible.9 An untargeted approach allows for the potential to provide an 
understanding of biological processes from a global perspective in response to disease or 
environmental changes.8 Results from an untargeted experiment are used to generate new 
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hypotheses for future experiments.1 The disadvantage to this type of analysis is a large 
number of metabolites change as a result of changing conditions and many of these 
changing metabolites remain uncharacterized by structure and function.9 Output from an 
untargeted metabolomics analysis results in a large number of unidentified spectral 
features, which must be searched in a database such as Human Metabolome Database10 
(HMDB) or METLIN (The Scripps Research Institute) for punitive matches based on 
exact mass. Most searches do not return any matches or return multiple matches for each 
exact mass making identification difficult.1,11 Any possible matches may not be accurate 
but can be confirmed by comparing retention times of standards and performing 
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Separation techniques prior to analysis by mass spectrometry are used to reduce 
the complexity of a mass spectrum and aid in metabolite identification by providing 
information on physiochemical properties of a metabolite. Mainly, separations reduce the 
number of ions entering a mass spectrometry ion source at one time which reduces ion 
suppression leading to a reduction in background noise and an improvement in detection 
thus improving quality of the mass spectra. Liquid chromatography (LC) is commonly 
coupled with mass spectrometry because of its ability to separate a wide range of polar, 
water-soluble molecules such as metabolites.12  
In LC, mixtures are separated based on their retention time, or the amount of time 
spent in the column, which is influenced by their interaction with the mobile phase and 
stationary phase. As the name suggests, the stationary phase is stationary in the column 
and is passed over by the mobile phase. Analytes migrate through the column at different 
rates due to chemical interactions with the stationary phase. An analyte that has a greater 
affinity for the mobile phase means the analyte will spend more time in the mobile phase 
and will travel faster and elute off the column before an analyte with a greater affinity for 
the stationary phase. An LC separation reduces ion suppression so ion pairing agents can 
be added to the mobile phase to decrease detectability of unwanted analytes.13  
Isocratic or gradient elutions can be used to facilitate LC separations. Isocratic 
conditions consist of a constant solvent composition throughout analysis. In gradient 
conditions, the composition of the mobile phase changes as analysis progresses. In 
reverse-phase high performance liquid chromatography (RP-HPLC), the stationary phase 
is nonpolar and the starting mobile phase is very polar. As analysis progresses, the mobile 
phase is changed by increasing the proportion of the less polar component. Gradients are 
chosen to separate complex samples and shorten analysis times.13  
High performance liquid chromatography (HPLC) is a type of liquid 
chromatography that has led to the development of ultra-high performance liquid 
chromatography (UPLC).14 HPLC offers higher resolution, more reproducible responses, 
  
4 
and an increased speed of analysis than other LC techniques. HPLC utilizes particle sizes 
of 3-5µm while UPLC can use particle sizes of less than 2µm. The use of smaller particle 
size increases resolution, efficiency, and sensitivity, but also increases backpressure due 
to an increase in flow rate. HPLC columns can withstand a maximum pressure of around 
600 bar where as UPLC columns can withstand pressures of over 1200 bar.14 The 
improved chromatographic efficiency of UPLC systems over other LC techniques allows 
for the detection of more metabolites.12      
Mass Spectrometry  
The purpose of mass spectrometry is to generate ions, separate those ions by their 
mass to charge ratio (m/z), and detect those ions by their respective m/z and abundance 
using an ion source, a mass analyzer, and a detector.15 A schematic of a basic mass 
spectrometer is shown in Figure 2. Mass spectrometry is an important analytical tool in 
the area of metabolomics because when coupled with LC, it offers high selectivity and 
low detection limits for trace compounds in complex mixtures, such as the detection of 
metabolites in biological samples, allowing for rapid measurements from minimal 
amounts of sample.9,15 When coupled with LC, mass spectrometry reduces the 
complexity of the mass spectra by separating co-eluting compounds.3   
Once a sample has been introduced through a sample inlet, the ion source is 
responsible for transferring ions from the sample into the gas phase. Ion sources can be 
tailored to each experiment based on the type of sample and the ions being produced. For 
metabolomics experiments, electrospray ionization (ESI) is chosen because it is 
considered a soft ionization technique that forms intact molecular ions and is capable of 
producing a large number of ions.1  
ESI sources are often referred to as ESI interfaces because they do not actively 
produce ions. ESI requires ions to be present in the sample and will transfer them to the 
gas phase through a three-step process: Taylor cone formation, reduction of droplet size, 
and ion liberation. The Taylor cone is formed from increasing field strength surrounding 
the spray capillary. Once a critical electric field strength is reached, a fine jet of liquid is 





Figure 2. Schematic of mass spectrometer. 
 
of one particular charge sign determined by ionization mode that break up into smaller 
droplets and are driven apart by Columbic repulsion. The charge density of the droplet 
increases as solvent evaporates until the Rayleigh limit is reached and the droplet breaks 
into smaller droplets. Two theories currently exist for ion liberation. The charge-residue 
model (CRM) suggests the droplet size is reduced until the droplet contains one ion and 
the remaining solvent is then evaporated. The ion-evaporation model (IEM) suggests an 
increasing charge density of a small droplet causes the ejection of an ion out of solution. 
Evidence shows that both theories are correct with CRM being the mostly likely model 
for large mass ions while IEM is the most likely model for small mass ions.15 
An orbitrap is a mass analyzer that uses an electrostatic field to trap ions in a 
stable trajectory. An orbitrap has a spindle-like center electrode and barrel-like outer 
electrode.15 Ions orbit around the central electrode while simultaneously oscillating in the 
z-direction.16 All ions have the same amplitude but the axial motion is determined by m/z 
ratio. The m/z of an ion can be determined from the frequency of oscillation after Fourier 










transform. A C-trap is used to accumulate and store ions before being injected into the 
orbitrap by a high voltage electric pulse.15 An orbitrap mass analyzer has a high mass 
resolution, which is necessary to resolve two peaks with small mass differences. High 
mass resolution is important for experiments with complex mixtures because they contain 
a large number of background ions.17 
The performance of a mass spectrometer is determined by its sensitivity, limit of 
detection (LOD), and signal to noise ratio (S/N). Sensitivity is electric charge of a 
specified ion reaching the detector per mass of analyte used and can be affected by the 
ionization method, mass range, and transmission of the mass analyzer. The LOD is the 
smallest amount of analyte necessary to obtain a signal that can be distinguished from the 
background noise. The S/N describes the uncertainty of the intensity of a measured ion. 
Orbitrap mass spectrometers are known to have high resolution and low mass 
accuracy. Resolution refers to the smallest difference in m/z that can be separated for a 
signal and can be calculated by dividing the m/z for a given signal by the difference in 
m/z. There are two ways to refer to mass accuracy. Absolute mass accuracy is the 
difference between the experimental m/z and the calculated m/z. Relative mass accuracy 
is usually reported in parts per million (ppm) and is the absolute mass accuracy divided 
by the m/z it is determined for.15 
Metabolomics Data 
 Computer programs are used to not only control mass spectrometers but also aid 
in analyzing the large amounts of data collected by the instrument. Software programs 
such as XcaliburTM (Thermo Fisher Scientific, San Jose, CA) allows for method setup, 
data acquisition, and data processing while also allowing users the ability to view the 
total ion chromatogram (TIC) and the extracted ion chromatogram (EIC). The TIC shows 
the sum of ionic intensities per spectrum verses retention time while the EIC shows the 
signal intensity at a selected m/z verses retention time.15 Data files produced by 
XcaliburTM are in a RAW format and must be converted for analysis using programs like 
MSConvert by ProteoWizard.18 MSConvert changes the file format from a RAW file to a 
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mzML file that is readable by processing software such as MAVEN 
(htpp://maven.princeton.edu). 19  
 Software programs such as MAVEN and XCMS Online 
(https://xcmsonline.scripps.edu) align mass spectrometry data from each sample in order 
to make processing easier. Data files obtained from samples analyzed with mass 
spectrometry platforms contain a large number of metabolites that were measured 
through a single analysis with untargeted analysis resulting in tens of thousands of 
spectral features.20 MAVEN and XCMS Online are commonly used to align and group 
peaks across all samples correcting for factors such as retention time drift.19–21 MAVEN 
can be downloaded for use and is best used for matching detected metabolites to a known 
library while XCMS Online is better used for unknown analysis due to its additional 
features such as statistical analysis, visualizing metabolomics data, and metabolite 
assignment.19,21  
 After determining the metabolites detected, intensities are normalized using either 
mass or volume before averaging the intensities of replicates to determine fold changes 
and statistical significance. Fold changes are found by dividing each treatment group by 
the control group. A student’s t-test can be used to determine statistical significance 
between each treatment group and the control group with a resulting p value below 0.1 
representing there is a 90% probability the differences between the groups did not occur 
by chance.22 Fold changes and statistical significance can be displayed on a heatmap, one 
of the most widely used bioinformatics graphic representations.  A heatmap is a 
visualization tool in which fold changes of relative abundance are represented using a 
color intensity scale. Heatmaps can be used for visually recognizing patterns in changing 
intensities for finding interesting features.20  
  Partial Least Squares-Discriminant Analysis (PLS-DA) plots are constructed to 
identify class differences from a multivariate dataset and are commonly used for 
classification purposes and biomarker selection.23,24 PLS-DA plots are based on PLS 
regression model in which the dependent variable represents the class of membership. 
24,25 PLS-DA plots can be made in programs such as RStudio (https://www.rstudio.com/) 
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or from metabolomics processing websites such as MetaboAnalyst26. From PLS-DA 
plots, metabolites are assigned a variable importance in projection (VIP) score that is 
used to determine the most important variables and their contributions to the model. VIP 
scores above 1 are considered significant and represent the metabolites that are greatly 





UNTARGETED METABOLOMICS OF GALLERIA MELLONELLA 








An untargeted metabolomics experiment was performed on Galleria mellonella 
samples infected with entomopathogenic Steinernema carpocapsae nematodes to detect 
known and unknown spectral features. Samples were collected at various time points post 
infection then metabolites were extracted and analyzed by UPLC-HRMS. A total of 110 
known metabolites were detected and over 54,000 unknown spectral features were 
detected. The amount of unknown spectral features was condensed using average 
intensity and p values. Fold changes and statistical differences in the intensity of both 
known and unknown metabolites were determined. Results showed that fold changes of 
intensity were more drastic as infection progressed. After initial processing of unknown 
metabolites, specific metabolites related to virulence and nicotinate and nicotinamide 
metabolism pathway were investigated in the untargeted spectral features.  
Introduction 
The greater wax moth Galleria mellonella (G. mellonella) has become an 
increasingly used model in recent years to study pathogenesis on non-mammal species.29 
Steinernema carpocapsae (S. carpocapsae) nematodes commonly infect G. mellonella 
along with other lepidopteron species.30 With the help of Xenorhabdus nematophila (X. 
nematophila) bacteria, S. carpocapsae nematodes become pathogenic to a wide variety of 
insects.30 X. nematophila alternates between a pathogenic stage of a variety of insects and 
a mutualistic stage with S. carpocapsae.31 
S. carpocapsae colonized by X. nematophila are called infective juveniles (IJs). 
IJs enter an insect host through natural openings and release bacteria killing the insect. 
By day 5 post infection, IJs have developed into adult stages that reproduce within the 
insect cadaver. By approximately days 9-11, offspring has developed through multiple 
juvenile stages into adult stages. Reproduction continues until around day 16 when low 
nutrient availability and high nematode density signals IJ development, which are then 
colonized with X. nematophila. Once IJs are re-colonized, they leave the cadaver to find a 
new host to infect.32   
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This model of parasite-host interactions between X. nematophila, S. carpocapsae, 
and G. mellonella can be used to study both mutualistic and pathogenic processes.33 G. 
mellonella is a pest that lives in beehives and feeds off wax and pollen causing 
destruction of the hive and causing bee and wasp galleriosis.34 A better understanding of 
X. nematophila-S. carpocapsae-G. mellonella interactions could lead to a safe and precise 
control of G. mellonella population through the improvement of bioinsecticides.34 An 
insect model is often easier and cheaper to work with when studying pathogenesis as well 
as more ethically acceptable. An insect model can be used to better understand virulence 
factors before studying mammalian organisms. G. mellonella is commonly chosen as a 
model organism due to large larvae being easy to work with. A disadvantage to using G. 
mellonella is its genome is not fully sequenced and there are currently no methods to 
create mutant strains.34  
Materials and Methods 
G. mellonella Samples 
G. mellonella samples infected with entomopathogenic nematodes were collected 
from the Goodrich-Blair lab at the University of Tennessee, Knoxville. Samples were 
collected at 1 hour, 12 hours, 24 hours, 2 days, 4 days, 6 days, 8 days, 10 days, 12 days, 
and 16 days after infection. The 24-hour time point was split into two time points, 24 
hours alive and 24 hours dead groups, to analyze differences between specimens that had 
succumb to infection and those that had not. There were 5 biological replicates of each 
time point and 5 uninfected G. mellonella samples were used as the control.  
Metabolomics Extraction  
Extraction procedures were adapted from Rabinowitz et al.35 At 4°C, infected G. 
mellonella larvae were homogenized in 1.3 mL of extraction solvent made of HPLC 
grade 40/40/20 methanol, acetonitrile, and water with 0.1% formic acid. After 
homogenization, samples were placed on a vortex for 5 seconds before being placed in -
20°C for 20 minutes. Samples were then centrifuged for 5 minutes to pack the sample 
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into a pellet. Supernatant was extracted into labeled Eppendorf tubes. An additional 0.2 
mL of extraction solvent was added to the pellet for a second extraction in which samples 
were vortexed, placed in -20°C for 20 minutes, centrifuged, and supernatant was 
extracted. The supernatant was dried with a Thermo Fisher Savant ISS110 SpeedVac 
Concentrator and under nitrogen gas. Dried samples were suspended in 300 µL of Milli-
Q water and placed in autosampler vials for analysis.35  
UPLC-HRMS 
After extraction, samples were immediately analyzed in negative mode by UPLC-
HRMS using a Thermo Fisher Exactive Plus Orbitrap Mass Spectrometer equipped with 
an UltiMate 3000 liquid chromatogram controlled by XcaliburTM. After cleaning and 
calibrating the instrument, samples were placed in the 4°C autosampler tray. An injection 
volume of 10µL of sample was separated on a 2.5-micron Synergi Hydro-RP 100, 
100mm x 2 mm column (Phenomenex, Torrance, CA, USA) at 25°C with a constant flow 
rate of 200µL/minute. An acidic gradient was used with Solvent A consisting of 97:3 
HPLC grade water:methanol with 15mM acetic acid and 10mM tributylamine used as an 
ion pairing agent. Solvent B was HPLC grade methanol. The gradient began at 0% B at 0 
minutes and increased to 20% B at 5 minutes, 55% B at 13 minutes, and 95% B at 15.5 
minutes. The percent methanol was decreased to 0% B from 15.5 minutes to 19 minutes 
and held at 0% B from 19 minutes to 25 minutes.  Samples were analyzed with a scan 
window of 85 to 800 m/z from 0 to 9 min and 110 to 1000 m/z from 9 to 25 min and with 
a resolution of 140,000.  
Known Metabolites Processing 
Once samples were analyzed, RAW data files from the mass spectrometer were 
converted into MZML files using MSConvert. MZML files were opened with MAVEN19 
and peaks were aligned and picked from the negative mode known compounds list 
containing approximately 260 metabolites. Metabolites were matched based on exact 
mass and retention time. The area of the peak represents the intensity of metabolites in 
the sample. Once all observable peaks were found, the data was exported to begin 
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processing in Microsoft Excel. Peak areas were normalized based on the amount of 
sample by taking the intensity and dividing it by the mass of each sample. Once samples 
were grouped by their respective time points, the average, standard error, and standard 
deviation of each group was determined. Fold changes were determined by dividing the 
average of each group by the average of the control group. P values were determined 
using a student’s t-test and comparing each group to the control group. PLS-DA plots and 
heat maps were made to display the data using RStudio.  
Unknown Metabolites Processing 
 Unprocessed MZML files were opened with MAVEN and analyzed for unknown 
spectral features at 10 ppm. The data was exported to an excel file then normalized, 
grouped, and averaged based on previously described methods. Due to the large number 
of spectral features detected, the list had to be reduced in order to process. In order to 
remain, at least 4 of the 12 groups had to have an average intensity over 105. Next, the 
unknowns were reduced according to their p-value, which was determined by a student’s 
t-test. In order to remain, at least one group had to have a p-value less than 0.005. 
Usually, a p value of less than 0.1 can be considered significant but due to the large 
number of unknowns a stricter p value was used.  
 The Goodrich-Blair lab provided a list of metabolites they were interested in 
determining their presence in the unknown spectral features. Using MAVEN, chemical 
formulas were searched and all observable peaks for that metabolite were picked. If 
multiple peaks were found at varying retention times, then all peaks were picked. The 
data was exported and processed using the same methods as described above. PLS-DA 
plots were made in R studio and an unknown heatmap was made with was made using 
Cluster 3.0 and Java TreeView 3.0. 
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Results and Discussion 
Known Metabolites 
A total of 111 known metabolites were detected throughout the infection model 
(Appendix, Tables 18-30). Table 1 displays the total number of known and unknown 
spectral features detected. When compared to the uninfected group, the number of 
statically varying metabolites increased as infection progressed reaching a peak of 63 
statistically significant metabolites at 4 days after infection then decreasing to 38 
statistically significant metabolites by day 16. The exact number of statistically 
significant metabolites for each time point is displayed in Figure 3. A p value below 0.1 
was considered statistically significant. While there were no statistically significant 
metabolites at 1-hour post infection, 4 metabolites were significant at 12 hours after 
infection. These metabolites were guanine, uric acid, homocysteic acid, and glycinamide 
ribonucleotide (GAR). Four nematode samples were also compared to the uninfected 
group and resulted in 86 out of 111 metabolites being statistically significant. 
Too many time points were present to include all time points on one PLS-DA plot 
so time points were grouped into early, middle, and late infection groups. PLS-DA plots 
for each infection group are shown in Figure 4. The early infection group contains 
samples from 1-hour post infection through 24 hours dead (Figure 4-A). The middle 
infection group contains samples from 2 days after infection through 8 days after 
infection (Figure 4-B). The late infection group contains samples from 10 days after 
infection through 16 days after infection (Figure 4-C). As these three PLS-DA plots 
 
Table 1. G. mellonella detected features. 
Result Number of Features 
Knowns detected 111 
Unknowns detected 54259 
Intensity over 105 25335 






Figure 3. Number of Statistically significant metabolites. 
 
show, separation between the time points increases as the length of infection increases. 
Although these plots do not display the z-axis, the uninfected groups were separated 
along the z-axis from the other time points in both the middle and late groups when 
plotted in 3-D PLS-DA plots (not shown).  
Top VIP scores from each PLS-DA plot were determined and are displayed in 
Figure 5. In the early infection groups, 25 metabolites had a significant VIP score in both 
components. In the middle infection groups, 35 metabolites had a significant VIP score in 
both components. In the late infection groups, 38 metabolites had a significant VIP score 
in both components. An increase in the number of top VIP scores indicates more 
metabolites are differentiated by class as infection progresses.  
There were 5 metabolites that had a VIP score above 1 in both components in all 
three PLS-DA plots (Table 2). All 5 metabolites listed in Table 1 have significant p 
values at multiple time points throughout infection with most significance being in the 
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Figure 4. PLSDA plots of known metabolites in G. mellonella infected with 
entomopathogenic nematodes from early infection (A) to middle infection (B) and 


















































Table 2. Metabolites with VIP scores above 1 in both components of all groups.  
Metabolite 
Early Middle Late 
Comp 1 Comp 2 Comp 1 Comp 2 Comp 1 Comp 2 
Phenyllactic acid 1.6505 1.3167 1.5087 1.1783 1.2511 1.1197 
Phosphoenolpyruvate 1.1607 1.2045 1.5359 1.3461 1.2550 1.1412 
Uracil 1.3847 1.0642 1.7937 1.5348 1.3799 1.1626 
Uridine 2.2981 1.8439 1.3648 1.0639 1.0231 1.0409 
Xylitol 2.3974 1.8718 1.3825 1.0741 1.1903 1.2219 
 
 
found in the appendix in Tables 11-13. All of these metabolites in Table 1 except uracil 
also have a significant p value when compared to the nematode group. Uridine shows the 
most significant intensity changes with significant p values observed in 8 of 12 time 
points and in the nematodes. When all time points were analyzed, all 5 metabolites show 
significance at day 6 after infection. At or around day 6 of infection, IJs have developed 
into adult stages and should be reproducing. According to KEGG database (Kyoto 
Encyclopedia of Genes and Genomes), uracil and uridine are both involved in pyrimidine 
metabolism. Xylitol is involved in pentose and glucuronate interconversions. Phenyllactic 
acid and Phosphoenolpyruvate are both involved in phenylalanine, tyrosine, and 
tryptophan biosynthesis. All these pathways can be linked together through glycolysis 
and the pentose phosphate pathway.36–38  
Fold changes were calculated to determine the change in intensity from each 
infected group compared to the uninfected group. Figure 6 is a heatmap displaying the 
fold changes and p values of all known metabolites detected for each group compared to 
the control group (Appendix, Tables 8-10). Fold changes in this heatmap are based on a 
log2 scale of 5. The bright orange color represents the intensity is 32 times higher in the 
infected group compared to the uninfected group while the bright blue color means the 
intensity is 1/32 or 0.03125 times the intensity of the uninfected group. As infection 
progresses fold changes between the treatment groups and the uninfected group increase 
in either the positive or negative direction. The metabolites with increasing relative 
concentrations indicate more production as infection progresses. Since the insect itself 




Figure 6. Heatmap displaying fold changes and p values of G. mellonella infected 






carpocapsae, X. nematophila, or both. Metabolites with decreasing relative 
concentrations indicate reduced production.     
Visual inspection of average intestines across all groups revealed a subset of 
metabolites that were present in the infective juveniles but not present in the early 
infection groups of G. mellonella and other metabolites that were present in the early  
infection groups but not present in IJs. Folate and S-ribosyl-L-homocysteine were 
detected in the IJs but not in the uninfected, 1 hour, or 12 hour post infection groups. For 
both of these metabolites, the average intensity increases as infection increases with the 
highest average intensity at day 16 after infection. Glycinamide ribonucleotide (GAR), 5-
Aminoimidazole-4-carboxamide ribonucleotide (AICAR), and Xanthosine 5-phosphate 
(XMP) were found in uninfected, 1 hour, and 12 hour groups but not in the IJs. The 
average intensity of AICAR decreases over time while the average intensity of XMP 
increases over time. According to the KEGG database, GAR, AICAR, and XMP are all 
involved in purine metabolism and the biosynthesis of secondary metabolites or 
metabolites that are not directly involved in normal growth, development, and 
reproduction.3,36–38   
Unknown Metabolites 
 During the untargeted, unknown metabolomics analysis over 54,000 spectral 
features were detected. This many spectral features cannot be processed so the number of 
spectral features was reduced by average intensity and p values as described in the 
methods section. Once reduced, a manageable number of just over 2,000 spectral features 
were analyzed.  
PLS-DA plots are depicted for early, middle, and late groups in Figure 7. 
Although the early and middle infection groups do not show clear separation, the late 
groups are clearly separated. In the middle and late infection groups, the uninfected time 
point is separated in the z-direction that is not shown in a 2-D plot. Table 2 shows the 
total number of spectral features included in the PLS-DA plots and the number of spectral 
features with a VIP score over 1. In the early groups a total of 190 metabolites had VIP 




Figure 7. PLS-DA plots of unknown G. mellonella spectral features of early (A), 














 Table 3. Unknown spectral features of G. mellonella groups and number of VIP 
scores above 1. 
Group Number of 
Spectral Features 
Top VIP scores in 
Component 1  
Top VIP scores in 
Component 2 
Early 1600 623 468 
Middle  2049 1082 870 
Late 2196 1161 854 
 
 
metabolites with VIP scores above 1 in both components. An increase in the number of 
metabolites with a significant VIP score indicates more metabolic differences by class as 
infection progresses.  
A heatmap of the reduced unknown spectral features was made without p values 
because of the large number of unknown spectral features (Figure 8). Most of the 
heatmap is blue representing a decrease in fold change from the infected time point to the 
uninfected group. This occurrence is due to the reduction of spectral features by 
significant p values compared to the uninfected group. Unknown spectral features 
displayed in the heatmap were searched through both HMDB and METLIN with 
inconclusive results. Most spectral features did not return any matches or returned 
multiple matches per spectral feature.  
After initial analysis of the unknown data, the Goodrich-Blair lab provided two 
lists of metabolites they were interest in studying in more detail. The first list was related 
to virulence of the insect and the second list was related to nicotinate and nicotinamide 
metabolism. Using MAVEN, the chemical formula of each metabolite was matched to a 
m/z value in the unknown spectral features. After normalization, separate heatmaps were 
made of the metabolites detected (Figures 9 and 10). Several chemical formulas were 
found to have multiple peaks at varying retention times so all observable peaks were 
chosen to analyze. Although these chemical formulas of these spectral features matched 














Figure 10. Heatmap of possible metabolites involved in nicotinate and nicotinamide 
metabolism matched by chemical formula. 
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confirmed without additional experiments in which high purity standards for each 
compound in the pathway are purchased or synthesized and analyzed using the same 
conditions as the samples to compare exact mass and retention time.  
The metabolites related to virulence have increasing concentrations when 
compared to the uninfected as time progresses. Many metabolites in this heatmap show 
an increase in fold change at 12 hours after infection then a decrease in fold change at 24 
hours alive. At 24 hours after infection, about half the G. mellonella samples had 
succumb to infection with all being deceased by 48 hours after infection. This change in 
intensities can also be seen in many of the known metabolites, which caused 
collaborators to develop an interest in the early infection time points for future studies.    
The nicotinate and nicotinamide metabolism pathway includes known metabolites 
detected such as nicotinate, quinolinate, NAD+, NADP+, and NADH. Figure 10 shows 
unknown spectral features matched by chemical formula to a metabolite within this 
pathway. More than one peak was observed for several metabolites at both M-H and M-
2H. Most metabolites show statistically significant fold changes in the middle and late 
infection groups as well as in the nematode samples, which correlates with the results 
from the known analysis.   
Conclusion 
Metabolite differences were detected between uninfected G. mellonella samples 
and samples infected with entomopathogenic S. carpocapsae nematodes. As time of 
infection and nematode development progressed, significant metabolites were revealed 
with most significant changes occurring between day 4 and day 10 after infection. 
Phenyllactic acid, phosphoenolpyruvate, uracil, uridine, and xylitol were determined to 
be among the most significant metabolites within this biological system. Unknown 
analysis resulted in a large number of spectral features that had to be reduced in order to 
align with current processing methods. This reduction, based on statistical significance 
and average intensity of infected time points compared to the uninfected group, could be 
causing important spectral features related to the IJs being removed leading to an 
incomplete model. Metabolites search by chemical formula relating to virulence and 
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nicotinate and nicotinamide metabolism were detected but cannot be confirmed without 
further experiments. Based on current results from this experiment, future experiments 
could focus on metabolite changes from beginning of infection until the insect host dies 
and confirming the presence of metabolites related to virulence and the nicotinate and 






UNTARGETED METABOLOMICS OF XENORHABDUS 






Whole cell samples and supernatant samples of two strains of Xenorhabdus 
nematophila were analyzed by UPLC-HRMS using an untargeted metabolomics 
approach. In both strains the nil locus had been deleted but was complemented in the 
control strain. A total of 85 known metabolites were detected in the whole cell samples 
and 67 known metabolites were detected in the supernatant samples. Of the metabolites 
not detected in the supernatant samples, most had higher intensities in the control strain. 
Results of this metabolomics experiments was compared to the infection model of the 
previous chapter. A total of 7465 unknown spectral features were detected in the whole 
cell samples and 6181 unknown features were detected in the supernatant samples. 
Unknown spectral features were reduced by p value then exact masses were searched 
through online databases for potential matches.   
Introduction 
Xenorhabdus nematophila are gram-negative, gammaproteobacteria that have 
mutualistic relationship with Steinernema carpocapsae nematodes. Together, they work 
to infect and kill a host becoming a pathogen of a large variety of insects.33,39 S. 
carpocapsae nematodes carry between 50-200 colony-forming units of X. nematophila in 
a region known as the receptacle.39,40 The non-feeding, soil-dwelling IJs can survive for 
long periods of time without an insect host. Once a suitable host is found, the nematode 
enters the host through natural openings, sheds the outer cuticle, and migrates to the 
blood cavity. The ingestion of blood from the insect triggers the release of X. 
nematophila. X. nematophila multiply within the blood of the insect and work to produce 
compounds that suppress insect immunity leading to death of the insect along with 
producing compounds that protect the cadaver from other infections and ant scavengers. 
Hundreds of thousands of eggs can undergo development into the IJ stage within one 
insect cadaver. X. nematophila colonize the newly developed IJ’s before they emerge 
from the cadaver to complete the cycle.39 
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 X. nematophila is thought to convert cadaver biomass into substrates that support 
nematode development. While both X. nematophila and S. carpocapsae both benefit from 
this mutualistic relationship, studies have shown that colonized IJs do not live as long as 
un-colonized IJs.39 The basis of this colonization is believed to stem from the nematode 
intestine localization (nil) locus consisting of nilA, nilB, and nilC, located at symbiosis 
region 1 (SR1).30,40 nilA is an inner membrane protein consisting of 90 amino acids while 
nilB and nilC are outer membrane proteins consisting of 466 and 282 amino acids, 
respectively.40 The location of nilB as a surface exposed beta barrel protein is thought to 
be responsible for colonization due to its interaction with the receptacle surface within 
the nematode.40,41  
Studies have shown that mutant strains lacking SR1 completely are not able to 
colonize a nematode host.41 Certain mutations in nilA lead to colonization of 
approximately 2.5% of the wild type level but nilB and nilC mutants are not able to 
colonize over the detection limit.40 X. nematophila are known to specifically colonize S. 
carpocapsae nematodes in nature.33 Interestingly, of all Xenorhabdus species, only X. 
nematophila have the nil locus but when nil loci were incorporated into the chromosomes 
of other Xenorhabdus bacteria, they were able to colonize S. carpocapsae.42  
Materials and Methods 
X. Nematophila Samples 
X. nematophila samples were supplied by the Goodrich-Blair lab from the 
University of Tennessee, Knoxville. Samples consisted of three biological replicates of 
two X. nematophila strains and three biological replicates of supernatant samples from 
the two strains. The strain considered the wild type or the control strain (1496) had the nil 
locus deleted but was complemented with SR1 in the Tn7 site. The mutant strain (1465) 
had the nil locus deleted but was not complemented with SR1. Cells were grown in 




Samples were extracted using the same procedures detailed in Chapter 1. After 
extraction, samples were dried under nitrogen gas before being suspended in 300µL of 
Milli-Q water. Samples were analyzed using UPLC-HRMS using the same mass 
spectrometer, protocols, and specifications as described in Chapter 1. For known 
metabolite analysis, RAW files were converted to MZML files using MS Convert before 
being loaded onto MAVEN to match peaks according to retention time and exact mass 
with metabolites from the known compound list.  
For unknown analysis, RAW data files were uploaded to XCMS Online (Scripps 
Research Institute) for analysis. Dataset 1 was the control strain and dataset 2 was the 
1495 strain. A pairwise job was chosen to compare the two whole cell strains. 
UPLC/Orbitrap parameters were used altering only the polarity to negative mode. 
Isotopes and adducts were removed from the unknown spectral features and punitive 
identities of remaining spectral features were given from the METLIN database. 
Unknown spectral features for the supernatant samples were then processed using the 
same procedures.  
Results and Discussion 
Known Metabolomics 
A total of 85 known metabolites and 7465 unknown spectral features were 
detected in the whole cell samples (Appendix, Table 31). A total of 67 known metabolites 
and 6181 unknown spectral features were detected in the supernatant samples (Appendix, 
Table 32). Table 4 displays the total number of known and unknown metabolites detected 
in each sample set along with significant p values and VIP scores. Of the unknown 
spectral features detected, annotations were possible in 11.4% of whole cell unknown 
spectral features and 13.1% of supernatant unknown spectral features. Annotations were 
confirmed in 1.6% of whole cell unknown spectral features and 2.2% of supernatant 




Table 4. Knowns and unknowns detected in X. nematophila samples. 
 Whole Cell Supernatant 
Knowns detected 85 67 
Knowns with significant p value 21 11 
 Knowns with significant VIP score 34 26 
Unknowns detected 7465 6181 
Unknowns with significant p value 743 908 
Unknowns with significant VIP score 2962 2617 
Percent of unknowns annotated 11.4% 13.1% 
Percent of confirmed unknown annotations 1.6% 2.2% 
  
 
All 67 metabolites from the supernatant samples were detected in the whole cell 
samples. Table 5 displays a list of metabolites that were detected in the whole cell 
samples but not in the supernatant samples. Of these metabolites listed, all but 
Xanthosine, NAD+, and sedoheptulose bisphosphate have a higher intensity in the 
control group compared to the 1495 strain. NAD+ is used in the nicotinate and 
nicotinamide pathway, which was studied in the infection model. Xanthosine was also 
detected in the infection model and is involved in purine metabolism. Although 
Xanthosine was not determined to be significant in the infection model, XMP, a 
precursor for Xanthosine, was significant.   
Of the metabolites with higher intensities in the control samples, many belong to 
the same pathways. Alpha-ketoglutarate and UDP-glucuronate are involved in pentose 
and glucuronate interconversions.  UDP-N-acetylglucosamine and glucosamine 
phosphate are involved in amino sugar and nucleotide sugar metabolism. Guanine, 
adenosine, AMP/dGMP, and GAR are involved in purine metabolism. Fumarate and 
FMN are involved in oxidative phosphorylation. Xylitol 5-phosphate is only involved in 
one reaction in which ATP reacts with Xylitol to form ADP and Xylitol 5-phosphate. 
CMP is involved in pyrimidine metabolism.36–38 
PLS-DA plots shown in Figure 11 show clear separation between two strains in 
both whole cell and supernatant samples. In the whole cell samples, 34 metabolites had a 
VIP score above 1 in both components with 39 in component 1 and 46 in component 2  
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Figure 11. PLS-DA plots of known metabolites in X. nematophila whole cell (A) and 








(Appendix, Table 16). In the supernatant samples, 26 metabolites had a VIP score above 
1 in both components with 29 in component 1 and 35 in component 2 (Appendix, Table 
17). A complete list of these metabolites with significant VIP scores can be found in the 
appendix in Tables 14 and 15. Of the metabolites with VIP scores above 1 in both 
components, 9 metabolites were detected in both the whole cell and the supernatant 
samples. These metabolites are adenosine, citrate/isocitrate, deoxyribose phosphate, 
guanosine, phenylalanine, tryptophan, tyrosine, UDP-glucuronate, and uracil.  
A heatmap of fold changes with significant p values is displayed in Figure 12 on a 
log2 scale of 3 (Appendix, Tables 14-15). Of the 21 metabolites in the whole cell samples 
with significant p values, 12 metabolites also had a significant VIP score. These 
metabolites are sedoheptulose 1/7-phosphate, UMP, guanosine, 6-phospho-D-gluconate, 
CMP, citrate/isocitrate, methionine, valine, D-gluconate, lipoate, uridine, 
acetylphosphate. Of the 11 metabolites with a significant p value in the supernatant 
samples, 5 metabolites also had a significant VIP score. These metabolites are uracil, 
alanine/sarcosine, thymine, 2-dehydro-D-gluconate, and pyruvate. 
When significant metabolites from this experiment were compared to the 
significant metabolites from infection model experiment in Chapter 1, several metabolites 
were determined to be significant in both experiments. Uridine had a significant p value 
in all time points in the infection model except 1 hour, 12 hours, and 8 days as well as a 
significant VIP score in all PLS-DA plots. Uridine also had a significant p value and VIP 
score in the whole cells samples in experiment 2. Uridine is in the pyrimidine metabolism 
pathway and is involved in converting uracil to UMP and vice versa.36–38 Another 
pyrimidine metabolism pathway metabolite, uracil, had a significant p values and VIP 
scores in the infection model and was also detected and significant in the supernatant 
samples. Uridine and uracil both had a higher relative intensity in the control strain and 
increased in relative intensity as infection progressed in the infection model. Other 
metabolites from the pyrimidine pathway detected in the whole cell samples such as 
malate, thymine, dTDP, orortate, and UDP-glucose follow the same trend as having a 




Figure 12. Heatmap of X. nematophila mutant strain compared to the control strain 
in whole cell and supernatant samples. 
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a lower relative intensity in the mutant strain, this is an indication that the deletion of the 
nil loci without complementing for the deletion affects the pyrimidine pathway. To 
confirm this hypothesis, a targeted metabolomics experiment should be performed to 
determine concentration changes of all the metabolites involved in the pyrimidine 
pathway.   
  Another pathway of interest determined to be meaningful in both experiments is 
the purine metabolism pathway. Xanthosine and XMP were both detected in G. 
mellonella but only XMP was detected in the whole cell samples. Other metabolites 
within this pathway that were also down regulated in the mutant strain are adenosine, 
AICAR, allantoin, AIR, GAR, IMP, and inosine. When compared to the infection model, 
adenosine, AIR, and inosine were not detected. XMP, Xanthosine, allantoin, and GAR all 
increased in relative concentration as infection progressed with AICAR and IMP 
decreasing. AICAR is also influenced by histidine metabolism and IMP is directly related 
to AICAR through FAICAR, which could explain the difference in intensity compared to 
other metabolites in the pathway.   
Unknown Metabolomics 
 After processing from XCMS Online, the X. nematophila whole cell samples had 
a total of 7465 unknown spectral features with 743 having a p value of less than 0.1 and 
the supernatant samples had a total of 6181 unknown spectral features with 908 having a 
significant p value. After making PLS-DA plots of all spectral features, whole cell 
samples had 2962 spectral features with a VIP score above 1 in both components. 
Supernatant had 2617 spectral features with a VIP score above 1 in both components. 
None of the spectral features in the whole cell samples or supernatant samples had a 
significant p value and a significant VIP score indicating the model produced from the 
unknown spectral features is being heavily influenced by insignificant metabolites and is 
not an accurate model of metabolic changes.  
 To specifically analyze significant metabolites, the list of unknown spectral 
features was reduced to only spectral features with a significant p value. A second set of  
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PLS-DA plots were made for whole cell and supernatant samples (Figure 13). The whole 
cell samples had 306 metabolites with significant VIP score in both components (332 in 
component 1 and 339 in component 2). In supernatant samples, 404 metabolites had a 
significant VIP score above 1 in both components (421 in component 1 and 432 in 
component 2). With so many metabolites having a high VIP score, this model is more 
indicative of significant metabolites within the biological system. 
 Unknown spectral features with a significant p value and VIP score above 1 were 
then analyzed using HMDB to determine any punitive matches. While most matches 
resulted in numerous identities, 35 metabolites were identified in whole cell samples and 
53 identified in supernatant samples. These matches from HMBD were also compared to 
the METLIN database for cross-validation with 9 confirmed in supernatant and 4 
confirmed in whole cell. The m/z, compound identities, and chemical formulas of 
validated metabolites are shown in Tables 6 and 7. 
Of the 4 metabolites in the whole cell samples identified by database matches, 
dCMP (deoxycytidine monophosphate) is the only metabolite identified that is likely to 
be present in the sample and is involved in pyrimidine metabolism. All other possible 
matches are extremely unlikely to be found in this biological system. Neoacrimarine G is 
an alkaloid found in citrus, chloropentafluoroethane is a chlorofluorocarbon once used as 
a refrigerant but has been banned by the Montreal Protocol since January 1, 1996, and 
(2r)-2-hydroxy-2-(4-hydroxyphenyl)ethyl glucosinolate is found in mustard family 
plants.  
 
Table 6. Confirmed annotations for X. nematophila whole cell samples. 
m/z Compound Identity Chemical formula 
514.1533705 Neoacrimarine G C29H25NO8 
134.9433168 Chloropentafluoroethane C2ClF5 
436.0340522 (2r)-2-hydroxy-2-(4-hydroxyphenyl)ethyl glucosinolate C15H21NO11S2 






Figure 13. PLS-DA plots of X. nematophila unknown spectral features for whole cell 
(A) and supernatant (B) samples. 






Table 7. Confirmed annotations for X. nematophila supernatant samples. 
m/z Compound Identity Chemical formula 
313.0442653 5'-phosphoribosyl-n-formylglycinamide (FGAR) C8H15N2O9P 
403.5555379 Acetyl-CoA C23H38N7O17P3S 
311.1979392 Oseltamivir C16H28N2O4 
366.2286597 Buspirone C21H31N5O2 
141.016891 Naphthalene-2-thiol C10H8S 
201.0255251 5-hydroxy-2-oxo-4-ureido-2,5-dihydro-1h-imidazole-5-carboxylate C5H6N4O5 
523.3749211 3beta-acetoxy-11alpha-methoxy-12-ursen-28-oic acid C34H54O5 
172.8989722 Bis(methylthio) selenide C2H6S2Se 
255.179631 Lysyl-lysine C12H26N4O3 
 
 
Metabolites identified by both databases in the supernatant samples show 6 
metabolites that are likely to be present in the samples. FGAR is involved in 
aminoimidazole ribonucleotide biosynthesis and purine metabolism. Acetyl-CoA 
participates in biosynthesis of fatty acids and sterol as well as the oxidation of fatty acids 
and metabolism of many amino acids. Naphthalene-2-thiol is found in cell membranes, 5-
hydroxy-2-oxo-4-ureido-2,5-dihydro-1h-imidazole-5-carboxylate exists in all living 
organisms, and 3beta-acetoxy-11alpha-methoxy-12-ursen-28-oic acid is found in cellular 
membranes and extracellular space. Lysyl-lysine is a dipeptide of two lysine residues 
resulting from the incomplete breakdown of protein digestion. Other metabolites matched 
by exact mass are unlikely to be present in the supernatant samples. Oseltamivir and 
Buspirone are both drugs that are only found when those drugs have been taken and 
Bis(methylthio) selenide is found in onion-family vegetables.  
Out of the 711 unknown spectral features searched for, only 88 returned unique 
matches using HMDB. After validating with METLIN database, 13 m/z values had 
unique metabolite matches by both databases. Disregarding matches that do not 
reasonably apply to the biological system leaves less than 1% of significant unknown 
metabolites annotated by databases matches. This low annotation rate reveals one 
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disadvantage to unknown metabolomics analysis. Annotating unknown spectral features 
is extremely important to get a thorough representation of phenotype since known 
chemical libraries are generally small compared to the amount of detected spectral 
features. Building a large known metabolite library is not practical so better annotation 
tools for easily and accurately identifying unknown spectral features would be beneficial 
for unknown analysis.   
Conclusion 
Deletion of the nil locus of X. nematophila causes many metabolite differences in 
both whole cell and supernatant. When compared to the control strain, deletion of nil loci 
without complementing for the deletion caused a higher intensity in 21% of metabolites 
detected in the whole cell samples and about 42% of metabolites detected in the 
supernatant samples. Unfortunately, proteomics analysis revealed cell lyses within the 
supernatant that could lead to flawed conclusions. The 18 metabolites not detected in the 
supernatant is likely underrepresented with far fewer metabolites in supernatant that does 
not contain cell lyses. Many unknown spectral features had both significant p values and 






 In conclusion, using UPLC-HRMS to study metabolomics of mutualistic and 
pathogenic relations can offer great insight into the functions of a biological system. A 
detailed understanding of the relationships between G. mellonella, S. carpocapsae, and X. 
nematophila can lead to the development of bio insecticides to control insect populations. 
The purpose of an untargeted metabolomics approach is to detect as many spectral 
features as possible and develop new hypotheses for future studies. By studying both the 
complete biological system of G. mellonella, S. carpocapsae, and X. nematophila, then 
studying X. nematophila mutants in detail, we have been able to determine specific 
metabolic pathways that relate the two experiments. 
 The infection model consisted of G. mellonella infected with entomopathogenic 
nematodes carrying X. nematophila bacteria. By comparing statistical significance with 
significant VIP scores, several key metabolites were detected throughout the infection 
model. The metabolites belonged are involved in pyrimidine metabolism, pentose and 
glucuronate interconversions, and phenylalanine/tyrosine/tryptophan biosynthesis. Three 
metabolites were also detected within the infection model but was not detected in the IJs, 
which are involved in purine metabolism.  Unknown analysis revealed many significant 
spectral features, but annotation was unsuccessful.  
 Several metabolic differences were detected between control and mutant strains of 
X. nematophila. In both strains the nil locus was deleted but this deletion was 
complemented for in the control strain. Whole cell samples and supernatant samples for 
both strains were analyzed. 18 more metabolites were detected in the whole cell samples 
that were not detected in the supernatant samples. Fold changes for metabolites detected 
in X. nematophila within pyrimidine and purine metabolism pathways had lower 
intensities in the mutant strain compared to the control strain. Of the significant unknown 
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Table 8. Fold changes and p values of early groups compared to uninfected group.  
 Fold Changes compared to uninfected P values compared to uninfected 
Metabolites 1 Hour 12 Hours 
24 Hours  
Alive 
24 Hours  
Dead 1 Hour 12 Hours 




Glycine 0.000 2.075 0.001 2.316 0.3735 0.5325 0.3737 0.5105 
Pyruvate 1.122 1.312 4.731 1.337 0.6689 0.3088 0.0447 0.5123 
Alanine/Sarcosine 0.741 0.864 1.799 2.339 0.3298 0.7670 0.3037 0.0069 
Lactate 0.774 1.228 7.479 24.826 0.3579 0.6129 0.3572 0.0001 
Dimethylglycine 0.908 1.213 1.882 2.632 0.6671 0.4067 0.1122 0.0220 
Serine 1.843 2.365 2.282 2.030 0.2104 0.1270 0.3016 0.0116 
Histamine 1.156 1.035 1.371 1.012 0.5220 0.8693 0.2894 0.9502 
Uracil 0.666 0.821 1.458 2.128 0.3576 0.6450 0.3103 0.2059 
Proline 1.157 1.393 1.575 1.136 0.6479 0.1996 0.2998 0.6958 
Fumarate 1.117 1.309 1.659 1.354 0.7158 0.5408 0.3889 0.3693 
2-Oxoisovalerate 0.823 0.893 1.767 0.869 0.4866 0.6347 0.1796 0.6347 
Indole 1.309 0.988 1.278 1.047 0.4799 0.9747 0.5132 0.9079 
Valine 1.001 1.281 1.912 1.378 0.9962 0.2597 0.1161 0.1907 
3-Hydroxyisovaleric 
acid 0.555 0.604 1.438 1.964 0.2285 0.2779 0.4083 0.4767 
Homoserine/Threonine 1.231 0.678 1.643 1.233 0.7524 0.4240 0.2951 0.6555 
3-Methylthiopropionate 0.442 0.722 1.424 0.925 0.3891 0.7332 0.4944 0.9222 
Cysteine 0.895 0.641 0.045 1.357 0.7842 0.2826 0.0285 0.5712 
Nicotinate 0.768 1.223 3.031 2.561 0.4054 0.5126 0.0266 0.0006 
Taurine 1.817 0.982 1.826 0.780 0.2369 0.9751 0.3896 0.6544 
Thymine 0.711 0.723 1.001 0.759 0.1459 0.3477 0.9946 0.2711 
Hydroxyproline 1.253 1.256 1.364 3.181 0.3878 0.4970 0.1613 0.3944 
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Fold Changes compared to uninfected P values compared to uninfected 









N-Acetyl-beta-alanine 1.101 1.030 1.593 3.114 0.7691 0.9149 0.1402 0.0027 
Leucine/Isoleucine 1.039 1.384 2.230 1.345 0.9002 0.2447 0.0744 0.3477 
Glutaric acid 1.411 0.871 1.891 1.219 0.4756 0.6700 0.3998 0.6956 
Asparagine 1.446 0.919 0.513 1.182 0.6018 0.7396 0.2423 0.6785 
Hydroxyisocaproic acid 0.558 0.938 2.932 6.639 0.3311 0.8995 0.2443 0.2579 
Ornithine 0.899 0.755 1.090 0.998 0.7437 0.3600 0.7750 0.9958 
Salicylate 0.890 0.989 1.078 1.095 0.6917 0.9654 0.7948 0.8058 
Hydroxybenzoate 1.476 0.635 1.450 0.776 0.3666 0.2044 0.4440 0.4306 
Histidinol 1.541 1.029 1.407 1.015 0.2724 0.8945 0.1011 0.9646 
2-Oxoglutaric acid 2.040 1.602 5.479 0.581 0.2414 0.1493 0.3054 0.2993 
Glutamine 0.976 0.931 1.392 0.937 0.9377 0.7993 0.2039 0.8221 
2-hydroxyglutarate 1.245 4.345 13.648 49.553 0.6140 0.2105 0.2060 0.0167 
2-Hydroxy-2-
methylsuccinate 1.245 4.352 13.612 49.591 0.6154 0.2106 0.2061 0.0169 
L-Methionine 0.952 1.120 3.145 1.265 0.8860 0.7107 0.0895 0.3634 
Guanine 1.068 0.322 0.280 0.560 0.8807 0.0731 0.0619 0.2562 
3-Methylphenylacetic acid 0.842 0.896 1.177 1.371 0.7410 0.8674 0.6492 0.6399 
Hydroxyphenylacetate 0.701 0.835 0.712 1.263 0.1702 0.4725 0.1978 0.2971 
Xylitol 0.735 1.148 2.904 8.280 0.2381 0.5052 0.1609 0.0000 
Dopamine 1.292 1.696 0.872 1.416 0.5824 0.2083 0.8113 0.5249 
2_3-Dihydroxybenzoate 0.844 0.650 1.451 3.356 0.7261 0.4275 0.4816 0.0833 
Histidine 1.043 0.988 1.370 1.038 0.8439 0.9496 0.2799 0.8401 




Table 8. Continued. 
Metabolites 
Fold Changes compared to uninfected P values compared to uninfected 









Dihydroorotate 1.245 2.157 4.168 2.825 0.6896 0.3756 0.0455 0.3847 
Allantoin 1.000 1.045 2.254 3.971 0.9999 0.9396 0.4618 0.2413 
Indole-3-carboxylate 1.572 0.872 2.102 1.139 0.4662 0.7296 0.1262 0.7446 
Phenylpyruvate 0.875 1.638 7.916 1.093 0.7044 0.3614 0.1513 0.8264 
Phenylalanine 0.828 0.799 1.555 0.776 0.6954 0.6523 0.3501 0.6243 
Phenyllactic acid 0.622 0.600 2.621 3.038 0.4595 0.4175 0.0770 0.1726 
Quinolinate 3.606 2.735 0.641 5.119 0.4575 0.5198 0.5279 0.1249 
Phosphoenolpyruvate 1.284 0.981 3.965 2.069 0.5767 0.9617 0.1815 0.0549 
Uric acid 0.730 0.320 0.821 0.568 0.5801 0.0180 0.5575 0.1083 
DOPAC 1.737 0.788 2.070 0.969 0.4609 0.3491 0.1617 0.9124 
Sulfolactate 1.404 0.826 2.685 0.841 0.6190 0.5281 0.1525 0.5742 
Glycerone phosphate 1.770 1.298 1.982 1.575 0.2052 0.5482 0.4195 0.2588 
Arginine 1.004 1.097 1.571 1.173 0.9796 0.6556 0.2105 0.3164 
Citrulline 0.821 1.366 3.466 1.237 0.5822 0.3560 0.0712 0.5542 
Ascorbate 1.234 1.257 0.003 0.893 0.5451 0.7073 0.0235 0.8072 
N-Carbamoyl-L-aspartate 1.405 1.722 2.775 1.325 0.4796 0.5026 0.0323 0.7239 
Allantoate 1.032 0.904 1.205 0.982 0.9384 0.7036 0.6099 0.9617 
2-Isopropylmalate 1.110 0.534 1.233 1.185 0.8656 0.1961 0.7486 0.7013 
Glucosamine 0.585 0.930 1.170 1.045 0.1369 0.7950 0.6422 0.9010 
myo-Inositol 0.840 0.606 1.190 2.818 0.5854 0.1148 0.7722 0.0001 
Tyrosine 1.005 1.038 0.828 0.954 0.9863 0.8931 0.6257 0.8773 
Homovanillic acid (HVA) 0.884 0.687 0.582 0.962 0.8514 0.3990 0.2222 0.9329 
Homocysteic acid 1.815 0.000 0.697 0.277 0.6335 0.0805 0.6263 0.2015 
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Metabolites 
Fold Changes compared to uninfected P values compared to uninfected 









4-Pyridoxate 1.372 0.927 1.458 1.534 0.4069 0.7556 0.1284 0.0633 
N-Acetylglutamine 1.793 2.199 3.501 6.045 0.4916 0.1958 0.0191 0.0052 
Citrate/isocitrate 1.138 1.016 1.207 0.353 0.7173 0.9571 0.6696 0.0621 
D-Gluconate 1.037 1.006 1.682 1.420 0.9068 0.9789 0.2023 0.2156 
N-N Dimethylarginine 0.828 0.709 0.926 0.622 0.3164 0.1609 0.7091 0.0366 
Tryptophan 1.293 1.035 1.313 1.124 0.4624 0.9208 0.4233 0.7361 
Xanthurenic acid 10.219 0.440 4.993 1.024 0.3039 0.4973 0.3707 0.9808 
D-Glucarate 0.715 0.632 1.125 0.697 0.4202 0.2917 0.7220 0.3986 
Pantothenate 1.198 1.029 1.253 0.993 0.5907 0.9129 0.4632 0.9781 
Cystathionine 4.703 0.406 0.629 0.296 0.2755 0.2885 0.5217 0.2169 
Cystine 0.812 0.384 0.566 1.339 0.6146 0.1369 0.2581 0.5427 
Uridine 1.293 1.053 2.094 7.836 0.4974 0.8292 0.0184 0.0009 
Biotin 0.971 0.804 0.698 0.956 0.9334 0.4827 0.3267 0.8986 
Deoxyinosine 0.668 1.684 1.773 1.326 0.6783 0.6719 0.5908 0.7768 
Glucose 6-phosphate 0.769 0.932 1.583 0.578 0.3027 0.7248 0.3161 0.0645 
S-Ribosyl-L-homocysteine 0.000 1.11E+07 2.11E+08 1.11E+07 #DIV/0! 0.3739 0.1269 0.3739 
6-Phospho-D-gluconate 0.962 1.311 10.789 0.977 0.8856 0.4072 0.0873 0.9539 
Guanosine 1.362 0.898 1.127 1.357 0.3776 0.7693 0.8057 0.3568 
Xanthosine 1.886 0.467 3.867 197.576 0.5714 0.3095 0.4287 0.0005 
Glycinamide ribotide (GAR) 0.406 4.340 2.741 0.574 0.4674 0.0523 0.1131 0.6397 
Ophthalmate 1.009 1.637 1.561 0.721 0.9839 0.1807 0.3720 0.5125 





Table 8. Continued. 
Metabolites 
Fold Changes compared to uninfected P values compared to uninfected 









UMP 1.229 1.206 1.171 0.147 0.5310 0.5009 0.6873 0.0206 
AICAR 0.402 0.551 0.156 0.207 0.4254 0.5767 0.2663 0.2947 
Trehalose/Sucrose/Cellobiose 1.158 1.082 1.154 0.915 0.5129 0.7938 0.5458 0.6440 
AMP/dGMP 0.865 0.978 1.290 0.397 0.6297 0.9264 0.4812 0.0471 
IMP 0.657 2.794 3.110 7.889 0.4534 0.1188 0.2065 0.0197 
GMP 0.823 1.056 1.808 0.736 0.5587 0.8291 0.1306 0.3464 
Xanthosine 5--phosphate 1.587 1.025 5.190 12.913 0.3501 0.9531 0.0879 0.0069 
Riboflavin 1.290 0.556 0.657 0.870 0.7055 0.1684 0.2493 0.6958 
S-Adenosyl-L-homocysteine 1.272 0.818 1.255 2.118 0.6457 0.3348 0.6816 0.0850 
ADP 1.369 1.145 0.766 0.314 0.5919 0.8410 0.6672 0.2350 
Folate 0.000 0.000 4.57E+06 0.000 #DIV/0! #DIV/0! 0.3910 #DIV/0! 
CDP-ethanolamine 1.039 1.127 1.514 0.785 0.8931 0.6741 0.3627 0.4218 
FMN 1.189 0.896 1.490 1.132 0.4610 0.6590 0.4711 0.6432 
UDP-glucose 1.031 0.786 0.664 0.068 0.9434 0.4763 0.4042 0.0247 
NAD+ 1.157 0.923 0.872 0.614 0.6504 0.7782 0.5642 0.1864 
NADH 0.828 1.009 0.534 2.146 0.6973 0.9827 0.4129 0.1857 
Dephospho-CoA 0.856 0.972 0.272 0.397 0.6768 0.9260 0.0462 0.1025 
NADP+ 1.071 0.978 2.987 0.923 0.8288 0.9410 0.0407 0.8227 
FAD 1.068 0.767 0.945 0.828 0.9084 0.6669 0.9242 0.7587 
N-Acetylglutamate 1.220 1.024 0.800 0.643 0.6341 0.9587 0.5874 0.3429 
Kynurenic acid 5.714 1.975 16.585 7.612 0.2766 0.2118 0.0542 0.2067 
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Table 9. Fold changes and p values of middle groups compared to uninfected group.  
Metabolites 
Fold Changes compared to the uninfected P values compared to uninfected 
2 Days 4 Days 6 Days 8 Days 2 Days 4 Days 6 Days 8 Days 
Glycine 4.792 2.067 0.001 2.972 0.51052 0.58106 0.37392 0.45756 
Pyruvate 6.409 0.200 0.328 0.286 0.51234 0.00163 0.00432 0.00307 
Alanine/Sarcosine 2.547 0.132 2.972 3.208 0.00691 0.00691 0.28361 0.39061 
Lactate 33.305 0.866 2.451 1.611 0.00012 0.66469 0.03176 0.22099 
Dimethylglycine 2.915 1.599 8.413 7.686 0.02204 0.23466 0.13109 0.12141 
Serine 2.718 1.124 2.042 1.339 0.01162 0.70979 0.13992 0.48825 
Histamine 0.708 1.070 9.976 4.400 0.95021 0.89187 0.03294 0.03998 
Uracil 4.394 16.293 100.473 93.704 0.20591 0.04228 0.00515 0.00237 
Proline 0.473 0.094 0.725 0.793 0.69584 0.01812 0.38395 0.53966 
Fumarate 0.826 0.111 0.459 0.281 0.36926 0.00882 0.05139 0.01616 
2-Oxoisovalerate 7.444 5.049 45.681 5.119 0.63473 0.06135 0.27502 0.05421 
Indole 1.035 0.325 0.722 1.177 0.90789 0.08085 0.50679 0.85735 
Valine 1.199 0.420 3.358 2.552 0.19072 0.03848 0.23859 0.51087 
3-Hydroxyisovaleric 
acid 9.084 12.066 92.980 7.524 0.47665 0.01535 0.12331 0.10206 
Homoserine/Threonine 1.538 1.185 3.167 5.224 0.65552 0.64121 0.02501 0.28062 
3-Methylthiopropionate 4.226 9.772 148.925 10.883 0.92223 0.20738 0.20707 0.32083 
Cysteine 0.259 0.571 0.451 0.453 0.57115 0.25162 0.12901 0.15296 
Nicotinate 9.210 3.191 5.023 3.947 0.00056 0.11202 0.01171 0.02336 
Taurine 1.295 0.160 0.445 0.467 0.65444 0.10512 0.25720 0.32224 
Thymine 19.165 114.556 302.136 269.657 0.27105 0.00890 0.02013 0.00931 





Table 9. Continued. 
Metabolites 
Fold Changes compared to the uninfected P values compared to uninfected 
2 Days 4 Days 6 Days 8 Days 2 Days 4 Days 6 Days 8 Days 
N-Acetyl-beta-alanine 2.683 7.351 70.665 61.108 0.00270 0.05300 0.04994 0.25044 
Leucine/Isoleucine 0.874 0.492 2.282 2.843 0.34767 0.12230 0.20158 0.47965 
Glutaric acid 2.306 3.130 11.815 4.749 0.69556 0.02445 0.07333 0.01453 
Asparagine 1.099 0.235 2.197 0.926 0.67846 0.01300 0.14360 0.84672 
Hydroxyisocaproic acid 8.834 6.447 116.020 10.983 0.25789 0.08193 0.16961 0.25487 
Ornithine 5.009 6.155 28.656 62.339 0.99584 0.00163 0.11175 0.31047 
Salicylate 1.341 31.566 14.333 5.733 0.80576 0.31000 0.15179 0.33922 
Hydroxybenzoate 21.561 11.108 61.260 34.617 0.43055 0.04212 0.03185 0.06085 
Histidinol 77.448 343.644 106.747 64.686 0.96459 0.00802 0.25252 0.08561 
2-Oxoglutaric acid 0.747 0.164 0.926 0.493 0.29934 0.05400 0.90553 0.19339 
Glutamine 0.728 0.090 0.334 0.397 0.82209 0.01382 0.03563 0.04888 
2-hydroxyglutarate 27.272 2.548 14.312 35.538 0.01672 0.00709 0.04671 0.27122 
2-Hydroxy-2-
methylsuccinate 27.260 2.550 14.346 35.625 0.01690 0.00720 0.04594 0.27111 
L-Methionine 2.064 1.045 2.025 3.124 0.36341 0.91086 0.26663 0.40944 
Guanine 42.531 211.056 908.328 499.976 0.25615 0.30159 0.19389 0.28031 
3-Methylphenylacetic acid 1.030 2.015 544.929 80.221 0.63993 0.50735 0.17919 0.36781 
Hydroxyphenylacetate 15.366 106.390 298.925 291.173 0.29706 0.02409 0.09366 0.12242 
Xylitol 10.888 6.039 16.487 13.494 0.00003 0.05388 0.01841 0.10481 
Dopamine 0.662 0.009 0.156 0.315 0.52487 0.08042 0.11852 0.23163 
2_3-Dihydroxybenzoate 19.629 431.561 374.372 674.269 0.08331 0.10891 0.27523 0.24281 
Histidine 0.546 0.090 0.335 0.862 0.84007 0.00136 0.00278 0.86056 
Orotate 17.908 62.614 192.883 127.407 0.45255 0.07855 0.06108 0.05728 
Dihydroorotate 6.824 6.522 8.572 17.943 0.38466 0.11281 0.10735 0.25847 
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Table 9. Continued. 
Metabolites 
Fold Changes compared to the uninfected P values compared to uninfected 
2 Days 4 Days 6 Days 8 Days 2 Days 4 Days 6 Days 8 Days 
Allantoin 3.410 6.361 69.455 50.345 0.24131 0.17298 0.03317 0.05632 
Indole-3-carboxylate 6.051 48.481 107.196 106.805 0.74457 0.01282 0.00365 0.05101 
Phenylpyruvate 11.211 8.056 320.823 29.530 0.82642 0.12060 0.28221 0.07190 
Phenylalanine 1.206 0.261 1.962 2.408 0.62425 0.11072 0.33706 0.51309 
Phenyllactic acid 118.656 321.702 710.170 145.612 0.17260 0.05204 0.01641 0.04612 
Quinolinate 4.542 49.406 457.420 1123.157 0.12494 0.10754 0.02599 0.11338 
Phosphoenolpyruvate 10.344 5.371 36.612 21.661 0.05493 0.12881 0.00390 0.04747 
Uric acid 0.722 0.391 0.637 0.259 0.10834 0.02755 0.15243 0.01259 
DOPAC 19.712 67.054 399.223 136.540 0.91242 0.00434 0.00111 0.07956 
Sulfolactate 1.865 0.619 12.615 4.753 0.57417 0.18177 0.18006 0.04050 
Glycerone phosphate 1.313 0.215 0.393 0.340 0.25883 0.11744 0.19737 0.17840 
Arginine 0.662 0.290 0.694 0.494 0.31638 0.00176 0.05712 0.01212 
Citrulline 41.678 65.756 312.333 171.161 0.55416 0.00182 0.20294 0.23443 
Ascorbate 0.002 0.000 0.002 0.001 0.80717 0.02328 0.02337 0.02329 
N-Carbamoyl-L-aspartate 7.981 5.088 22.889 32.337 0.72394 0.15983 0.09300 0.13994 
Allantoate 1.448 0.410 1.511 0.708 0.96167 0.04922 0.48452 0.65862 
2-Isopropylmalate 179.099 255.459 584.853 454.850 0.70127 0.03129 0.01129 0.05943 
Glucosamine 3.401 6.899 17.109 36.100 0.90098 0.05300 0.07609 0.12901 
myo-Inositol 5.255 0.408 0.765 0.727 0.00007 0.02893 0.33327 0.25749 
Tyrosine 0.671 0.182 0.360 0.188 0.87732 0.02102 0.05194 0.02198 
Homovanillic acid (HVA) 2.669 1.940 10.699 2.205 0.93293 0.12820 0.20677 0.17569 





Table 9. Continued. 
Metabolites 
Fold Changes compared to the uninfected P values compared to uninfected 
2 Days 4 Days 6 Days 8 Days 2 Days 4 Days 6 Days 8 Days 
4-Pyridoxate 5.154 19.564 57.666 77.471 0.06328 0.03150 0.06271 0.03771 
N-Acetylglutamine 3.363 0.359 3.900 10.001 0.00524 0.18438 0.06102 0.34041 
Citrate/isocitrate 0.429 0.188 0.677 0.182 0.06214 0.03227 0.38929 0.03167 
D-Gluconate 1.844 1.960 4.624 3.941 0.21557 0.07356 0.00000 0.00531 
N-N Dimethylarginine 2.634 3.349 5.006 2.805 0.03661 0.00781 0.08934 0.17102 
Tryptophan 1.057 0.384 0.791 1.019 0.73609 0.07430 0.57173 0.97972 
Xanthurenic acid 1.641 2.259 1.038 1.358 0.98076 0.28515 0.97010 0.70499 
D-Glucarate 0.923 0.506 1.499 0.670 0.39857 0.26408 0.36212 0.37628 
Pantothenate 1.179 1.221 2.025 0.998 0.97814 0.48107 0.02351 0.99663 
Cystathionine 0.403 0.775 0.963 0.999 0.21688 0.66738 0.94990 0.99828 
Cystine 2.844 5.508 0.408 0.848 0.54273 0.08380 0.17188 0.76874 
Uridine 56.301 246.279 504.667 373.328 0.00088 0.03610 0.04706 0.26154 
Biotin 0.701 0.415 0.346 0.519 0.89865 0.06001 0.03921 0.16646 
Deoxyinosine 123.288 1842.869 6062.509 3666.716 0.77676 0.10843 0.04260 0.03827 
Glucose 6-phosphate 0.377 0.039 0.109 0.087 0.06451 0.00464 0.00550 0.00517 
S-Ribosyl-L-homocysteine 1.61E+10 5.16E+09 6.61E+09 2.93E+09 0.37390 0.28146 0.31559 0.06872 
6-Phospho-D-gluconate 2.079 2.023 5.269 3.127 0.95388 0.24139 0.04294 0.23053 
Guanosine 1.555 1.478 1.818 5.202 0.35683 0.38841 0.18522 0.15072 
Xanthosine 48.545 29.320 44.130 27.453 0.00050 0.07392 0.13650 0.09269 
Glycinamide ribotide 
(GAR) 4.933 0.308 29.803 36.939 0.63972 0.41207 0.21219 0.20156 
Ophthalmate 4.931 6.181 35.378 17.365 0.51249 0.04846 0.15629 0.11826 





Table 9. Continued. 
Metabolites 
Fold Changes compared to the uninfected P values compared to uninfected 
2 Days 4 Days 6 Days 8 Days 2 Days 4 Days 6 Days 8 Days 
UMP 0.217 0.312 0.920 0.884 0.02060 0.03918 0.83856 0.75138 
AICAR 0.152 0.081 0.130 0.069 0.29472 0.23294 0.25434 0.22754 
Trehalose/Sucrose/Cellobiose 0.631 0.271 0.720 0.638 0.64396 0.00567 0.29239 0.14309 
AMP/dGMP 0.227 0.180 0.226 0.417 0.04713 0.01839 0.02019 0.05848 
IMP 2.145 0.204 0.247 0.182 0.01970 0.12226 0.13900 0.11485 
GMP 0.665 0.773 1.322 3.161 0.34635 0.50651 0.59308 0.18783 
Xanthosine 5--phosphate 19.449 52.468 147.733 21.200 0.00688 0.33973 0.04360 0.04579 
Riboflavin 0.898 0.773 1.657 3.151 0.69581 0.53213 0.28250 0.31463 
S-Adenosyl-L-homocysteine 1.187 4.990 4.986 5.915 0.08497 0.06598 0.04512 0.03787 
ADP 0.386 0.106 0.430 0.343 0.23502 0.14251 0.31985 0.25428 
Folate 2.81E+08 2.68E+09 5.71E+09 1.72E+10 #DIV/0! 0.00274 0.09309 0.08407 
CDP-ethanolamine 0.537 0.155 0.399 0.265 0.42183 0.01647 0.05535 0.02614 
FMN 1.351 1.257 1.061 1.336 0.64325 0.36812 0.79650 0.45186 
UDP-glucose 0.258 0.356 1.120 0.812 0.02469 0.07114 0.79310 0.64166 
NAD+ 0.309 0.200 0.312 0.158 0.18641 0.01256 0.02005 0.01121 
NADH 0.223 0.024 0.039 0.067 0.18567 0.04903 0.05130 0.05466 
Dephospho-CoA 0.186 0.529 1.357 1.052 0.10249 0.17794 0.48999 0.91004 
NADP+ 2.407 1.612 2.429 0.994 0.82268 0.31269 0.16649 0.98662 
FAD 1.043 1.475 2.478 1.873 0.75866 0.50882 0.06953 0.31540 
N-Acetylglutamate 6.512 4.915 9.298 5.726 0.34290 0.00770 0.01771 0.00386 




Table 10. Fold changes and p values of late groups compared to uninfected group.  
Metabolites 
Fold changes compared to the uninfected P values compared to uninfected 
10 Days 12 Days 16 Days 10 Days 12 Days 16 Days 
Glycine 4.258 9.942 0.685 0.4932 0.1896 0.7949 
Pyruvate 0.374 0.175 0.740 0.0059 0.0030 0.6172 
Alanine/Sarcosine 2.026 2.039 1.716 0.4479 0.4959 0.6329 
Lactate 2.353 28.355 2.180 0.1764 0.3647 0.0726 
Dimethylglycine 11.472 13.655 16.762 0.1565 0.2508 0.1001 
Serine 1.818 0.758 3.022 0.0358 0.5901 0.2352 
Histamine 12.281 9.751 14.569 0.0238 0.0777 0.2373 
Uracil 123.687 60.977 114.216 0.0061 0.0256 0.2715 
Proline 1.182 0.419 0.773 0.6558 0.1107 0.6247 
Fumarate 0.304 0.100 0.346 0.0179 0.0081 0.0336 
2-Oxoisovalerate 31.558 20.332 12.962 0.0810 0.3346 0.3028 
Indole 0.565 0.721 0.473 0.3733 0.6158 0.2285 
Valine 2.007 2.009 1.724 0.5566 0.4570 0.6616 
3-Hydroxyisovaleric acid 26.672 44.341 37.643 0.0591 0.1475 0.3212 
Homoserine/Threonine 2.743 3.365 4.256 0.1711 0.3390 0.3952 
3-Methylthiopropionate 173.653 118.922 314.975 0.3372 0.2298 0.1997 
Cysteine 0.350 0.200 0.647 0.0857 0.0464 0.3951 
Nicotinate 2.201 3.097 5.177 0.1574 0.2605 0.0867 
Taurine 0.583 0.316 1.188 0.4551 0.1726 0.7356 
Thymine 255.496 115.787 144.941 0.0065 0.0845 0.2907 
Hydroxyproline 26.682 6.065 18.293 0.0111 0.0564 0.0957 
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Table 10. Continued.  
Metabolites 
Fold changes compared to the uninfected P values compared to uninfected 
10 Days 12 Days 16 Days 10 Days 12 Days 16 Days 
N-Acetyl-beta-alanine 35.250 32.070 37.023 0.0092 0.1800 0.0801 
Leucine/Isoleucine 2.007 2.208 1.925 0.5656 0.4619 0.6176 
Glutaric acid 15.354 5.289 10.799 0.0952 0.1601 0.1654 
Asparagine 2.011 1.418 2.947 0.2412 0.6278 0.2427 
Hydroxyisocaproic acid 21.865 39.732 24.531 0.0664 0.1532 0.3379 
Ornithine 34.781 45.329 19.233 0.2968 0.0600 0.2121 
Salicylate 5.810 2.449 3.214 0.2559 0.2722 0.0957 
Hydroxybenzoate 305.421 111.028 362.953 0.0353 0.2012 0.1076 
Histidinol 60.620 32.374 42.209 0.2415 0.0752 0.0774 
2-Oxoglutaric acid 0.293 0.109 0.324 0.0854 0.0458 0.1056 
Glutamine 0.331 0.334 0.391 0.0352 0.0703 0.0542 
2-hydroxyglutarate 14.582 27.552 13.872 0.0194 0.3012 0.0929 
2-Hydroxy-2-methylsuccinate 14.644 27.614 13.972 0.0194 0.3011 0.0933 
L-Methionine 2.704 4.711 3.303 0.4585 0.3321 0.4486 
Guanine 89.340 56.306 129.946 0.0039 0.2368 0.1023 
3-Methylphenylacetic acid 163.778 168.432 2.084 0.3699 0.3747 0.0728 
Hydroxyphenylacetate 411.449 133.297 457.681 0.0348 0.0573 0.0976 
Xylitol 9.882 6.643 31.981 0.0002 0.1393 0.0828 
Dopamine 0.015 0.581 0.017 0.0816 0.5729 0.0820 
2_3-Dihydroxybenzoate 297.354 263.830 502.594 0.0446 0.1500 0.1232 






Table 10. Continued. 
Metabolites 
Fold changes compared to the uninfected P values compared to uninfected 
10 Days 12 Days 16 Days 10 Days 12 Days 16 Days 
Allantoin 89.180 37.012 78.934 0.0172 0.1582 0.1169 
Indole-3-carboxylate 357.678 160.493 277.190 0.0035 0.0301 0.0876 
Phenylpyruvate 413.759 148.335 119.827 0.0571 0.2971 0.1103 
Phenylalanine 1.312 1.694 1.589 0.7760 0.5444 0.6986 
Phenyllactic acid 133.578 113.759 63.962 0.0158 0.0521 0.3039 
Quinolinate 4990.106 1609.825 10077.656 0.0887 0.1868 0.0708 
Phosphoenolpyruvate 69.222 31.383 44.422 0.1334 0.2017 0.0629 
Uric acid 0.543 0.216 0.614 0.1310 0.0108 0.3584 
DOPAC 1045.916 389.290 877.422 0.0173 0.1443 0.0803 
Sulfolactate 24.279 19.741 56.909 0.0712 0.0765 0.0099 
Glycerone phosphate 0.366 0.145 0.811 0.1802 0.0921 0.7287 
Arginine 0.481 0.217 0.824 0.0068 0.0018 0.6547 
Citrulline 176.391 223.750 164.660 0.2869 0.1706 0.2978 
Ascorbate 0.001 0.002 0.001 0.0234 0.0234 0.0234 
N-Carbamoyl-L-aspartate 106.963 49.179 268.745 0.2229 0.3223 0.3277 
Allantoate 1.454 1.108 2.143 0.5679 0.8838 0.3623 
2-Isopropylmalate 1715.044 713.690 1764.979 0.0445 0.1586 0.1006 
Glucosamine 21.719 11.875 50.631 0.0080 0.0545 0.0066 
myo-Inositol 1.146 5.289 4.488 0.6049 0.3583 0.0163 
Tyrosine 0.156 0.251 0.613 0.0192 0.0258 0.4731 




Table 10. Continued. 
Metabolites 
Fold changes compared to the uninfected P values compared to uninfected 
10 Days 12 Days 16 Days 10 Days 12 Days 16 Days 
4-Pyridoxate 99.502 29.529 110.628 0.0309 0.2081 0.0255 
N-Acetylglutamine 3.160 10.737 3.480 0.0776 0.3718 0.2769 
Citrate/isocitrate 0.213 0.042 0.192 0.0355 0.0195 0.0313 
D-Gluconate 5.375 2.788 7.319 0.0012 0.1631 0.0430 
N-N Dimethylarginine 2.568 2.192 5.442 0.3259 0.0030 0.2650 
Tryptophan 0.629 0.808 0.603 0.4234 0.7323 0.3645 
Xanthurenic acid 0.936 0.146 0.877 0.9405 0.3174 0.8976 
D-Glucarate 1.616 0.658 1.764 0.2083 0.4273 0.4712 
Pantothenate 2.463 1.667 2.719 0.1128 0.2523 0.2935 
Cystathionine 0.635 0.461 0.675 0.4991 0.3366 0.5878 
Cystine 0.399 0.710 2.984 0.2071 0.6884 0.3603 
Uridine 246.099 309.847 65.809 0.0717 0.0930 0.0958 
Biotin 0.672 0.582 1.188 0.2657 0.1422 0.6731 
Deoxyinosine 3527.064 1086.591 2116.136 0.0478 0.1849 0.3450 
Glucose 6-phosphate 0.077 0.046 0.064 0.0052 0.0047 0.0050 
S-Ribosyl-L-homocysteine 4.83E+09 5.50E+09 2.13E+10 0.2000 0.0215 0.2537 
6-Phospho-D-gluconate 5.427 2.107 5.102 0.0584 0.3408 0.0361 
Guanosine 2.626 0.580 1.333 0.1305 0.2309 0.4510 
Xanthosine 27.111 9.649 21.699 0.1073 0.0426 0.3366 
Glycinamide ribotide (GAR) 14.269 0.248 1.844 0.0875 0.3706 0.6249 





Table 10. Continued. 
Metabolites 
Fold changes compared to the uninfected P values compared to uninfected 
10 Days 12 Days 16 Days 10 Days 12 Days 16 Days 
UMP 0.764 0.273 0.624 0.4312 0.0412 0.2389 
AICAR 0.055 0.002 0.009 0.2221 0.2016 0.2043 
Trehalose/Sucrose/Cellobiose 0.752 0.456 1.537 0.3469 0.1820 0.5144 
AMP/dGMP 0.376 0.205 0.473 0.0418 0.0205 0.0890 
IMP 0.132 0.093 0.157 0.0998 0.0892 0.1071 
GMP 2.371 0.902 1.997 0.1188 0.9062 0.2518 
Xanthosine 5--phosphate 403.992 149.259 274.389 0.2593 0.1164 0.1039 
Riboflavin 1.986 1.951 4.368 0.1786 0.1190 0.0760 
S-Adenosyl-L-homocysteine 2.739 0.813 2.015 0.1791 0.6711 0.2836 
ADP 0.537 0.108 0.712 0.4098 0.1434 0.6597 
Folate 5.34E+09 6.02E+09 1.85E+10 0.0319 0.0578 0.0612 
CDP-ethanolamine 0.143 0.036 0.112 0.0173 0.0118 0.0145 
FMN 0.658 1.004 1.255 0.0667 0.9917 0.7097 
UDP-glucose 0.892 0.362 0.678 0.7482 0.0978 0.3336 
NAD+ 0.179 0.065 0.162 0.0129 0.0084 0.0098 
NADH 0.003 0.031 0.023 0.0462 0.0501 0.0488 
Dephospho-CoA 0.580 0.337 0.444 0.2235 0.0823 0.1405 
NADP+ 1.380 0.856 0.894 0.2859 0.6858 0.7879 
FAD 1.426 2.977 2.587 0.4378 0.2124 0.1351 
N-Acetylglutamate 8.838 3.296 3.122 0.0585 0.1524 0.1712 




Table 11. Metabolites with VIP scores above 1 in G. mellonella early infection 
groups. 
Metabolite Component 1 Component 2 
2-3-Dihydroxybenzoate 1.5869 1.2547 
2-Hydroxy-2-methylsuccinate 2.2357 1.7410 
2-hydroxyglutarate 2.2367 1.7417 
2-Oxoglutaric acid 0.2764 1.0562 
2-Oxoisovalerate 0.3018 1.0449 
3-Hydroxyisovaleric-acid 1.0413 0.8204 
6-Phospho-D-gluconate 0.5088 1.5479 
ADP 1.2044 0.9568 
Alanine/Sarcosine 1.7096 1.3124 
Allantoin 1.1409 0.8779 
AMP/dGMP 1.1497 1.3461 
Ascorbate 0.9151 1.3537 
Citrate/isocitrate 1.3093 1.2499 
Citrulline 0.7014 1.3385 
Cysteine 0.1700 1.2688 
Dephospho-CoA 1.5255 1.2729 
Dimethylglycine 1.9226 1.4751 
Glucose-6-phosphate 0.3793 1.1412 
Glutathione 1.0743 1.1795 
GMP 0.0027 1.1881 
Hydroxyisocaproic acid 1.5034 1.1533 
Hydroxyphenylacetate 0.9852 1.0460 
IMP 1.8978 1.4806 
Kynurenic acid 0.9303 1.1735 
L-Methionine 0.8580 1.3640 
Lactate 2.2690 1.7879 
Leucine/Isoleucine 0.7744 1.1339 
myo-Inositol 1.9032 1.5627 
N-Acetyl-beta-alanine 2.0101 1.5722 
N-Acetylglutamine 1.8574 1.4248 
NAD+ 1.0673 0.8609 
NADH 0.7192 1.0764 
NADP+ 0.3900 1.4325 
Nicotinate 1.9260 1.6152 
Phenyllactic acid 1.6506 1.3167 
Phenylpyruvate 0.4665 1.2661 
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Table 11. Continued. 
 
Metabolite Component 1 Component 2 
Phosphoenolpyruvate 1.1608 1.2046 
Pyruvate 0.6499 1.4863 
S-Ribosyl-L-homocysteine 0.7014 1.3681 
UDP-glucose 1.8526 1.4801 
UMP 1.7513 1.5589 
Uracil 1.3847 1.0643 
Uridine 2.2981 1.8439 
Valine 0.9571 1.0844 
Xanthosine 2.2370 1.9188 
Xanthosine-5-phosphate 2.2546 1.7373 
Xylitol 2.3975 1.8718 
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Table 12. Metabolites with VIP scores above 1 in G. mellonella middle infection 
groups. 
Metabolite Component 1 Component 2 
2-Isopropylmalate 1.5248 1.1871 
3-4-Dihydroxyphenylacetate (DOPAC) 1.7436 1.4597 
3-Hydroxyisovaleric acid 1.1293 0.9594 
4-Pyridoxate 1.4166 1.1114 
6-Phospho-D-gluconate 1.0473 0.8986 
ADP 0.7249 1.2095 
AICAR 1.0346 1.0580 
Allantoin 1.4607 1.3469 
AMP/dGMP 1.0007 1.1633 
Arginine 0.5502 1.2637 
Ascorbate 1.5786 1.5895 
Asparagine 0.3048 1.1124 
Biotin 1.0826 0.9057 
CDP-ethanolamine 0.9094 1.0994 
Citrate/isocitrate 0.8538 1.2493 
Citrulline 1.2375 0.9671 
Creatinine 1.2335 0.9765 
Cystine 0.3144 1.2624 
D-Gluconate 1.6660 1.3972 
Deoxyinosine 1.6059 1.2677 
Dephospho-CoA 0.4148 1.0852 
Dimethylglycine 1.1988 1.0838 
Dopamine 0.9652 1.0429 
FAD 1.0092 0.8260 
Folate 1.2633 0.9814 
Fumarate 0.7947 1.0874 
Glucosamine 1.2807 1.0128 
Glucose-6-phosphate 1.4496 1.4740 
Glutamine 0.8161 1.1785 
Glutaric acid 1.4200 1.1905 
Glutathione 0.9395 1.4395 
Guanine 1.1134 0.9052 
Histamine 1.2110 1.3731 
Histidine 0.6522 1.0409 





Table 12. Continued. 
 
Metabolite Component 1 Component 2 
Hydroxybenzoate 1.4315 1.1662 
Hydroxyisocaproic acid 1.0166 0.9681 
Hydroxyphenylacetate 1.3266 1.0348 
Hydroxyproline 1.6513 1.3042 
Indole-3-carboxylate 1.6935 1.3208 
Kynurenic acid 1.3748 1.0706 
N-Acetyl-beta-alanine 1.3496 1.2184 
N-Acetylglutamate 1.3348 1.0555 
N-Carbamoyl-L-aspartate 1.0631 0.8541 
NAD+ 1.3386 1.3988 
NADH 1.4399 1.3930 
Ophthalmate 1.2818 1.0675 
Ornithine 1.0276 0.8366 
Orotate 1.5241 1.1980 
Phenyllactic acid 1.5088 1.1783 
Phenylpyruvate 1.0228 1.0159 
Phosphoenolpyruvate 1.5359 1.3461 
Proline 0.1203 1.4211 
Quinolinate 1.3176 1.1325 
Sulfolactate 1.0324 1.1891 
Thymine 1.7589 1.3729 
Trehalose/Sucrose/Cellobiose 0.6078 1.0729 
Tyrosine 1.1051 1.1166 
UDP-glucose 0.0540 1.0075 
UMP 0.0043 1.0181 
Uracil 1.7937 1.5348 
Uridine 1.3648 1.0640 
Xanthosine-5-phosphate 1.1893 0.9888 





Table 13. Metabolites with VIP scores above 1 in G. mellonella late infection groups. 
Metabolite Component 1 Component 2 
2-3-Dihydroxybenzoate 1.0320 0.8792 
2-Isopropylmalate 1.3026 1.2170 
2-Oxoglutaric acid 1.3035 1.2662 
3-4-Dihydroxyphenylacetate (DOPAC) 1.3602 1.2859 
4-Pyridoxate 1.4160 1.4405 
6-Phospho-D-gluconate 0.9082 1.1774 
ADP 0.7134 1.1609 
AICAR 1.4942 1.3018 
Allantoin 1.2080 1.1331 
AMP/dGMP 1.1334 1.2708 
Arginine 0.8909 1.3022 
Ascorbate 2.0234 1.7104 
CDP-ethanolamine 1.7134 1.5556 
Citrate/isocitrate 1.6885 1.6503 
Creatinine 1.2483 1.2107 
Cysteine 0.9511 1.1353 
D-Gluconate 1.3744 1.4450 
Deoxyinosine 1.1311 0.9658 
Dopamine 1.2318 1.1108 
Folate 1.2604 1.0862 
Fumarate 1.4351 1.4405 
Glucosamine 1.3690 1.3559 
Glucose-6-phosphate 2.0301 1.7400 
Glutamine 1.2314 1.1224 
Glutaric acid 1.0303 0.9935 
Glutathione 1.3890 1.3276 
Glycerone phosphate 0.7610 1.0485 
Histidinol 1.1034 0.9261 
Homocysteic acid 0.8962 1.0255 
Hydroxybenzoate 1.1602 1.2013 
Hydroxyphenylacetate 1.2509 1.1862 
Hydroxyproline 1.3826 1.4534 
IMP 1.5350 1.3501 
Indole-3-carboxylate 1.5819 1.4033 
N-Acetyl-beta-alanine 1.1138 0.9329 
N-Acetylglutamate 1.0512 0.9051 




Table 13. Continued. 
Metabolite Component 1 Component 2 
NADH 1.8958 1.5881 
Ophthalmate 1.0731 1.0745 
Phenyllactic acid 1.2511 1.1197 
Phenylpyruvate 1.1234 1.0432 
Phosphoenolpyruvate 1.2550 1.1412 
Pyruvate 1.1156 1.2633 
Quinolinate 1.2148 1.3644 
S-Ribosyl-L-homocysteine 1.0276 0.8849 
Serine 0.4471 1.1688 
Sulfolactate 1.2581 1.2289 
Thymine 1.3403 1.1227 
Tyrosine 1.2468 1.1105 
UMP 0.5836 1.0554 
Uracil 1.3800 1.1627 
Uric acid 0.9737 1.0744 
Uridine 1.0231 1.0409 





Table 14. X. nematophila whole cell fold changes and p values.  
Metabolite Fold Change P Value 
Sedoheptulose 1/7-phosphate 0.76 0.00128 
Glucosamine phosphate 0.79 0.47906 
Phenyllactic acid 0.63 0.25859 
dTDP 0.62 0.34339 
Xanthosine 1.20 0.81673 
Guanine 0.81 0.18632 
UMP 0.72 0.02615 
Succinate/Methylmalonate 0.93 0.64195 
AICAR 0.92 0.38993 
N-Acetylglucosamine 1/6-phosphate 0.90 0.40928 
Phenylalanine 1.07 0.31171 
FAD 1.72 0.48248 
Guanosine 0.54 0.01558 
6-Phospho-D-gluconate 0.49 0.06740 
UDP-glucuronate 0.68 0.18971 
2-Hydroxy-2-methylsuccinate 0.70 0.10960 
Tryptophan 1.24 0.15837 
Malate 0.98 0.87020 
CMP 0.59 0.04616 
2-Dehydro-D-gluconate 0.86 0.31347 
Deoxyribose phosphate 0.86 0.15399 
Cysteine 0.98 0.66185 
NADH 0.87 0.31984 
Citrate/isocitrate 0.74 0.00801 
Methionine 0.79 0.04967 
Tyrosine 0.56 0.36929 
Homoserine/Threonine 0.81 0.48235 
Lysine 0.72 0.46062 
Histidinol 1.11 0.67313 
Adenosine 0.37 0.13234 
Uracil 0.88 0.57351 
Homocystine 0.96 0.63439 
Fumarate 0.74 0.59933 
2-Aminoadipate 1.07 0.80972 






Table 14. Continued.  
Metabolite  Fold Change P Value 
Valine 1.56 0.07954 
D-Gluconate 0.64 0.06387 
Alanine/Sarcosine 0.75 0.19224 
Lipoate 0.82 0.08314 
Histidine 0.71 0.63894 
Glycerone phosphate 0.77 0.35253 
Ribose phosphate 1.04 0.77023 
Uridine 0.54 0.03225 
S-Adenosyl-L-methioninamine 0.90 0.24800 
Acetylphosphate 0.49 0.09175 
Allantoin 0.95 0.84082 
Dephospho-CoA 1.13 0.58790 
Citrulline 0.75 0.29892 
Sedoheptoluse bisphosphate 1.60 0.04071 
Aconitate 0.82 0.66109 
Leucine/Isoleucine 0.57 0.30088 
Thymine 0.81 0.25397 
UDP 1.15 0.10726 
UDP-N-acetylglucosamine 0.81 0.55600 
Ornithine 1.38 0.22683 
Cystine 0.77 0.14722 
alpha-Ketoglutarate 0.65 0.08855 
N-Acetylornithine 0.60 0.22501 
Aminoimidazole ribotide (AIR) 0.60 0.02536 
S-Ribosyl-L-homocysteine 0.82 0.24673 
2-Isopropylmalate 0.79 0.08162 
N-Carbamoyl-L-aspartate 0.78 0.29371 
Phosphoenolpyruvate 0.89 0.13809 
sn-Glycerol 3-phosphate 0.55 0.11985 
3-Phosphoglycerate 0.97 0.88636 
Nicotinate 0.95 0.57030 
Pyruvate 0.97 0.74516 
5-Hydroxyindoleacetic acid (5-HIAA) 1.12 0.68806 
Fructose 1_6-bisphosphate 0.94 0.61374 







Table 14. Continued. 
Metabolite Fold Change P Value 
Hypoxanthine 1.39 0.59010 
O-Acetyl-L-serine 1.74 0.09607 
IMP 0.47 0.21822 
Indole-3-carboxylate 0.44 0.38005 
Trehalose/Sucrose/Cellobiose 0.87 0.56669 
Inosine 0.97 0.89701 
Phenylpyruvate 0.81 0.07534 
N-Acetylglutamate 1.14 0.82379 
Glycinamide ribotide (GAR) 0.18 0.34977 
Xylitol 5-phosphate 0.63 0.37619 
NAD+ 1.59 0.18374 
AMP/dGMP 0.68 0.47922 
NADP+ 1.29 0.09645 
UDP-glucose 0.23 0.04314 




Table 15. X. nematophila fold changes and p values in supernatant samples. 
Metabolite  Fold Change P Value 
Alanine/Sarcosine 5.20 0.06791 
Uracil 0.21 0.06578 
Valine 1.17 0.43101 
Succinate/Methylmalonate 1.08 0.67436 
Homoserine/Threonine 0.91 0.53619 
Thymine 0.32 0.08048 
Leucine/Isoleucine 0.75 0.12441 
Ornithine 0.90 0.58356 
Acetylphosphate 1.33 0.26570 
Histidinol 1.04 0.68347 
Lysine 0.72 0.09591 
O-Acetyl-L-serine 1.00 0.94217 
Methionine 1.51 0.38199 
Histidine 0.94 0.67606 
Orotate 1.28 0.64708 
Allantoin 0.93 0.55882 
2-Aminoadipate 0.79 0.18348 
Phenylpyruvate 0.64 0.12927 
Phenylalanine 0.86 0.29660 
Phenyllactic acid 0.93 0.67408 
Aconitate 1.17 0.42953 
N-Acetylornithine 0.82 0.04817 
Citrulline 0.81 0.42511 
N-Carbamoyl-L-aspartate 0.86 0.36051 
2-Isopropylmalate 4.33 0.34999 
Tyrosine 3.44 0.30039 
3-Phosphoglycerate 1.34 0.06789 
N-Acetylglutamate 0.92 0.72913 
5-Hydroxyindoleacetic acid (5-HIAA) 0.80 0.09693 
2-Dehydro-D-gluconate 0.80 0.07805 
D-Gluconate 0.56 0.12419 
Tryptophan 0.95 0.51508 
Lipoate 0.75 0.02948 
Deoxyribose phosphate 0.76 0.18628 
Ribose phosphate 0.77 0.27434 
Cystine 2.40 0.50162 




Table 15. Continued. 
Metabolite  Fold Change P Value 
S-Ribosyl-L-homocysteine 39.61 0.36545 
Homocystine 0.71 0.04432 
Inosine 3.04 0.15467 
6-Phospho-D-gluconate 0.67 0.12300 
Guanosine 0.98 0.90710 
Aminoimidazole ribotide (AIR) 0.86 0.57086 
N-Acetylglucosamine 1/6-phosphate 0.53 0.17174 
UMP 0.55 0.43299 
AICAR 155.19 0.35298 
Fructose 1-6-bisphosphate 0.93 0.50633 
IMP 0.76 0.24101 
S-Adenosyl-L-methioninamine 4700.60 0.38085 
dTDP 16410.75 0.38681 
UDP 2.58 0.36245 
UDP-glucose 79.48 0.36736 
NADH 16.67 0.41368 
Dephospho-CoA 287.28 0.42297 
NADP+ 0.91 0.86773 
FAD 0.82 0.15527 
Pyruvate 1.53 0.08027 
Cysteine 0.79 0.12319 
Nicotinate 1.53 0.15976 
Malate 0.53 0.15475 
Hypoxanthine 0.93 0.56312 
Indole-3-carboxylate 4.49 0.14188 
Phosphoenolpyruvate 1.10 0.63250 
Glycerone phosphate 0.91 0.30988 
sn-Glycerol 3-phosphate 2.29 0.19390 
Citrate/isocitrate 1.12 0.51990 






Table 16. X. nematophila whole cell top VIP scores. 
Metabolite Component 1 Component 2 
Sedoheptulose-1-7-phosphate 1.66968 1.63180 
Glucosamine phosphate 1.57479 1.41781 
Xanthosine 1.56944 1.37976 
N-Acetylglucosamine-1-6-phosphate 1.50243 1.29932 
Guanine 1.50208 1.36583 
AICAR 1.50206 1.30604 
dTDP 1.49856 1.39025 
Succinate/Methylmalonate 1.49764 1.30887 
FAD 1.45132 1.24881 
Guanosine 1.42062 1.22071 
UDP-glucuronate 1.41112 1.21236 
UMP 1.40906 1.33120 
Phenylalanine 1.39964 1.21857 
Tryptophan 1.39940 1.20299 
CMP 1.37684 1.18199 
2-Hydroxy-2-methylsuccinate 1.34826 1.19411 
Tyrosine 1.30842 1.12363 
Deoxyribose phosphate 1.30651 1.14087 
Methionine 1.30122 1.12507 
Lysine 1.30011 1.11473 
Citrate/isocitrate 1.28548 1.11829 
Histidinol 1.28216 1.11433 
FMN 1.25433 1.08018 
Homocystine 1.23846 1.06614 
NADH 1.22256 1.09975 
Glycerone phosphate 1.21841 1.04605 
S-Adenosyl-L-methioninamine 1.18527 1.02807 
Lipoate 1.17091 1.01205 
Ribose phosphate 1.16526 0.99911 
Uridine 1.14919 1.04710 
Histidine 1.11666 1.03669 
Acetylphosphate 1.10824 1.03810 
UDP-N-acetylglucosamine 1.10323 0.94880 
Citrulline 1.10294 0.99247 
Uracil 1.08479 1.10097 
Allantoin 1.06258 1.03374 
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Table 16. Continued. 
Metabolite Component 1 Component 2 
Adenosine 1.05546 1.08837 
Sedoheptoluse bisphosphate 1.04062 0.95559 
Leucine/Isoleucine 1.00898 0.96469 
Alanine/Sarcosine 0.97716 1.05681 
D-Gluconate 0.90413 1.04520 
Dephospho-CoA 0.89718 1.00083 
Phenyllactic acid 0.86806 1.35070 
Malate 0.56711 1.13021 
Valine 0.55355 1.07655 
Cysteine 0.48347 1.12674 
Homoserine/Threonine 0.41919 1.13215 
2-Dehydro-D-gluconate 0.35256 1.12877 
Fumarate 0.32495 1.07013 
2-Aminoadipate 0.19590 1.05751 






Table 17. X. nematophila supernatant top VIP scores. 
Metabolites Component 1 Component 2 
Valine 1.56439 1.42869 
Leucine/Isoleucine 1.53484 1.40497 
Uracil 1.49572 1.45030 
Deoxyribose phosphate 1.47138 1.30673 
Inosine 1.44952 1.29413 
Phosphoenolpyruvate 1.42618 1.26056 
O-Acetyl-L-serine 1.40388 1.24111 
Citrulline 1.40197 1.30565 
Tryptophan 1.36852 1.21813 
N-Acetylglutamate 1.35695 1.21030 
Phenylalanine 1.35167 1.55223 
6-Phospho-D-gluconate 1.34402 1.20394 
2-Dehydro-D-gluconate 1.34070 1.18615 
UDP glucose 1.31546 1.20901 
D-Gluconate 1.30653 1.16868 
Citrate/isocitrate 1.27542 1.14331 
Nicotinate 1.26601 1.11930 
Malate 1.22379 1.16489 
Guanosine 1.20259 1.07568 
Pyruvate 1.20054 1.12470 
Ornithine 1.19638 1.05909 
Hypoxanthine 1.17702 1.05332 
Ribose phosphate 1.16857 1.04021 
Fructose-1-6-bisphosphate 1.10632 1.04797 
Phenylpyruvate 1.09177 0.97723 
UDP 1.04696 1.02680 
3-Phosphoglycerate 1.03688 0.98286 
Tyrosine 1.03133 1.09314 
Xylitol-5-phosphate 1.00944 0.90164 
Dephospho-CoA 0.90985 1.05237 
NADP+ 0.75328 1.04958 
Thymine 0.57284 1.19543 
N-Acetylglucosamine-1-6-phosphate 0.48750 1.15191 
Uridine 0.30100 1.07233 




Table 18. Intensities of G. mellonella replicates in uninfected group. 
Metabolite Uninfected-1 Uninfected-2 Uninfected-3 Uninfected-4 Uninfected-5 
Glyoxylate 0.00E+00 0.00E+00 0.00E+00 2.10E+03 5.29E+06 
Glycine 8.98E+04 1.00E+05 7.59E+04 2.09E+05 2.64E+08 
Pyruvate 3.72E+08 6.15E+08 3.48E+08 5.10E+08 2.47E+08 
Alanine/Sarcosine 5.66E+08 9.27E+08 5.53E+08 1.33E+09 6.29E+08 
Lactate 3.58E+08 3.63E+08 3.42E+08 8.62E+08 4.73E+08 
Dimethylglycine 2.21E+07 2.24E+07 2.25E+07 2.74E+07 2.37E+07 
Serine 2.97E+07 4.15E+07 2.01E+07 4.84E+07 5.55E+07 
Histamine 2.38E+05 3.74E+05 2.00E+05 3.43E+05 2.41E+05 
Uracil 1.90E+07 6.39E+06 1.34E+07 4.04E+07 1.55E+07 
Creatinine 7.71E+03 2.51E+04 0.00E+00 1.92E+03 2.26E+03 
Proline 5.25E+09 1.44E+10 4.45E+09 7.66E+09 8.04E+09 
Fumarate 9.34E+07 1.38E+08 7.53E+07 2.10E+08 1.22E+08 
2-Oxoisovalerate 8.73E+06 1.02E+07 5.81E+06 1.47E+07 4.31E+06 
Indole 1.72E+06 4.73E+06 1.19E+06 3.97E+06 9.57E+05 
Valine 7.58E+08 1.34E+09 4.69E+08 1.10E+09 4.61E+08 
3-Hydroxyisovaleric acid 1.13E+07 2.17E+07 1.10E+07 4.33E+07 8.72E+06 
Homoserine/Threonine 1.17E+08 2.53E+08 8.89E+07 2.20E+08 2.83E+07 
3-Methylthiopropionate 8.74E+04 2.07E+05 1.70E+05 8.51E+05 1.48E+04 
Cysteine 1.45E+06 2.16E+06 1.36E+06 5.13E+06 3.35E+06 
Nicotinate 4.76E+07 1.68E+07 3.85E+07 7.21E+07 4.05E+07 





Table 18. Continued.  
Metabolite Uninfected-1 Uninfected-2 Uninfected-3 Uninfected-4 Uninfected-5 
Thymine 8.18E+06 1.18E+07 8.83E+06 1.11E+07 4.58E+06 
Hydroxyproline 1.10E+06 2.08E+06 1.86E+06 1.13E+06 1.08E+06 
N-Acetyl-beta-alanine 4.92E+06 1.25E+07 5.29E+06 1.25E+07 6.03E+06 
Leucine/Isoleucine 1.93E+09 4.87E+09 1.18E+09 2.23E+09 2.09E+09 
Glutaric acid 3.95E+07 1.49E+08 4.85E+07 1.42E+08 5.81E+07 
Asparagine 1.57E+08 3.49E+08 1.56E+08 2.75E+08 1.10E+08 
Hydroxyisocaproic acid 4.75E+07 1.27E+08 3.35E+07 2.38E+08 4.01E+07 
Ornithine 2.83E+06 5.20E+06 2.53E+06 8.34E+06 5.00E+06 
Salicylate 1.12E+07 3.77E+07 1.85E+07 2.45E+07 1.51E+07 
Hydroxybenzoate 7.35E+05 1.87E+06 6.44E+05 2.29E+06 1.08E+06 
Histidinol 4.68E+04 6.71E+04 3.23E+04 4.79E+04 3.48E+04 
2-Oxoglutaric acid 2.84E+08 7.80E+08 2.83E+08 2.88E+08 1.23E+08 
Glutamine 1.09E+09 3.00E+09 1.14E+09 1.62E+09 1.60E+09 
2-hydroxyglutarate 6.11E+07 1.45E+08 6.51E+07 1.42E+08 6.97E+07 
2-Hydroxy-2-methylsuccinate 6.08E+07 1.45E+08 6.48E+07 1.42E+08 6.93E+07 
L-Methionine 4.49E+07 9.11E+07 2.34E+07 4.99E+07 3.70E+07 
Guanine 1.04E+04 4.32E+04 9.91E+04 1.11E+05 3.85E+04 
3-Methylphenylacetic acid 1.38E+06 3.34E+06 1.38E+06 4.52E+06 4.04E+05 
Hydroxyphenylacetate 1.19E+06 1.89E+06 3.12E+06 1.56E+06 1.03E+06 
Xylitol 1.05E+07 6.26E+06 7.95E+06 1.38E+07 1.02E+07 
Dopamine 7.13E+07 7.78E+08 1.23E+08 3.79E+08 1.38E+08 





Table 18. Continued. 
Metabolite Uninfected-1 Uninfected-2 Uninfected-3 Uninfected-4 Uninfected-5 
Histidine 3.76E+08 5.20E+08 2.99E+08 4.70E+08 3.67E+08 
Orotate 4.59E+05 3.30E+06 5.06E+05 3.96E+06 2.48E+06 
Dihydroorotate 4.63E+05 1.20E+06 4.75E+05 1.46E+06 2.31E+05 
Allantoin 1.12E+07 3.53E+06 7.47E+06 6.04E+06 2.88E+06 
Indole-3-carboxylate 1.52E+05 5.44E+05 1.66E+05 6.94E+05 2.92E+05 
Phenylpyruvate 9.53E+05 2.75E+06 1.83E+06 2.42E+06 1.29E+06 
Phenylalanine 9.98E+08 4.14E+09 9.82E+08 1.64E+09 7.29E+08 
Phenyllactic acid 1.83E+06 6.46E+06 2.34E+06 1.45E+07 1.77E+06 
Quinolinate 5.22E+03 2.17E+05 2.88E+04 1.61E+05 1.70E+05 
Phosphoenolpyruvate 1.74E+06 5.34E+06 1.07E+06 2.51E+06 2.16E+06 
Uric acid 7.08E+08 9.28E+08 6.02E+08 1.61E+09 7.24E+08 
3_4-Dihydroxyphenylacetate 
(DOPAC) 1.68E+05 3.52E+05 1.92E+05 2.42E+05 1.29E+05 
Sulfolactate 2.58E+06 4.23E+06 1.47E+06 2.88E+06 3.03E+06 
Glycerone phosphate 5.84E+06 4.25E+07 8.52E+06 9.75E+06 2.20E+07 
Arginine 7.31E+07 1.19E+08 8.82E+07 7.87E+07 7.44E+07 
Citrulline 1.65E+06 1.67E+06 1.06E+06 2.66E+06 9.54E+05 
Ascorbate 2.79E+08 1.27E+09 4.72E+08 4.89E+08 5.90E+08 
N-Carbamoyl-L-aspartate 1.29E+06 5.39E+06 1.21E+06 5.14E+06 2.10E+06 
Allantoate 5.61E+08 8.20E+08 5.50E+08 2.71E+08 2.79E+08 
2-Isopropylmalate 1.49E+06 4.20E+06 1.00E+07 3.04E+06 4.86E+06 





Table 18. Continued. 
Metabolite Uninfected-1 Uninfected-2 Uninfected-3 Uninfected-4 Uninfected-5 
myo-Inositol 3.02E+07 3.13E+07 2.30E+07 5.94E+07 3.45E+07 
Tyrosine 1.04E+09 2.59E+09 8.48E+08 1.90E+09 8.50E+08 
Homovanillic acid (HVA) 1.58E+07 3.74E+07 1.39E+07 4.52E+07 8.50E+06 
Homocysteic acid 2.44E+03 0.00E+00 0.00E+00 3.85E+03 2.40E+03 
4-Pyridoxate 3.53E+06 6.81E+06 3.57E+06 6.27E+06 3.05E+06 
N-Acetylglutamine 1.01E+07 6.94E+07 7.26E+06 2.13E+07 2.89E+07 
Citrate/isocitrate 1.82E+10 4.48E+10 1.29E+10 1.74E+10 2.23E+10 
D-Gluconate 1.33E+08 2.49E+08 8.31E+07 2.26E+08 1.49E+08 
N-N Dimethylarginine 4.46E+05 5.16E+05 4.60E+05 7.69E+05 4.79E+05 
Tryptophan 5.34E+08 1.31E+09 3.80E+08 1.09E+09 3.21E+08 
Xanthurenic acid 1.75E+07 5.37E+06 1.27E+07 1.67E+08 5.40E+06 
D-Glucarate 2.00E+09 2.96E+09 6.08E+08 2.79E+09 3.68E+09 
Pantothenate 9.43E+08 2.11E+09 7.89E+08 1.66E+09 9.17E+08 
Cystathionine 1.48E+07 4.43E+06 3.57E+06 3.56E+07 3.44E+06 
Cystine 6.39E+05 2.47E+05 9.47E+05 1.47E+06 1.60E+05 
Uridine 1.36E+05 3.96E+05 1.96E+05 2.95E+05 2.03E+05 
Biotin 2.23E+06 2.64E+06 2.83E+06 5.22E+06 9.59E+05 
Deoxyinosine 3.36E+03 2.16E+03 0.00E+00 0.00E+00 0.00E+00 
Glucose 6-phosphate 3.73E+08 2.75E+08 3.61E+08 4.45E+08 4.51E+08 
S-Ribosyl-L-homocysteine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
6-Phospho-D-gluconate 4.72E+06 3.79E+06 7.52E+06 4.79E+06 2.80E+06 





Table 18. Continued. 
Metabolite Uninfected-1 Uninfected-2 Uninfected-3 Uninfected-4 Uninfected-5 
Xanthosine 1.50E+05 2.93E+05 7.89E+04 2.69E+05 6.27E+05 
Glycinamide ribotide (GAR) 2.48E+04 1.91E+05 0.00E+00 3.38E+04 0.00E+00 
Ophthalmate 2.01E+06 4.54E+06 1.32E+06 1.33E+06 1.39E+06 
Glutathione 1.29E+08 4.00E+08 6.89E+07 3.50E+08 3.69E+08 
UMP 1.58E+08 4.38E+08 1.46E+08 3.06E+08 2.97E+08 
AICAR 5.74E+06 2.67E+07 7.18E+05 3.96E+06 7.04E+05 
Trehalose/Sucrose/Cellobiose 2.70E+07 3.06E+07 2.90E+07 1.69E+07 2.80E+07 
AMP/dGMP 1.97E+09 1.29E+09 1.90E+09 2.50E+09 2.78E+09 
IMP 3.36E+07 2.44E+07 2.37E+07 1.41E+08 3.34E+07 
GMP 1.26E+08 7.27E+07 1.05E+08 2.28E+08 1.66E+08 
Xanthosine 5--phosphate 3.32E+04 2.96E+04 0.00E+00 5.75E+04 3.02E+04 
Riboflavin 2.75E+06 3.39E+06 3.89E+06 7.44E+06 1.29E+06 
S-Adenosyl-L-homocysteine 7.97E+04 7.65E+04 5.25E+04 1.03E+05 5.36E+04 
ADP 2.10E+08 1.33E+09 2.21E+08 2.05E+08 2.34E+08 
Folate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
CDP-ethanolamine 4.20E+06 1.14E+07 4.71E+06 5.49E+06 6.31E+06 
FMN 7.96E+06 1.27E+07 6.48E+06 9.70E+06 5.90E+06 
UDP-glucose 8.72E+07 2.42E+08 4.50E+07 1.86E+08 8.92E+07 
NAD+ 4.06E+07 1.03E+08 4.29E+07 6.68E+07 5.30E+07 
NADH 2.24E+06 1.46E+06 3.18E+06 5.05E+06 6.42E+06 
Dephospho-CoA 9.34E+05 1.98E+06 7.16E+05 2.07E+06 2.12E+06 





Table 18. Continued.  
Metabolite Uninfected-1 Uninfected-2 Uninfected-3 Uninfected-4 Uninfected-5 
FAD 8.93E+05 6.34E+06 5.33E+05 7.90E+05 2.61E+06 
N-Acetylglutamate 5.59E+07 2.48E+08 5.92E+07 1.01E+08 1.66E+08 





Table 19. Intensities of G. mellonella replicates in 1-Hour post infection group. 
Metabolite 1 Hour-1 1 Hour-2 1 Hour-3 1 Hour-4 1 Hour-5 
Glyoxylate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Glycine 7.21E+04 4.83E+04 2.26E+04 3.28E+04 1.86E+04 
Pyruvate 5.61E+08 7.10E+08 3.96E+08 1.98E+08 5.17E+08 
Alanine/Sarcosine 3.96E+08 7.99E+08 1.06E+09 3.97E+08 4.61E+08 
Lactate 4.66E+08 3.48E+08 4.64E+08 3.63E+08 3.80E+08 
Dimethylglycine 1.95E+07 3.19E+07 1.70E+07 1.61E+07 2.95E+07 
Serine 1.79E+08 4.25E+07 5.17E+07 8.45E+07 6.20E+07 
Histamine 4.63E+05 4.18E+05 3.27E+05 1.90E+05 3.10E+05 
Uracil 5.10E+06 6.65E+06 1.87E+07 1.35E+07 2.27E+07 
Creatinine 2.36E+04 3.01E+04 1.20E+04 5.77E+03 2.08E+04 
Proline 1.68E+10 9.07E+09 1.07E+10 5.16E+09 8.38E+09 
Fumarate 1.62E+08 2.44E+08 1.60E+08 7.69E+07 1.13E+08 
2-Oxoisovalerate 7.36E+06 1.13E+07 8.25E+06 4.83E+06 4.95E+06 
Indole 4.75E+06 2.76E+06 3.99E+06 7.18E+05 4.24E+06 
Valine 9.86E+08 1.03E+09 8.93E+08 5.86E+08 7.85E+08 
3-Hydroxyisovaleric acid 1.53E+07 1.43E+07 9.81E+06 9.40E+06 6.49E+06 
Homoserine/Threonine 1.09E+08 4.72E+08 1.90E+08 3.31E+07 3.11E+07 
3-Methylthiopropionate 2.73E+05 1.64E+05 1.09E+04 1.40E+05 1.50E+04 
Cysteine 1.26E+06 2.36E+06 3.18E+06 1.70E+06 4.60E+06 
Nicotinate 1.88E+07 2.11E+07 5.68E+07 3.84E+07 4.34E+07 
Taurine 5.45E+06 3.93E+06 3.95E+06 1.76E+06 8.82E+06 




Table 19. Continued.  
Metabolite 1 Hour-1 1 Hour-2 1 Hour-3 1 Hour-4 1 Hour-5 
Hydroxyproline 2.59E+06 1.43E+06 1.82E+06 1.05E+06 2.60E+06 
N-Acetyl-beta-alanine 1.23E+07 1.54E+07 7.69E+06 3.82E+06 7.84E+06 
Leucine/Isoleucine 3.90E+09 2.47E+09 3.15E+09 1.82E+09 2.43E+09 
Glutaric acid 2.56E+08 1.95E+08 1.05E+08 2.64E+07 5.61E+07 
Asparagine 1.66E+08 8.94E+08 2.46E+08 8.57E+07 1.08E+08 
Hydroxyisocaproic acid 1.22E+08 6.55E+07 4.37E+07 2.92E+07 1.93E+07 
Ornithine 5.73E+06 2.42E+06 6.58E+06 2.76E+06 5.81E+06 
Salicylate 2.65E+07 2.92E+07 1.43E+07 1.52E+07 1.56E+07 
Hydroxybenzoate 2.50E+06 3.77E+06 1.35E+06 5.81E+05 1.91E+06 
Histidinol 6.41E+04 9.75E+04 3.91E+04 3.81E+04 1.25E+05 
2-Oxoglutaric acid 1.53E+09 1.03E+09 1.97E+08 1.86E+08 6.52E+08 
Glutamine 2.90E+09 1.10E+09 2.43E+09 1.17E+09 1.40E+09 
2-hydroxyglutarate 2.91E+08 1.38E+08 6.97E+07 6.46E+07 7.45E+07 
2-Hydroxy-2-methylsuccinate 2.91E+08 1.37E+08 6.96E+07 6.45E+07 7.42E+07 
L-Methionine 4.58E+07 7.74E+07 3.77E+07 1.79E+07 6.27E+07 
Guanine 1.03E+05 9.72E+04 9.24E+04 0.00E+00 3.09E+04 
3-Methylphenylacetic acid 4.05E+06 2.92E+06 6.96E+05 1.07E+06 5.91E+05 
Hydroxyphenylacetate 1.65E+06 1.56E+06 1.02E+06 1.10E+06 1.05E+06 
Xylitol 5.25E+06 5.88E+06 1.09E+07 6.99E+06 9.73E+06 
Dopamine 5.30E+08 4.83E+08 4.71E+08 9.01E+07 3.87E+08 
2_3-Dihydroxybenzoate 1.26E+04 1.66E+05 3.92E+04 2.34E+05 1.14E+05 
Histidine 5.94E+08 5.72E+08 3.72E+08 2.66E+08 4.46E+08 




Table 19. Continued.  
Metabolite 1 Hour-1 1 Hour-2 1 Hour-3 1 Hour-4 1 Hour-5 
Dihydroorotate 1.02E+06 2.20E+06 9.70E+05 2.90E+05 2.19E+05 
Allantoin 1.40E+06 2.99E+06 1.77E+07 6.23E+05 7.31E+06 
Indole-3-carboxylate 9.38E+05 1.41E+06 2.54E+05 1.68E+05 2.43E+05 
Phenylpyruvate 3.30E+06 2.39E+06 1.19E+06 5.99E+05 9.36E+05 
Phenylalanine 1.28E+09 1.73E+09 2.02E+09 9.22E+07 1.85E+09 
Phenyllactic acid 4.76E+06 6.64E+06 2.31E+06 7.21E+05 2.06E+06 
Quinolinate 4.49E+04 2.00E+06 1.33E+05 3.12E+04 3.33E+04 
Phosphoenolpyruvate 7.63E+06 3.62E+06 2.50E+06 1.20E+06 2.64E+06 
Uric acid 3.29E+07 2.05E+09 7.60E+08 2.97E+07 4.33E+08 
3_4-Dihydroxyphenylacetate 
(DOPAC) 2.39E+05 1.09E+06 1.89E+05 7.69E+04 2.65E+05 
Sulfolactate 3.18E+06 1.22E+07 1.94E+06 7.30E+05 2.63E+06 
Glycerone phosphate 4.21E+07 3.61E+07 3.20E+07 9.51E+06 5.16E+07 
Arginine 1.16E+08 7.59E+07 9.25E+07 8.79E+07 9.77E+07 
Citrulline 7.38E+05 7.72E+05 2.91E+06 8.89E+05 1.45E+06 
Ascorbate 1.50E+09 6.60E+08 5.87E+08 7.71E+08 7.30E+08 
N-Carbamoyl-L-aspartate 5.21E+06 5.85E+06 8.32E+06 3.76E+05 2.06E+06 
Allantoate 4.67E+08 3.22E+08 1.10E+09 7.23E+07 6.00E+08 
2-Isopropylmalate 3.46E+06 1.52E+07 4.53E+06 1.11E+06 2.47E+06 
Glucosamine 5.49E+05 1.75E+05 3.10E+05 6.01E+05 6.04E+05 
myo-Inositol 3.40E+07 5.74E+07 2.11E+07 2.07E+07 2.60E+07 
Tyrosine 1.48E+09 1.98E+09 1.74E+09 6.28E+08 1.60E+09 




Table 19. Continued.  
Metabolite 1 Hour-1 1 Hour-2 1 Hour-3 1 Hour-4 1 Hour-5 
Homocysteic acid 0.00E+00 1.40E+04 2.20E+03 0.00E+00 0.00E+00 
4-Pyridoxate 8.42E+06 1.22E+07 3.40E+06 4.38E+06 4.70E+06 
N-Acetylglutamine 1.78E+08 2.79E+07 3.15E+07 7.94E+06 2.73E+07 
Citrate/isocitrate 4.78E+10 3.56E+10 2.11E+10 1.12E+10 2.52E+10 
D-Gluconate 2.41E+08 2.96E+08 1.49E+08 7.35E+07 1.57E+08 
N-N Dimethylarginine 5.92E+05 5.89E+05 3.80E+05 5.04E+05 3.39E+05 
Tryptophan 1.36E+09 8.48E+08 1.11E+09 2.43E+08 1.17E+09 
Xanthurenic acid 3.02E+08 1.55E+09 4.89E+07 1.39E+07 5.11E+07 
D-Glucarate 2.60E+09 2.85E+09 1.14E+09 1.57E+09 1.68E+09 
Pantothenate 1.83E+09 2.74E+09 1.15E+09 7.35E+08 1.50E+09 
Cystathionine 3.15E+06 1.66E+08 3.63E+06 2.65E+06 9.28E+07 
Cystine 3.51E+05 4.60E+05 6.07E+05 6.01E+05 7.84E+05 
Uridine 3.90E+05 6.15E+05 2.34E+05 1.34E+05 2.79E+05 
Biotin 1.28E+06 4.78E+06 2.46E+06 1.89E+06 2.91E+06 
Deoxyinosine 0.00E+00 2.17E+03 0.00E+00 1.62E+03 0.00E+00 
Glucose 6-phosphate 1.97E+08 2.15E+08 3.51E+08 4.33E+08 4.47E+08 
S-Ribosyl-L-homocysteine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
6-Phospho-D-gluconate 4.73E+06 2.99E+06 3.81E+06 3.56E+06 8.10E+06 
Guanosine 2.72E+07 2.19E+07 5.62E+06 1.30E+07 1.17E+07 
Xanthosine 2.32E+05 2.35E+06 2.66E+05 3.25E+04 1.53E+05 
Glycinamide ribotide (GAR) 4.35E+04 8.54E+03 1.81E+04 6.56E+03 2.52E+04 
Ophthalmate 1.92E+06 4.20E+06 1.62E+06 7.86E+05 2.36E+06 




Table 19. Continued.  
Metabolite 1 Hour-1 1 Hour-2 1 Hour-3 1 Hour-4 1 Hour-5 
UMP 4.07E+08 5.54E+08 3.14E+08 1.57E+08 3.48E+08 
AICAR 6.49E+05 8.03E+06 4.70E+06 1.13E+05 1.07E+06 
Trehalose/Sucrose/Cellobiose 3.68E+07 3.64E+07 2.15E+07 2.73E+07 4.29E+07 
AMP/dGMP 1.55E+09 1.18E+09 2.82E+09 1.85E+09 2.67E+09 
IMP 3.42E+07 3.54E+07 5.08E+07 3.00E+07 2.61E+07 
GMP 9.35E+07 7.01E+07 1.85E+08 1.06E+08 1.75E+08 
Xanthosine 5--phosphate 1.02E+05 6.34E+04 2.64E+04 6.99E+03 5.27E+04 
Riboflavin 1.25E+06 1.37E+07 2.90E+06 1.27E+06 3.97E+06 
S-Adenosyl-L-homocysteine 1.81E+04 1.08E+05 7.44E+04 3.85E+04 2.28E+05 
ADP 1.27E+09 9.03E+08 3.47E+08 1.87E+08 4.22E+08 
Folate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
CDP-ethanolamine 1.10E+07 6.91E+06 7.29E+06 4.14E+06 6.79E+06 
FMN 1.04E+07 1.34E+07 1.16E+07 5.27E+06 1.17E+07 
UDP-glucose 2.15E+08 2.55E+08 7.72E+07 4.38E+07 1.01E+08 
NAD+ 9.94E+07 1.21E+08 5.39E+07 3.75E+07 6.27E+07 
NADH 2.53E+06 8.86E+05 4.10E+06 3.80E+06 6.44E+06 
Dephospho-CoA 1.36E+06 7.43E+05 2.68E+06 1.05E+06 1.69E+06 
NADP+ 1.14E+07 8.18E+06 5.54E+06 4.71E+06 5.33E+06 
FAD 4.92E+06 3.08E+06 1.35E+06 4.91E+05 3.21E+06 
N-Acetylglutamate 2.72E+08 2.47E+08 1.36E+08 4.83E+07 1.44E+08 




Table 20. Intensities of G. mellonella replicates in 12-Hour post infection group 
Metabolite 12 Hours-1 12 Hours-2 12 Hours-3 12 Hours-4 12 Hours-5 
Glyoxylate 0.00E+00 5.10E+06 5.23E+06 3.58E+03 3.16E+03 
Glycine 1.19E+05 7.22E+08 3.80E+08 1.06E+04 5.74E+04 
Pyruvate 1.17E+09 4.98E+08 5.92E+08 3.94E+08 6.53E+08 
Alanine/Sarcosine 1.03E+09 4.32E+08 3.07E+08 3.89E+08 1.58E+09 
Lactate 9.03E+08 5.77E+08 3.97E+08 4.89E+08 1.06E+09 
Dimethylglycine 3.76E+07 3.23E+07 2.74E+07 3.50E+07 3.95E+07 
Serine 1.63E+08 4.34E+07 7.04E+07 1.19E+08 1.63E+08 
Histamine 2.74E+05 4.69E+05 2.89E+05 3.54E+05 3.61E+05 
Uracil 4.21E+07 1.07E+07 8.36E+06 3.14E+07 8.29E+06 
Creatinine 4.66E+04 1.24E+04 9.05E+03 8.37E+03 1.95E+04 
Proline 1.47E+10 1.82E+10 1.16E+10 1.29E+10 1.27E+10 
Fumarate 3.40E+08 1.28E+08 1.04E+08 1.11E+08 3.02E+08 
2-Oxoisovalerate 1.58E+07 1.17E+07 5.64E+06 7.05E+06 7.86E+06 
Indole 3.56E+06 6.38E+06 1.46E+06 1.55E+06 2.59E+06 
Valine 1.98E+09 1.45E+09 1.18E+09 8.93E+08 1.03E+09 
3-Hydroxyisovaleric acid 1.67E+07 2.06E+07 8.43E+06 9.24E+06 1.43E+07 
Homoserine/Threonine 1.66E+08 3.38E+08 4.41E+07 5.06E+07 4.37E+07 
3-Methylthiopropionate 1.94E+05 1.30E+04 2.28E+04 2.65E+04 5.83E+05 
Cysteine 2.14E+06 3.42E+06 1.62E+06 2.35E+06 1.75E+06 
Nicotinate 1.27E+08 4.68E+07 2.95E+07 7.94E+07 5.06E+07 
Taurine 7.77E+06 2.02E+06 3.41E+05 5.52E+06 1.13E+06 
Thymine 8.18E+06 2.74E+06 2.57E+06 1.11E+07 1.04E+07 
Hydroxyproline 3.25E+06 2.05E+06 7.82E+05 4.10E+06 1.28E+06 
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Table 20. Continued.  
Metabolite 12 Hours-1 12 Hours-2 12 Hours-3 12 Hours-4 12 Hours-5 
N-Acetyl-beta-alanine 1.30E+07 1.03E+07 6.50E+06 9.28E+06 1.17E+07 
Leucine/Isoleucine 5.19E+09 3.67E+09 4.21E+09 3.94E+09 3.91E+09 
Glutaric acid 8.94E+07 1.22E+08 5.88E+07 9.85E+07 9.19E+07 
Asparagine 3.13E+08 4.18E+08 1.38E+08 1.76E+08 1.73E+08 
Hydroxyisocaproic acid 1.04E+08 2.84E+08 3.79E+07 4.85E+07 9.94E+07 
Ornithine 4.03E+06 6.83E+06 3.87E+06 4.76E+06 3.57E+06 
Salicylate 3.43E+07 3.39E+07 2.40E+07 1.63E+07 2.31E+07 
Hydroxybenzoate 1.31E+06 9.06E+05 7.94E+05 9.99E+05 1.07E+06 
Histidinol 5.33E+04 6.56E+04 4.37E+04 5.50E+04 6.22E+04 
2-Oxoglutaric acid 1.24E+09 6.01E+08 6.58E+08 5.55E+08 4.30E+08 
Glutamine 3.17E+09 2.26E+09 1.35E+09 1.35E+09 1.89E+09 
2-hydroxyglutarate 3.02E+08 2.37E+08 2.38E+08 3.23E+08 1.04E+09 
2-Hydroxy-2-methylsuccinate 3.01E+08 2.36E+08 2.38E+08 3.23E+08 1.04E+09 
L-Methionine 9.19E+07 5.91E+07 3.86E+07 6.56E+07 7.58E+07 
Guanine 3.86E+04 2.31E+04 1.16E+04 2.28E+03 3.59E+04 
3-Methylphenylacetic acid 2.82E+06 5.89E+05 9.48E+05 5.21E+05 4.82E+06 
Hydroxyphenylacetate 1.31E+06 3.25E+06 1.89E+06 1.08E+06 1.39E+06 
Xylitol 2.02E+07 1.40E+07 9.16E+06 1.49E+07 1.21E+07 
Dopamine 1.10E+09 6.05E+08 3.76E+08 5.17E+08 5.38E+08 
2_3-Dihydroxybenzoate 1.37E+05 0.00E+00 1.75E+05 1.83E+04 1.12E+05 
Histidine 4.93E+08 4.95E+08 4.16E+08 4.93E+08 5.17E+08 
Orotate 5.56E+06 3.40E+06 2.19E+06 2.82E+06 1.14E+07 
Dihydroorotate 1.42E+06 1.17E+06 8.28E+05 7.68E+05 4.01E+06 
Allantoin 2.92E+07 6.95E+06 2.17E+06 1.97E+06 3.54E+06 
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Table 20. Continued.  
Metabolite 12 Hours-1 12 Hours-2 12 Hours-3 12 Hours-4 12 Hours-5 
Indole-3-carboxylate 6.71E+05 3.70E+05 1.89E+05 2.25E+05 4.99E+05 
Phenylpyruvate 1.02E+07 6.79E+06 6.68E+05 9.25E+05 2.35E+06 
Phenylalanine 2.08E+09 3.93E+09 2.10E+08 1.81E+09 9.12E+08 
Phenyllactic acid 4.52E+06 6.25E+06 1.16E+06 2.81E+06 4.32E+06 
Quinolinate 6.38E+04 4.20E+03 1.88E+06 1.45E+04 7.60E+04 
Phosphoenolpyruvate 2.36E+06 7.04E+05 3.26E+06 4.66E+06 3.41E+06 
Uric acid 3.74E+08 9.42E+08 1.07E+08 7.32E+07 3.84E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 2.75E+05 2.72E+05 1.24E+05 1.38E+05 2.19E+05 
Sulfolactate 3.50E+06 4.28E+06 1.13E+06 2.43E+06 3.37E+06 
Glycerone phosphate 1.89E+07 3.16E+07 4.75E+07 2.14E+07 2.62E+07 
Arginine 1.36E+08 9.70E+07 1.10E+08 1.01E+08 1.24E+08 
Citrulline 5.86E+06 1.98E+06 9.89E+05 3.09E+06 1.84E+06 
Ascorbate 5.36E+08 6.40E+08 5.06E+08 6.41E+08 1.86E+09 
N-Carbamoyl-L-aspartate 3.58E+06 4.28E+06 3.22E+06 1.96E+06 1.36E+07 
Allantoate 9.99E+08 7.05E+08 3.15E+08 3.17E+08 4.65E+08 
2-Isopropylmalate 2.95E+06 1.49E+06 5.76E+06 1.94E+06 2.81E+06 
Glucosamine 9.00E+05 6.10E+05 7.12E+05 8.05E+05 8.12E+05 
myo-Inositol 3.26E+07 2.28E+07 2.51E+07 1.85E+07 3.07E+07 
Tyrosine 1.74E+09 2.74E+09 1.23E+09 1.52E+09 1.83E+09 
Homovanillic acid (HVA) 2.24E+07 5.06E+07 8.17E+06 7.01E+06 1.68E+07 
Homocysteic acid 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
4-Pyridoxate 6.34E+06 6.06E+06 3.18E+06 4.26E+06 5.81E+06 
N-Acetylglutamine 1.10E+08 2.18E+08 1.90E+07 5.08E+07 3.90E+07 
Citrate/isocitrate 3.47E+10 3.63E+10 2.42E+10 2.47E+10 2.78E+10 
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Table 20. Continued.  
Metabolite 12 Hours-1 12 Hours-2 12 Hours-3 12 Hours-4 12 Hours-5 
D-Gluconate 3.02E+08 2.37E+08 1.52E+08 1.69E+08 1.99E+08 
N-N Dimethylarginine 2.92E+05 3.49E+05 5.44E+05 5.49E+05 4.71E+05 
Tryptophan 1.05E+09 1.78E+09 4.91E+08 4.88E+08 8.43E+08 
Xanthurenic acid 2.68E+07 3.71E+07 9.80E+06 9.77E+06 2.28E+07 
D-Glucarate 1.87E+09 2.43E+09 2.73E+09 1.48E+09 1.57E+09 
Pantothenate 2.07E+09 1.69E+09 1.27E+09 1.14E+09 1.77E+09 
Cystathionine 5.19E+06 4.31E+06 4.31E+06 4.96E+06 7.99E+06 
Cystine 5.99E+05 5.64E+04 1.33E+05 3.43E+05 3.42E+05 
Uridine 4.92E+05 2.75E+05 2.52E+05 2.73E+05 3.04E+05 
Biotin 2.65E+06 2.73E+06 1.78E+06 2.51E+06 2.91E+06 
Deoxyinosine 1.96E+03 0.00E+00 0.00E+00 0.00E+00 5.90E+03 
Glucose 6-phosphate 5.99E+08 4.74E+08 4.85E+08 5.32E+08 2.38E+08 
S-Ribosyl-L-homocysteine 0.00E+00 0.00E+00 0.00E+00 1.22E+04 0.00E+00 
6-Phospho-D-gluconate 1.46E+07 2.67E+06 3.93E+06 9.95E+06 5.93E+06 
Guanosine 3.73E+06 8.87E+06 1.25E+07 1.03E+07 1.77E+07 
Xanthosine 4.28E+05 1.38E+05 8.11E+04 1.50E+05 1.66E+05 
Glycinamide ribotide (GAR) 1.97E+05 6.27E+05 1.95E+05 9.16E+04 2.21E+05 
Ophthalmate 5.99E+06 8.82E+06 2.74E+06 4.62E+06 1.34E+06 
Glutathione 8.23E+07 2.51E+08 2.96E+08 2.10E+08 5.31E+08 
UMP 3.57E+08 5.12E+08 3.63E+08 3.63E+08 4.25E+08 
AICAR 2.05E+06 2.43E+07 2.06E+06 5.14E+05 8.65E+05 
Trehalose/Sucrose/Cellobiose 2.81E+07 2.66E+07 3.47E+07 3.08E+07 4.51E+07 
AMP/dGMP 3.02E+09 3.21E+09 2.88E+09 2.55E+09 1.75E+09 
IMP 4.26E+08 9.91E+07 4.73E+07 2.58E+08 9.15E+07 
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Table 20. Continued.  
Metabolite 12 Hours-1 12 Hours-2 12 Hours-3 12 Hours-4 12 Hours-5 
GMP 3.10E+08 1.95E+08 1.55E+08 1.98E+08 1.16E+08 
Xanthosine 5--phosphate 1.71E+04 5.75E+04 4.13E+04 7.24E+04 1.20E+04 
Riboflavin 2.36E+06 6.42E+06 1.92E+06 1.83E+06 9.54E+05 
S-Adenosyl-L-homocysteine 1.37E+05 1.19E+05 4.16E+04 6.89E+04 3.27E+04 
ADP 4.28E+08 3.59E+08 4.56E+08 3.10E+08 1.11E+09 
Folate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
CDP-ethanolamine 9.44E+06 8.40E+06 6.85E+06 9.45E+06 9.83E+06 
FMN 1.84E+07 1.65E+07 5.34E+06 8.62E+06 3.28E+06 
UDP-glucose 1.21E+08 1.26E+08 1.38E+08 1.29E+08 1.05E+08 
NAD+ 5.30E+07 7.82E+07 7.12E+07 5.32E+07 8.01E+07 
NADH 2.46E+06 5.00E+06 6.27E+06 6.77E+06 3.61E+06 
Dephospho-CoA 3.14E+06 3.19E+06 1.23E+06 1.97E+06 1.10E+06 
NADP+ 1.12E+07 5.05E+06 5.58E+06 8.06E+06 6.86E+06 
FAD 1.67E+06 2.91E+06 2.02E+06 1.09E+06 2.90E+06 
N-Acetylglutamate 1.42E+08 1.87E+08 1.09E+08 9.95E+07 2.46E+08 




Table 21. Intensities of G. mellonella replicates in 24 hours alive group. 
Metabolite 24 HA-1 24 HA-3 24 HA-4 24 HA-5 
Glyoxylate 0.00E+00 0.00E+00 4.42E+03 0.00E+00 
Glycine 1.20E+05 4.75E+04 6.02E+04 6.32E+04 
Pyruvate 1.07E+09 2.44E+09 2.94E+09 1.06E+09 
Alanine/Sarcosine 2.18E+09 4.91E+08 3.38E+09 4.36E+08 
Lactate 9.24E+08 6.96E+08 1.54E+10 4.07E+08 
Dimethylglycine 5.42E+07 5.00E+07 6.92E+07 1.27E+07 
Serine 6.21E+07 9.56E+07 2.52E+08 4.92E+06 
Histamine 4.25E+05 4.95E+05 4.16E+05 1.72E+05 
Uracil 2.03E+07 3.55E+07 2.77E+07 1.88E+07 
Creatinine 2.76E+03 5.26E+04 1.40E+04 2.51E+03 
Proline 7.89E+09 1.84E+10 1.69E+10 6.22E+09 
Fumarate 2.43E+08 9.52E+07 5.67E+08 6.05E+07 
2-Oxoisovalerate 8.73E+06 1.78E+07 1.24E+07 1.46E+07 
Indole 2.97E+06 4.17E+06 3.25E+06 1.56E+06 
Valine 1.43E+09 1.90E+09 2.31E+09 5.65E+08 
3-Hydroxyisovaleric acid 1.22E+07 1.78E+07 3.81E+07 3.12E+07 
Homoserine/Threonine 1.98E+08 3.32E+08 1.78E+08 1.15E+08 
3-Methylthiopropionate 3.89E+05 2.46E+05 4.87E+05 2.71E+05 
Cysteine 3.49E+05 0.00E+00 2.63E+05 0.00E+00 
Nicotinate 1.59E+08 1.23E+08 2.17E+08 4.58E+07 
Taurine 1.23E+07 3.09E+06 4.21E+06 8.11E+05 
Thymine 6.95E+06 1.06E+07 1.01E+07 5.35E+06 
Hydroxyproline 2.87E+06 1.91E+06 2.26E+06 9.07E+05 
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Table 21. Continued.  
Metabolite 24 HA-1 24 HA-3 24 HA-4 24 HA-5 
N-Acetyl-beta-alanine 1.73E+07 9.96E+06 2.30E+07 5.14E+06 
Leucine/Isoleucine 5.76E+09 7.13E+09 6.92E+09 2.20E+09 
Glutaric acid 4.71E+08 4.16E+07 1.35E+08 7.34E+07 
Asparagine 3.19E+08 2.07E+06 1.85E+08 8.81E+05 
Hydroxyisocaproic acid 8.73E+07 7.23E+07 7.54E+08 2.38E+08 
Ornithine 8.81E+06 5.32E+06 5.27E+06 2.28E+06 
Salicylate 2.63E+07 1.95E+07 4.15E+07 8.93E+06 
Hydroxybenzoate 1.05E+06 3.09E+06 2.12E+06 9.59E+05 
Histidinol 6.55E+04 5.94E+04 1.01E+05 3.40E+04 
2-Oxoglutaric acid 4.56E+08 4.49E+09 5.68E+08 7.56E+08 
Glutamine 3.16E+09 2.54E+09 2.26E+09 1.43E+09 
2-hydroxyglutarate 1.23E+09 3.74E+08 4.40E+09 1.67E+08 
2-Hydroxy-2-methylsuccinate 1.22E+09 3.73E+08 4.38E+09 1.67E+08 
L-Methionine 1.34E+08 2.26E+08 1.90E+08 5.55E+07 
Guanine 3.24E+03 1.92E+04 4.28E+04 3.92E+03 
3-Methylphenylacetic acid 3.12E+06 2.65E+06 2.91E+06 1.12E+06 
Hydroxyphenylacetate 1.16E+06 1.33E+06 1.75E+06 5.91E+05 
Xylitol 2.43E+07 1.87E+07 7.31E+07 9.11E+06 
Dopamine 3.04E+08 3.91E+08 2.75E+08 4.97E+07 
2_3-Dihydroxybenzoate 3.27E+05 9.01E+03 3.09E+05 1.12E+05 
Histidine 6.05E+08 7.22E+08 5.95E+08 2.66E+08 
Orotate 1.00E+07 7.69E+06 4.85E+06 2.79E+06 
Dihydroorotate 6.12E+06 2.28E+06 3.28E+06 1.17E+06 
Allantoin 4.71E+07 2.56E+06 6.54E+06 3.71E+06 
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Table 21. Continued.  
Metabolite 24 HA-1 24 HA-3 24 HA-4 24 HA-5 
Indole-3-carboxylate 5.77E+05 1.10E+06 7.56E+05 4.83E+05 
Phenylpyruvate 4.73E+06 1.94E+07 2.92E+06 1.97E+07 
Phenylalanine 3.56E+09 3.55E+09 1.98E+09 9.84E+08 
Phenyllactic acid 6.30E+06 1.60E+07 1.50E+07 1.21E+07 
Quinolinate 4.14E+04 4.17E+04 2.79E+05 9.17E+03 
Phosphoenolpyruvate 1.06E+07 1.90E+07 5.86E+06 3.08E+06 
Uric acid 1.16E+09 1.40E+08 9.68E+08 7.59E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 3.64E+05 6.53E+05 3.29E+05 2.74E+05 
Sulfolactate 1.66E+07 8.25E+06 6.28E+06 1.62E+06 
Glycerone phosphate 1.56E+07 7.58E+07 3.82E+07 8.60E+06 
Arginine 1.10E+08 1.85E+08 1.25E+08 8.96E+07 
Citrulline 1.12E+07 4.33E+06 5.20E+06 1.96E+06 
Ascorbate 8.84E+06 2.10E+05 8.41E+05 2.73E+05 
N-Carbamoyl-L-aspartate 1.53E+07 6.47E+06 6.75E+06 5.21E+06 
Allantoate 1.20E+09 5.25E+08 3.98E+08 2.54E+08 
2-Isopropylmalate 2.85E+06 1.19E+07 5.23E+06 1.63E+06 
Glucosamine 1.36E+06 9.28E+05 7.03E+05 2.89E+05 
myo-Inositol 2.39E+07 2.16E+07 1.32E+08 1.39E+07 
Tyrosine 2.07E+09 1.01E+09 1.98E+09 1.11E+08 
Homovanillic acid (HVA) 1.26E+07 1.67E+07 1.10E+07 1.00E+07 
Homocysteic acid 2.55E+03 2.38E+03 0.00E+00 0.00E+00 
4-Pyridoxate 9.04E+06 6.20E+06 9.66E+06 2.70E+06 




Table 21. Continued. 
Metabolite 24 HA-1 24 HA-3 24 HA-4 24 HA-5 
Citrate/isocitrate 2.23E+10 4.54E+10 2.43E+10 1.44E+10 
D-Gluconate 2.32E+08 3.46E+08 4.81E+08 9.88E+07 
N-N Dimethylarginine 4.94E+05 5.70E+05 4.42E+05 3.67E+05 
Tryptophan 8.75E+08 1.20E+09 1.02E+09 4.83E+08 
Xanthurenic acid 1.71E+07 5.11E+08 4.49E+07 6.62E+07 
D-Glucarate 2.99E+09 3.31E+09 3.08E+09 1.84E+09 
Pantothenate 1.79E+09 2.04E+09 1.88E+09 6.36E+08 
Cystathionine 1.20E+07 2.14E+06 1.81E+07 1.45E+06 
Cystine 5.58E+05 2.87E+05 3.73E+05 2.38E+05 
Uridine 5.80E+05 4.94E+05 7.94E+05 2.40E+05 
Biotin 2.74E+06 1.21E+06 3.59E+06 4.96E+05 
Deoxyinosine 6.02E+03 0.00E+00 2.63E+03 0.00E+00 
Glucose 6-phosphate 3.07E+08 9.05E+08 5.27E+08 4.88E+08 
S-Ribosyl-L-homocysteine 0.00E+00 4.77E+04 2.07E+04 5.68E+04 
6-Phospho-D-gluconate 1.50E+07 7.21E+07 3.30E+07 4.88E+07 
Guanosine 2.95E+06 2.12E+07 1.51E+07 5.96E+06 
Xanthosine 5.26E+05 2.16E+05 5.35E+06 1.73E+04 
Glycinamide ribotide (GAR) 1.89E+05 1.08E+05 5.93E+04 1.30E+05 
Ophthalmate 3.67E+06 5.12E+06 2.03E+06 1.52E+06 
Glutathione 3.96E+07 7.24E+05 3.10E+07 2.44E+06 
UMP 3.72E+08 4.82E+08 2.36E+08 1.51E+08 
AICAR 2.06E+06 6.31E+05 1.39E+06 6.33E+05 
Trehalose/Sucrose/Cellobiose 2.30E+07 3.53E+07 3.39E+07 2.40E+07 
AMP/dGMP 2.34E+09 3.93E+09 2.32E+09 1.83E+09 
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Table 21. Continued.  
Metabolite 24 HA-1 24 HA-3 24 HA-4 24 HA-5 
IMP 2.89E+08 4.93E+07 3.67E+08 2.00E+07 
GMP 2.71E+08 3.33E+08 3.23E+08 1.02E+08 
Xanthosine 5--phosphate 1.16E+05 1.88E+05 3.28E+05 3.30E+04 
Riboflavin 3.80E+06 1.88E+06 3.01E+06 1.03E+06 
S-Adenosyl-L-homocysteine 1.70E+05 3.37E+04 2.17E+05 3.35E+03 
ADP 3.34E+08 4.22E+08 3.66E+08 1.76E+08 
Folate 0.00E+00 0.00E+00 4.20E+03 0.00E+00 
CDP-ethanolamine 1.00E+07 1.51E+07 1.03E+07 3.27E+06 
FMN 7.51E+06 2.23E+07 1.17E+07 5.17E+06 
UDP-glucose 8.64E+07 1.51E+08 2.76E+07 4.54E+07 
NAD+ 5.73E+07 4.51E+07 8.30E+07 3.26E+07 
NADH 1.76E+06 8.83E+04 8.53E+06 7.29E+04 
Dephospho-CoA 6.14E+05 2.85E+05 1.04E+06 7.20E+04 
NADP+ 1.68E+07 2.29E+07 1.37E+07 1.45E+07 
FAD 3.92E+06 8.51E+05 4.51E+06 7.05E+05 
N-Acetylglutamate 1.39E+08 1.11E+08 1.48E+08 4.03E+07 




Table 22. Intensities of G. mellonella replicates in 24 hours dead group. 
Metabolite 24 HD-1 24 HD-2 24 HD-3 24 HD-4 24 HD-5 
Glyoxylate 5.58E+06 0.00E+00 0.00E+00 0.00E+00 5.94E+06 
Glycine 3.58E+08 6.18E+04 0.00E+00 6.07E+04 4.33E+08 
Pyruvate 8.73E+08 1.40E+09 1.59E+08 4.90E+08 3.03E+08 
Alanine/Sarcosine 1.81E+09 2.64E+09 2.39E+09 2.00E+09 1.65E+09 
Lactate 1.87E+10 1.34E+10 1.53E+10 1.37E+10 9.10E+09 
Dimethylglycine 7.92E+07 9.64E+07 1.06E+08 5.70E+07 3.09E+07 
Serine 1.43E+08 1.08E+08 8.53E+07 1.31E+08 4.47E+07 
Histamine 2.89E+05 4.30E+05 3.83E+05 2.81E+05 2.25E+05 
Uracil 1.15E+07 9.96E+07 5.09E+07 2.89E+07 2.85E+07 
Creatinine 0.00E+00 5.65E+04 3.68E+04 1.53E+04 8.09E+03 
Proline 1.15E+10 1.54E+10 1.61E+10 8.62E+09 3.54E+09 
Fumarate 1.58E+08 3.74E+08 1.91E+08 2.58E+08 7.07E+07 
2-Oxoisovalerate 5.29E+06 9.24E+06 1.51E+07 7.49E+06 4.76E+06 
Indole 1.97E+06 3.88E+06 5.29E+06 1.91E+06 1.43E+06 
Valine 1.28E+09 1.51E+09 1.79E+09 1.52E+09 5.42E+08 
3-Hydroxyisovaleric acid 1.08E+07 2.40E+07 1.43E+08 1.70E+07 1.20E+07 
Homoserine/Threonine 8.92E+07 3.17E+08 3.51E+08 6.45E+07 9.37E+07 
3-Methylthiopropionate 4.09E+04 1.31E+05 7.89E+05 2.94E+05 7.73E+04 
Cysteine 4.59E+06 1.05E+05 7.34E+06 2.14E+06 5.54E+06 
Nicotinate 1.20E+08 1.54E+08 1.36E+08 1.55E+08 7.82E+07 
Taurine 4.29E+06 9.96E+05 1.16E+06 1.63E+06 2.78E+06 
Thymine 3.54E+06 1.02E+07 1.06E+07 1.28E+07 2.48E+06 
Hydroxyproline 1.59E+06 2.24E+06 1.38E+06 1.32E+06 1.25E+07 
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Table 22. Continued. 
Metabolite 24 HD-1 24 HD-2 24 HD-3 24 HD-4 24 HD-5 
N-Acetyl-beta-alanine 2.15E+07 3.64E+07 3.46E+07 3.27E+07 2.05E+07 
Leucine/Isoleucine 3.15E+09 4.93E+09 5.82E+09 4.29E+09 1.61E+09 
Glutaric acid 4.79E+07 1.39E+08 2.92E+08 5.92E+07 5.58E+07 
Asparagine 1.32E+08 3.22E+08 5.78E+08 1.48E+08 1.61E+08 
Hydroxyisocaproic acid 1.29E+08 5.33E+08 2.52E+09 3.24E+08 9.83E+07 
Ornithine 4.27E+06 4.77E+06 4.39E+06 5.11E+06 7.08E+06 
Salicylate 2.37E+07 3.43E+07 5.23E+07 2.00E+07 7.58E+06 
Hydroxybenzoate 2.15E+06 1.25E+06 1.38E+06 1.19E+06 3.91E+05 
Histidinol 7.23E+04 4.76E+04 1.09E+05 3.00E+04 1.63E+04 
2-Oxoglutaric acid 2.55E+08 5.33E+08 1.15E+08 2.21E+08 6.30E+07 
Glutamine 1.50E+09 2.11E+09 2.27E+09 1.31E+09 1.63E+09 
2-hydroxyglutarate 5.23E+09 5.81E+09 1.04E+10 5.59E+09 1.57E+09 
2-Hydroxy-2-methylsuccinate 5.23E+09 5.80E+09 1.04E+10 5.57E+09 1.56E+09 
L-Methionine 1.11E+08 4.96E+07 9.15E+07 9.27E+07 3.42E+07 
Guanine 0.00E+00 6.54E+04 3.09E+04 1.76E+04 4.87E+04 
3-Methylphenylacetic acid 1.68E+06 2.40E+06 9.55E+06 2.91E+06 4.72E+05 
Hydroxyphenylacetate 4.05E+06 2.76E+06 2.82E+06 2.25E+06 1.06E+06 
Xylitol 1.04E+08 1.08E+08 1.04E+08 1.10E+08 5.44E+07 
Dopamine 4.67E+08 3.17E+08 1.08E+09 3.06E+08 2.28E+08 
2_3-Dihydroxybenzoate 4.04E+05 9.93E+05 2.84E+05 5.97E+05 1.38E+05 
Histidine 4.34E+08 5.72E+08 6.18E+08 4.26E+08 3.49E+08 
Orotate 7.54E+06 4.60E+06 3.72E+06 1.45E+06 1.32E+06 
Dihydroorotate 1.06E+07 9.92E+05 8.21E+05 7.83E+05 5.15E+05 
Allantoin 4.73E+06 2.98E+07 1.44E+07 5.12E+06 5.04E+07 
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Table 22. Continued. 
Metabolite 24 HD-1 24 HD-2 24 HD-3 24 HD-4 24 HD-5 
Indole-3-carboxylate 3.02E+05 8.34E+05 7.43E+05 5.35E+05 1.19E+05 
Phenylpyruvate 1.20E+06 4.42E+06 3.90E+06 1.53E+06 6.11E+05 
Phenylalanine 1.17E+09 1.95E+09 2.95E+09 2.69E+08 7.98E+08 
Phenyllactic acid 1.40E+07 2.35E+07 4.31E+07 8.48E+06 3.13E+06 
Quinolinate 2.95E+04 4.06E+05 3.14E+05 2.03E+06 8.70E+05 
Phosphoenolpyruvate 6.94E+06 8.70E+06 5.10E+06 3.72E+06 5.26E+06 
Uric acid 3.06E+08 8.21E+08 9.80E+08 2.78E+08 4.29E+08 
3_4-Dihydroxyphenylacetate 
(DOPAC) 1.47E+05 3.86E+05 3.36E+05 2.30E+05 9.92E+04 
Sulfolactate 1.79E+06 4.58E+06 3.77E+06 3.78E+06 8.41E+05 
Glycerone phosphate 4.66E+07 2.90E+07 4.92E+07 2.07E+07 2.31E+07 
Arginine 1.02E+08 1.39E+08 1.22E+08 1.31E+08 8.64E+07 
Citrulline 1.23E+06 3.24E+06 1.50E+06 1.63E+06 2.51E+06 
Ascorbate 4.34E+08 8.34E+05 9.90E+08 7.81E+08 8.09E+08 
N-Carbamoyl-L-aspartate 1.95E+07 1.71E+06 1.61E+06 9.37E+05 1.89E+06 
Allantoate 1.94E+08 7.59E+08 5.52E+08 2.22E+08 6.61E+08 
2-Isopropylmalate 3.74E+06 1.42E+07 4.34E+06 7.88E+06 2.93E+06 
Glucosamine 8.25E+05 1.19E+06 4.03E+05 5.28E+05 9.15E+05 
myo-Inositol 1.31E+08 1.14E+08 1.23E+08 1.81E+08 6.29E+07 
Tyrosine 1.81E+09 1.63E+09 2.61E+09 1.22E+09 6.98E+08 
Homovanillic acid (HVA) 2.95E+07 2.56E+07 5.75E+07 1.89E+07 3.81E+06 
Homocysteic acid 0.00E+00 0.00E+00 0.00E+00 3.83E+03 0.00E+00 
4-Pyridoxate 5.63E+06 9.26E+06 9.52E+06 9.27E+06 6.07E+06 
N-Acetylglutamine 1.88E+08 2.76E+08 2.63E+08 1.33E+08 1.21E+08 
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Table 22. Continued. 
Metabolite 24 HD-1 24 HD-2 24 HD-3 24 HD-4 24 HD-5 
Citrate/isocitrate 9.99E+09 1.26E+10 1.80E+10 9.74E+09 1.04E+09 
D-Gluconate 2.70E+08 3.92E+08 3.89E+08 2.84E+08 1.02E+08 
N-N Dimethylarginine 3.56E+05 3.39E+05 3.62E+05 5.05E+05 3.31E+05 
Tryptophan 6.64E+08 1.16E+09 1.53E+09 6.42E+08 5.06E+08 
Xanthurenic acid 1.87E+07 5.05E+07 1.46E+08 8.40E+06 4.68E+06 
D-Glucarate 1.58E+09 3.16E+09 2.73E+09 3.04E+09 5.20E+08 
Pantothenate 1.35E+09 1.48E+09 2.42E+09 1.61E+09 6.42E+08 
Cystathionine 6.33E+06 2.06E+06 4.48E+06 2.85E+06 3.59E+06 
Cystine 5.04E+05 5.52E+05 5.76E+05 1.81E+06 1.24E+06 
Uridine 1.84E+06 2.07E+06 2.10E+06 3.30E+06 1.80E+06 
Biotin 3.33E+06 2.24E+06 5.81E+06 2.49E+06 1.07E+06 
Deoxyinosine 0.00E+00 5.33E+03 2.29E+03 0.00E+00 0.00E+00 
Glucose 6-phosphate 2.92E+08 2.94E+08 2.50E+08 4.23E+08 1.20E+08 
S-Ribosyl-L-homocysteine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 7.22E+03 
6-Phospho-D-gluconate 4.16E+06 1.22E+07 5.05E+06 4.32E+06 9.54E+05 
Guanosine 1.75E+07 1.63E+07 3.15E+07 2.07E+07 4.13E+06 
Xanthosine 7.81E+07 8.01E+07 9.55E+07 9.59E+07 3.37E+07 
Glycinamide ribotide (GAR) 3.08E+04 0.00E+00 0.00E+00 0.00E+00 8.12E+04 
Ophthalmate 1.29E+06 3.47E+06 3.34E+06 9.74E+05 3.59E+04 
Glutathione 1.41E+08 2.75E+07 4.08E+08 7.91E+07 1.11E+08 
UMP 5.39E+07 7.90E+07 5.92E+07 2.68E+07 1.97E+07 
AICAR 4.15E+05 1.24E+06 5.62E+06 5.41E+05 5.74E+05 
Trehalose/Sucrose/Cellobiose 2.66E+07 3.90E+07 2.64E+07 3.35E+07 1.72E+07 
AMP/dGMP 9.86E+08 1.05E+09 1.57E+09 8.21E+08 5.54E+08 
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Table 22. Continued. 
Metabolite 24 HD-1 24 HD-2 24 HD-3 24 HD-4 24 HD-5 
IMP 4.30E+08 6.10E+08 7.86E+08 4.24E+08 1.22E+08 
GMP 1.20E+08 1.60E+08 1.73E+08 1.24E+08 4.94E+07 
Xanthosine 5--phosphate 4.72E+05 3.79E+05 7.78E+05 5.30E+05 2.00E+05 
Riboflavin 4.67E+06 2.82E+06 6.56E+06 3.81E+06 1.02E+06 
S-Adenosyl-L-homocysteine 1.08E+05 2.58E+05 2.61E+05 9.68E+04 1.20E+05 
ADP 1.29E+08 1.95E+08 2.17E+08 1.89E+08 7.71E+07 
Folate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
CDP-ethanolamine 7.44E+06 6.27E+06 8.71E+06 6.79E+06 2.06E+06 
FMN 8.72E+06 1.17E+07 1.58E+07 2.08E+07 2.72E+06 
UDP-glucose 1.30E+07 1.45E+07 8.96E+06 1.21E+07 4.61E+06 
NAD+ 4.22E+07 5.09E+07 9.02E+07 2.60E+07 1.36E+07 
NADH 9.75E+06 2.41E+06 1.99E+07 7.10E+06 8.18E+06 
Dephospho-CoA 3.17E+05 4.53E+05 2.20E+06 6.42E+05 2.25E+05 
NADP+ 4.43E+06 1.24E+07 7.08E+06 6.73E+06 2.70E+06 
FAD 2.85E+06 4.21E+06 1.64E+06 8.44E+04 1.82E+06 
N-Acetylglutamate 8.61E+07 1.17E+08 1.51E+08 7.45E+07 6.02E+07 





Table 23. Intensities of G. mellonella replicates in 2 days post infection group. 
Metabolite 2 Days-1 2 Days-2 2 Days-3 2 Days-4 2 Days-5 
Glyoxylate 0.00E+00 7.15E+06 0.00E+00 7.81E+03 5.24E+06 
Glycine 3.88E+04 3.59E+08 5.99E+04 3.87E+04 1.08E+09 
Pyruvate 1.12E+08 4.43E+07 7.89E+09 4.26E+07 5.74E+09 
Alanine/Sarcosine 2.10E+08 1.21E+08 4.84E+09 9.96E+07 5.09E+09 
Lactate 4.07E+08 2.75E+08 3.45E+10 3.11E+08 4.54E+10 
Dimethylglycine 5.99E+07 3.12E+07 1.06E+08 6.77E+07 9.07E+07 
Serine 9.95E+07 7.42E+07 1.87E+08 6.25E+07 1.41E+08 
Histamine 1.27E+05 3.23E+04 4.07E+05 3.59E+04 4.23E+05 
Uracil 1.93E+08 8.34E+07 5.30E+06 8.94E+07 3.91E+07 
Creatinine 2.73E+04 1.53E+04 2.26E+04 6.25E+04 5.18E+03 
Proline 2.51E+08 9.41E+07 1.35E+10 1.36E+08 7.00E+09 
Fumarate 1.10E+07 4.96E+06 3.04E+08 4.25E+06 2.36E+08 
2-Oxoisovalerate 1.45E+08 7.82E+07 4.76E+07 2.06E+07 2.20E+07 
Indole 3.99E+05 5.99E+05 2.95E+06 1.97E+05 7.64E+06 
Valine 8.24E+08 5.86E+08 1.96E+09 2.92E+08 1.27E+09 
3-Hydroxyisovaleric acid 3.53E+08 1.18E+08 9.42E+07 1.06E+08 1.85E+08 
Homoserine/Threonine 1.27E+08 4.81E+07 3.84E+08 6.89E+07 4.19E+08 
3-Methylthiopropionate 2.58E+06 1.18E+06 3.86E+05 1.13E+06 4.31E+03 
Cysteine 1.75E+06 3.99E+05 1.72E+04 1.70E+06 1.35E+04 
Nicotinate 7.50E+08 3.28E+08 3.82E+08 3.50E+08 2.27E+08 
Taurine 2.28E+06 4.32E+06 1.56E+06 4.46E+06 2.22E+06 
Thymine 1.83E+08 2.52E+08 2.20E+07 2.85E+08 3.74E+06 
Hydroxyproline 5.91E+06 6.94E+06 2.38E+06 5.15E+06 1.84E+06 
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Table 23. Continued. 
Metabolite 2 Days-1 2 Days-2 2 Days-3 2 Days-4 2 Days-5 
N-Acetyl-beta-alanine 1.77E+07 1.07E+07 4.00E+07 1.85E+07 2.64E+07 
Leucine/Isoleucine 7.99E+08 9.64E+08 5.42E+09 5.59E+08 3.40E+09 
Glutaric acid 1.95E+08 1.75E+08 2.58E+08 1.59E+08 1.94E+08 
Asparagine 7.34E+06 1.86E+07 3.19E+08 6.90E+06 7.18E+08 
Hydroxyisocaproic acid 6.14E+08 2.86E+08 1.46E+09 2.75E+08 1.57E+09 
Ornithine 1.67E+07 2.97E+07 1.68E+07 2.24E+07 2.53E+07 
Salicylate 2.74E+07 1.16E+07 6.11E+07 2.27E+07 2.88E+07 
Hydroxybenzoate 3.70E+07 4.52E+07 3.39E+06 4.28E+07 1.42E+06 
Histidinol 5.34E+06 3.78E+06 9.45E+04 7.87E+06 3.96E+04 
2-Oxoglutaric acid 4.53E+07 3.57E+07 1.07E+09 2.52E+07 2.55E+08 
Glutamine 2.24E+08 6.49E+07 2.50E+09 4.84E+07 3.44E+09 
2-hydroxyglutarate 5.05E+08 1.79E+08 8.42E+09 1.63E+08 4.82E+09 
2-Hydroxy-2-methylsuccinate 5.05E+08 1.79E+08 8.39E+09 1.63E+08 4.81E+09 
L-Methionine 3.14E+07 1.09E+07 2.16E+08 1.72E+07 2.42E+08 
Guanine 1.02E+06 6.54E+06 1.64E+05 1.62E+06 1.68E+04 
3-Methylphenylacetic acid 1.49E+06 5.91E+05 2.29E+06 6.47E+06 4.82E+05 
Hydroxyphenylacetate 3.82E+06 1.18E+07 2.22E+06 1.09E+08 1.91E+06 
Xylitol 8.98E+07 4.76E+07 1.81E+08 9.15E+07 1.41E+08 
Dopamine 5.90E+06 5.90E+06 6.05E+08 6.69E+06 4.07E+08 
2_3-Dihydroxybenzoate 1.05E+07 5.07E+05 2.28E+06 5.33E+05 4.22E+05 
Histidine 1.19E+08 2.00E+07 5.68E+08 1.77E+07 4.55E+08 
Orotate 1.15E+08 4.31E+07 1.22E+07 2.72E+07 8.87E+06 
Dihydroorotate 1.01E+07 9.41E+05 1.07E+07 1.52E+06 5.00E+06 
Allantoin 1.33E+07 1.28E+07 4.92E+07 2.47E+07 6.24E+06 
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Table 23. Continued. 
Metabolite 2 Days-1 2 Days-2 2 Days-3 2 Days-4 2 Days-5 
Indole-3-carboxylate 1.27E+06 4.40E+06 2.17E+06 1.36E+06 4.04E+05 
Phenylpyruvate 3.11E+07 3.52E+07 1.13E+07 1.13E+07 4.20E+06 
Phenylalanine 2.39E+08 1.45E+08 2.96E+09 2.96E+08 6.03E+09 
Phenyllactic acid 9.83E+08 7.84E+08 1.13E+08 8.33E+08 1.77E+08 
Quinolinate 6.90E+05 2.32E+05 1.69E+06 5.80E+05 4.55E+04 
Phosphoenolpyruvate 3.87E+07 2.72E+07 2.64E+07 3.06E+07 1.07E+07 
Uric acid 5.94E+08 8.47E+07 1.28E+09 2.84E+08 1.22E+09 
3_4-Dihydroxyphenylacetate (DOPAC) 2.98E+06 8.71E+06 7.15E+05 4.29E+06 4.68E+05 
Sulfolactate 5.88E+06 3.62E+06 4.45E+06 6.14E+06 6.64E+06 
Glycerone phosphate 1.92E+07 1.64E+06 5.67E+07 2.30E+07 3.33E+07 
Arginine 2.43E+07 1.05E+07 1.30E+08 1.09E+07 1.20E+08 
Citrulline 6.80E+07 1.08E+08 1.43E+07 7.73E+07 1.81E+07 
Ascorbate 3.67E+05 1.90E+05 1.83E+05 1.67E+05 5.63E+06 
N-Carbamoyl-L-aspartate 3.93E+07 2.84E+07 2.06E+07 1.81E+07 1.11E+07 
Allantoate 8.60E+08 7.71E+08 6.88E+08 8.77E+08 2.19E+08 
2-Isopropylmalate 2.09E+09 7.99E+08 8.79E+06 1.47E+09 5.41E+06 
Glucosamine 3.31E+06 2.69E+06 6.56E+05 4.46E+06 2.35E+05 
myo-Inositol 9.63E+06 7.59E+06 5.02E+08 8.95E+06 4.51E+08 
Tyrosine 3.18E+08 9.95E+07 1.15E+09 2.77E+08 2.77E+09 
Homovanillic acid (HVA) 1.07E+08 3.09E+07 3.68E+07 4.40E+07 9.37E+07 
Homocysteic acid 1.35E+05 2.45E+05 0.00E+00 3.15E+05 0.00E+00 
4-Pyridoxate 2.62E+07 2.28E+07 1.62E+07 2.30E+07 2.41E+07 
N-Acetylglutamine 1.16E+07 5.76E+06 1.55E+08 2.05E+06 2.93E+08 
Citrate/isocitrate 7.88E+09 5.92E+09 1.98E+10 6.34E+09 1.18E+10 
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Table 23. Continued. 
Metabolite 2 Days-1 2 Days-2 2 Days-3 2 Days-4 2 Days-5 
D-Gluconate 2.41E+08 1.12E+08 7.11E+08 1.42E+08 4.38E+08 
N-N Dimethylarginine 1.86E+06 1.66E+06 6.49E+05 2.09E+06 4.64E+05 
Tryptophan 1.61E+08 2.28E+08 9.90E+08 8.37E+07 2.07E+09 
Xanthurenic acid 9.52E+07 7.37E+07 4.57E+07 1.27E+07 7.11E+07 
D-Glucarate 3.34E+09 1.13E+09 2.65E+09 2.30E+09 2.86E+09 
Pantothenate 2.01E+09 8.85E+08 2.32E+09 1.18E+09 1.42E+09 
Cystathionine 2.16E+06 2.68E+06 5.68E+06 1.75E+06 9.87E+06 
Cystine 3.76E+06 4.94E+05 2.54E+05 5.46E+06 0.00E+00 
Uridine 1.21E+07 2.61E+07 4.13E+06 1.50E+07 1.99E+06 
Biotin 2.80E+06 5.81E+05 2.70E+06 5.88E+05 3.00E+06 
Deoxyinosine 1.92E+05 1.68E+05 0.00E+00 2.22E+05 0.00E+00 
Glucose 6-phosphate 2.27E+07 8.47E+06 3.29E+08 9.78E+06 3.78E+08 
S-Ribosyl-L-homocysteine 1.30E+07 1.51E+06 0.00E+00 2.60E+06 1.06E+04 
6-Phospho-D-gluconate 1.93E+07 8.27E+06 7.31E+06 7.02E+06 6.25E+06 
Guanosine 3.63E+07 1.41E+07 1.18E+07 1.69E+07 8.04E+06 
Xanthosine 1.20E+07 1.21E+07 2.74E+07 1.43E+07 1.31E+07 
Glycinamide ribotide (GAR) 0.00E+00 0.00E+00 9.68E+05 0.00E+00 3.49E+05 
Ophthalmate 1.47E+07 7.60E+06 4.91E+06 2.06E+07 4.35E+06 
Glutathione 1.06E+07 6.92E+06 1.05E+08 7.41E+06 4.77E+07 
UMP 1.43E+07 5.08E+07 5.53E+07 5.30E+06 1.43E+08 
AICAR 4.30E+05 1.26E+06 1.89E+06 2.73E+05 1.27E+06 
Trehalose/Sucrose/Cellobiose 2.10E+07 1.41E+07 2.07E+07 2.11E+07 8.45E+06 
AMP/dGMP 1.07E+08 2.39E+08 3.22E+08 4.52E+07 1.49E+09 
IMP 3.84E+06 3.57E+06 4.19E+08 1.37E+06 1.68E+08 
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Table 23. Continued. 
Metabolite 2 Days-1 2 Days-2 2 Days-3 2 Days-4 2 Days-5 
GMP 1.49E+07 5.20E+07 7.93E+07 9.00E+06 2.73E+08 
Xanthosine 5--phosphate 7.62E+04 2.88E+05 1.22E+06 2.44E+04 1.29E+06 
Riboflavin 2.65E+06 9.11E+05 4.93E+06 1.10E+06 6.55E+06 
S-Adenosyl-L-homocysteine 7.49E+04 1.08E+05 5.93E+03 1.07E+05 8.43E+04 
ADP 2.09E+08 4.06E+07 3.48E+08 7.70E+07 2.33E+08 
Folate 7.17E+04 1.00E+05 0.00E+00 5.15E+04 0.00E+00 
CDP-ethanolamine 2.81E+05 5.50E+05 8.12E+06 1.18E+05 8.66E+06 
FMN 1.85E+07 5.44E+06 7.24E+06 1.03E+07 1.63E+07 
UDP-glucose 2.14E+07 3.46E+07 4.96E+07 2.28E+07 3.10E+07 
NAD+ 1.50E+07 8.60E+06 4.21E+07 7.23E+06 2.64E+07 
NADH 3.38E+04 2.26E+04 2.79E+06 3.01E+04 1.85E+06 
Dephospho-CoA 3.45E+05 1.05E+05 2.72E+05 9.89E+04 6.95E+05 
NADP+ 2.97E+07 9.70E+06 1.38E+07 1.78E+07 7.17E+06 
FAD 4.84E+06 1.26E+06 2.79E+06 2.70E+06 1.60E+06 
N-Acetylglutamate 7.06E+08 1.39E+09 2.14E+08 1.35E+09 1.78E+08 





Table 24. Intensities of G. mellonella replicates in 4 days post infection group. 
Metabolite 4 Days-1 4 Days-2 4 Days-3 4 Days-4 4 Days-5 
Glyoxylate 8.07E+07 0.00E+00 2.74E+08 1.10E+04 6.06E+03 
Glycine 8.45E+08 1.73E+04 2.00E+08 1.44E+05 4.13E+04 
Pyruvate 5.61E+07 6.47E+07 2.45E+08 7.88E+07 3.07E+07 
Alanine/Sarcosine 1.11E+08 4.42E+07 9.56E+07 1.87E+08 1.67E+08 
Lactate 5.41E+08 2.78E+08 3.34E+08 9.27E+08 3.84E+08 
Dimethylglycine 5.03E+07 2.19E+07 1.98E+07 8.27E+07 4.80E+07 
Serine 6.26E+07 3.59E+07 3.27E+07 8.26E+07 5.75E+07 
Histamine 1.87E+05 1.21E+05 2.25E+04 7.24E+05 6.29E+05 
Uracil 5.07E+08 9.04E+07 9.13E+07 5.12E+08 5.78E+08 
Creatinine 1.35E+05 5.12E+04 1.12E+04 7.40E+04 1.11E+05 
Proline 8.65E+08 1.04E+08 1.27E+08 1.60E+09 1.68E+09 
Fumarate 1.53E+07 4.31E+06 1.08E+07 3.34E+07 1.94E+07 
2-Oxoisovalerate 7.29E+07 1.29E+07 6.35E+07 9.24E+07 1.42E+07 
Indole 7.83E+05 3.89E+05 6.66E+05 1.33E+06 1.35E+06 
Valine 3.29E+08 1.00E+08 6.35E+08 6.30E+08 2.76E+08 
3-Hydroxyisovaleric acid 4.00E+08 1.70E+08 3.68E+08 3.47E+08 6.24E+07 
Homoserine/Threonine 1.71E+08 1.06E+08 2.28E+08 3.06E+08 1.13E+08 
3-Methylthiopropionate 1.69E+06 9.13E+06 2.33E+06 5.68E+05 2.84E+05 
Cysteine 3.72E+05 2.45E+06 2.39E+06 3.45E+06 5.01E+05 
Nicotinate 1.04E+08 2.77E+08 1.12E+08 2.87E+08 2.20E+07 
Taurine 1.08E+04 2.20E+06 1.04E+04 0.00E+00 9.73E+04 
Thymine 1.25E+09 5.23E+08 9.38E+08 1.95E+09 1.09E+09 
Hydroxyproline 1.41E+07 7.30E+06 3.93E+06 1.60E+07 4.49E+06 
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Table 24. Continued.  
Metabolite 4 Days-1 4 Days-2 4 Days-3 4 Days-4 4 Days-5 
N-Acetyl-beta-alanine 5.83E+07 5.97E+07 1.53E+08 5.97E+07 2.28E+07 
Leucine/Isoleucine 1.06E+09 5.47E+08 1.85E+09 2.02E+09 1.56E+09 
Glutaric acid 3.66E+08 2.78E+08 2.10E+08 5.52E+08 1.95E+08 
Asparagine 4.28E+07 2.74E+07 2.15E+07 4.20E+07 1.34E+08 
Hydroxyisocaproic acid 1.83E+09 2.63E+08 1.09E+09 4.46E+08 1.62E+08 
Ornithine 5.49E+07 2.28E+07 2.57E+07 3.86E+07 3.66E+07 
Salicylate 5.90E+07 1.79E+08 3.32E+09 2.41E+08 4.27E+07 
Hydroxybenzoate 3.93E+07 7.29E+06 3.55E+06 2.42E+07 1.59E+07 
Histidinol 1.81E+07 3.12E+07 1.97E+07 1.15E+07 1.11E+07 
2-Oxoglutaric acid 1.78E+08 1.46E+07 2.60E+07 7.64E+07 5.07E+07 
Glutamine 1.28E+08 1.75E+08 2.77E+07 3.03E+08 2.49E+08 
2-hydroxyglutarate 2.30E+08 3.92E+08 2.94E+08 3.18E+08 1.87E+08 
2-Hydroxy-2-methylsuccinate 2.30E+08 3.92E+08 2.93E+08 3.18E+08 1.86E+08 
L-Methionine 3.59E+07 2.09E+07 1.00E+08 1.03E+08 3.70E+07 
Guanine 2.49E+06 2.72E+06 1.68E+06 2.69E+06 5.60E+07 
3-Methylphenylacetic acid 2.20E+07 1.59E+06 1.99E+06 1.28E+06 1.15E+06 
Hydroxyphenylacetate 4.69E+07 1.79E+08 1.48E+08 3.65E+08 2.73E+08 
Xylitol 5.77E+07 3.84E+07 1.41E+08 8.83E+07 2.34E+07 
Dopamine 2.61E+06 5.64E+06 2.70E+06 1.74E+06 3.03E+06 
2_3-Dihydroxybenzoate 1.93E+08 6.62E+07 6.73E+07 2.03E+06 9.51E+05 
Histidine 6.28E+07 1.93E+07 2.23E+07 8.14E+07 3.23E+07 
Orotate 4.36E+08 1.08E+07 6.59E+07 2.87E+08 7.64E+07 
Dihydroorotate 1.63E+07 9.63E+05 6.21E+06 6.23E+06 6.01E+05 
Allantoin 2.08E+07 1.24E+07 6.69E+06 5.49E+07 1.11E+08 
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Table 24. Continued.  
Metabolite 4 Days-1 4 Days-2 4 Days-3 4 Days-4 4 Days-5 
Indole-3-carboxylate 4.01E+07 3.12E+07 1.52E+07 1.45E+07 8.55E+06 
Phenylpyruvate 1.48E+07 4.90E+06 4.62E+07 1.34E+07 6.98E+06 
Phenylalanine 4.99E+08 2.40E+08 4.06E+08 8.47E+08 5.21E+08 
Phenyllactic acid 8.51E+08 8.67E+08 1.67E+09 4.52E+09 1.55E+09 
Quinolinate 4.69E+06 6.99E+05 2.02E+06 1.89E+07 9.08E+06 
Phosphoenolpyruvate 3.76E+07 5.97E+04 3.89E+06 3.33E+07 1.09E+07 
Uric acid 2.43E+08 4.24E+08 5.50E+08 4.60E+08 3.62E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 2.52E+07 1.04E+07 1.09E+07 2.46E+07 1.35E+07 
Sulfolactate 1.40E+06 2.05E+06 4.97E+05 3.01E+06 3.27E+06 
Glycerone phosphate 7.45E+04 4.05E+05 4.22E+06 1.81E+07 2.07E+05 
Arginine 2.05E+07 1.37E+07 7.69E+06 4.63E+07 5.39E+07 
Citrulline 1.90E+08 8.62E+07 7.69E+07 1.49E+08 1.08E+08 
Ascorbate 8.34E+05 3.27E+05 1.36E+05 4.73E+05 1.52E+05 
N-Carbamoyl-L-aspartate 5.92E+07 6.34E+06 2.84E+06 2.10E+07 8.73E+06 
Allantoate 3.99E+08 4.63E+07 3.00E+06 2.22E+08 4.83E+08 
2-Isopropylmalate 2.14E+09 1.30E+09 3.64E+08 2.81E+09 6.69E+08 
Glucosamine 3.72E+06 3.91E+06 1.74E+06 1.12E+07 6.72E+06 
myo-Inositol 1.83E+07 1.30E+07 2.87E+07 1.86E+07 8.05E+06 
Tyrosine 2.32E+08 2.21E+08 4.42E+08 4.70E+08 1.45E+08 
Homovanillic acid (HVA) 5.64E+07 4.43E+07 9.66E+07 4.77E+07 2.02E+07 
Homocysteic acid 6.66E+05 7.87E+06 5.57E+05 9.31E+06 2.18E+06 
4-Pyridoxate 1.11E+08 5.39E+07 4.51E+07 2.12E+08 1.00E+08 
N-Acetylglutamine 1.86E+07 1.10E+07 8.24E+06 1.42E+07 9.18E+06 
Citrate/isocitrate 5.36E+09 4.02E+09 2.79E+09 5.90E+09 7.48E+09 
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Table 24. Continued.  
Metabolite 4 Days-1 4 Days-2 4 Days-3 4 Days-4 4 Days-5 
D-Gluconate 3.18E+08 4.11E+08 4.81E+08 5.90E+08 1.46E+08 
N-N Dimethylarginine 2.73E+06 1.07E+06 1.72E+06 2.88E+06 2.14E+06 
Tryptophan 2.74E+08 1.46E+08 2.43E+08 4.61E+08 4.28E+08 
Xanthurenic acid 6.70E+07 2.34E+08 9.38E+07 8.59E+07 2.69E+07 
D-Glucarate 5.27E+07 1.64E+07 1.67E+09 4.58E+09 1.05E+09 
Pantothenate 3.11E+09 1.59E+09 1.10E+09 2.62E+09 9.75E+08 
Cystathionine 9.60E+06 8.79E+06 1.35E+07 1.32E+07 7.28E+06 
Cystine 3.10E+05 6.74E+06 6.44E+06 5.98E+06 7.01E+05 
Uridine 1.46E+08 5.77E+07 1.23E+08 3.81E+07 8.88E+06 
Biotin 1.87E+06 2.62E+06 7.56E+05 8.60E+05 4.33E+05 
Deoxyinosine 1.65E+06 6.87E+05 1.16E+06 6.20E+06 1.09E+06 
Glucose 6-phosphate 3.01E+07 1.09E+07 1.60E+07 1.59E+07 1.88E+07 
S-Ribosyl-L-homocysteine 3.72E+04 6.51E+04 4.52E+06 8.01E+05 4.64E+03 
6-Phospho-D-gluconate 2.18E+07 3.35E+06 2.98E+06 2.17E+07 6.24E+06 
Guanosine 1.51E+07 2.37E+07 5.05E+06 3.91E+07 1.05E+07 
Xanthosine 1.53E+07 3.61E+06 1.45E+06 2.62E+07 9.55E+06 
Glycinamide ribotide (GAR) 7.83E+03 0.00E+00 0.00E+00 9.82E+03 6.12E+04 
Ophthalmate 3.71E+07 9.61E+06 4.62E+06 1.92E+07 9.70E+06 
Glutathione 2.04E+07 2.18E+07 4.37E+07 4.85E+07 2.31E+07 
UMP 1.37E+08 6.54E+07 4.26E+07 1.35E+08 1.28E+08 
AICAR 3.06E+05 4.25E+05 1.32E+04 2.00E+06 6.08E+05 
Trehalose/Sucrose/Cellobiose 5.68E+06 1.04E+07 5.05E+06 8.94E+06 1.12E+07 
AMP/dGMP 5.75E+08 3.11E+08 2.03E+08 6.70E+08 5.32E+08 
IMP 8.28E+06 9.39E+06 6.30E+06 2.68E+07 8.43E+06 
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Table 24. Continued.  
Metabolite 4 Days-1 4 Days-2 4 Days-3 4 Days-4 4 Days-5 
GMP 1.47E+08 6.79E+07 3.26E+07 2.49E+08 1.49E+08 
Xanthosine 5--phosphate 1.05E+07 4.35E+04 4.76E+05 1.70E+05 1.05E+04 
Riboflavin 4.56E+06 2.18E+06 6.77E+06 2.02E+06 9.30E+05 
S-Adenosyl-L-homocysteine 1.11E+06 2.15E+05 2.94E+05 4.62E+05 1.67E+05 
ADP 1.11E+08 2.97E+06 2.81E+07 1.00E+08 3.85E+07 
Folate 6.26E+05 2.67E+05 6.09E+05 7.69E+05 6.04E+05 
CDP-ethanolamine 1.05E+06 4.95E+05 2.78E+05 2.82E+06 1.22E+06 
FMN 1.99E+07 9.91E+06 1.68E+07 1.31E+07 4.25E+06 
UDP-glucose 9.60E+07 2.39E+07 2.27E+07 8.04E+07 5.32E+07 
NAD+ 1.43E+07 1.79E+07 6.75E+06 2.67E+07 6.85E+06 
NADH 1.78E+05 2.02E+05 1.49E+05 3.29E+04 1.18E+04 
Dephospho-CoA 9.15E+05 1.23E+05 2.15E+06 1.20E+06 7.00E+05 
NADP+ 1.54E+07 8.64E+06 4.37E+06 2.43E+07 6.26E+06 
FAD 5.09E+06 1.99E+06 3.06E+06 9.09E+06 1.49E+06 
N-Acetylglutamate 8.96E+08 1.23E+09 5.82E+08 4.56E+08 6.88E+08 





Table 25. Intensities of G. mellonella replicates in 6 days post infection group. 
Metabolite 6 Days-1 6 Days-2 6 Days-3 6 Days-4 6 Days-5 
Glyoxylate 2.64E+04 0.00E+00 2.78E+03 9.74E+03 0.00E+00 
Glycine 1.53E+05 1.63E+05 4.65E+04 0.00E+00 9.76E+04 
Pyruvate 5.80E+07 7.76E+07 1.15E+08 1.11E+08 1.78E+08 
Alanine/Sarcosine 6.94E+09 2.27E+09 3.96E+08 3.62E+08 6.60E+08 
Lactate 1.59E+09 1.30E+09 4.26E+08 6.41E+08 1.04E+09 
Dimethylglycine 5.49E+08 1.56E+08 3.73E+07 7.55E+07 8.13E+07 
Serine 1.04E+07 6.23E+07 5.58E+07 8.50E+07 1.25E+08 
Histamine 4.35E+04 3.10E+06 2.26E+06 1.93E+06 3.62E+06 
Uracil 9.43E+08 2.00E+09 1.24E+09 1.22E+09 2.17E+09 
Creatinine 5.00E+04 8.58E+04 6.33E+04 8.57E+05 2.56E+04 
Proline 2.20E+09 7.19E+09 3.63E+09 3.20E+09 7.44E+09 
Fumarate 2.14E+06 4.33E+07 4.20E+07 6.35E+07 8.61E+07 
2-Oxoisovalerate 8.80E+07 1.20E+09 4.32E+07 2.67E+07 1.39E+08 
Indole 4.15E+06 4.52E+05 8.80E+05 6.36E+05 1.58E+06 
Valine 7.43E+09 2.94E+09 3.59E+08 3.53E+08 9.64E+08 
3-Hydroxyisovaleric acid 2.71E+09 3.56E+09 1.99E+08 1.33E+08 6.02E+08 
Homoserine/Threonine 4.19E+08 5.15E+08 1.82E+08 1.84E+08 4.41E+08 
3-Methylthiopropionate 5.89E+07 9.25E+07 1.93E+05 7.22E+05 1.74E+05 
Cysteine 6.12E+05 6.63E+05 1.22E+06 1.02E+06 1.57E+06 
Nicotinate 2.43E+08 8.36E+07 9.11E+07 2.60E+08 2.41E+08 
Taurine 1.76E+06 1.98E+06 2.07E+05 7.52E+05 7.24E+04 
Thymine 5.24E+08 1.47E+09 1.59E+09 3.50E+09 3.47E+09 
Hydroxyproline 5.15E+06 8.24E+06 9.46E+06 8.53E+06 1.02E+07 
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Table 25. Continued. 
Metabolite 6 Days-1 6 Days-2 6 Days-3 6 Days-4 6 Days-5 
N-Acetyl-beta-alanine 1.27E+09 2.78E+08 5.05E+08 6.82E+07 3.64E+08 
Leucine/Isoleucine 1.20E+10 6.40E+09 1.34E+09 1.24E+09 3.60E+09 
Glutaric acid 2.23E+08 3.27E+08 1.08E+09 5.55E+08 1.88E+09 
Asparagine 7.13E+06 6.02E+08 3.97E+08 4.93E+08 2.57E+08 
Hydroxyisocaproic acid 1.44E+10 2.63E+10 5.81E+08 3.88E+08 3.21E+09 
Ornithine 1.48E+08 3.00E+08 2.37E+07 5.52E+07 4.78E+07 
Salicylate 2.15E+07 4.14E+07 5.80E+08 7.28E+07 4.44E+08 
Hydroxybenzoate 2.80E+07 1.16E+08 3.95E+07 1.12E+08 3.41E+07 
Histidinol 7.65E+04 3.15E+06 2.16E+05 1.65E+07 6.58E+05 
2-Oxoglutaric acid 1.45E+07 9.55E+07 2.02E+08 1.31E+08 8.06E+08 
Glutamine 1.11E+08 6.62E+08 4.43E+08 5.09E+08 5.54E+08 
2-hydroxyglutarate 4.15E+08 2.32E+09 6.23E+08 1.26E+09 8.72E+08 
2-Hydroxy-2-methylsuccinate 4.15E+08 2.31E+09 6.23E+08 1.27E+09 8.74E+08 
L-Methionine 2.50E+07 1.85E+08 4.76E+07 4.46E+07 9.09E+07 
Guanine 1.75E+08 5.25E+06 1.87E+06 6.62E+07 2.57E+06 
3-Methylphenylacetic acid 2.56E+09 2.31E+09 1.87E+06 2.58E+06 1.93E+06 
Hydroxyphenylacetate 2.27E+07 1.59E+08 6.02E+08 1.08E+09 1.74E+08 
Xylitol 3.09E+08 7.53E+07 1.10E+08 8.88E+07 1.15E+08 
Dopamine 1.02E+08 8.29E+07 3.56E+06 4.25E+06 5.08E+06 
2_3-Dihydroxybenzoate 4.55E+06 6.17E+06 8.20E+05 2.12E+07 1.50E+08 
Histidine 1.74E+08 1.60E+08 5.81E+07 6.28E+07 1.16E+08 
Orotate 1.12E+08 6.71E+08 2.52E+08 4.79E+07 6.13E+08 
Dihydroorotate 8.96E+05 6.29E+06 4.64E+06 4.54E+05 1.23E+07 
Allantoin 2.66E+07 4.15E+08 2.34E+08 6.86E+08 2.85E+08 
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Table 25. Continued. 
Metabolite 6 Days-1 6 Days-2 6 Days-3 6 Days-4 6 Days-5 
Indole-3-carboxylate 5.56E+07 1.38E+07 2.98E+07 4.07E+07 2.86E+07 
Phenylpyruvate 2.08E+08 1.88E+09 5.89E+07 5.38E+07 8.81E+07 
Phenylalanine 8.35E+09 2.38E+09 1.16E+09 4.60E+08 1.97E+09 
Phenyllactic acid 6.97E+09 1.86E+09 1.44E+09 3.36E+09 2.30E+09 
Quinolinate 3.13E+06 7.95E+07 3.16E+07 5.90E+07 5.48E+07 
Phosphoenolpyruvate 1.07E+08 8.08E+07 3.03E+07 7.17E+07 1.10E+08 
Uric acid 2.94E+08 2.14E+08 5.17E+08 7.19E+08 6.19E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 5.36E+07 8.09E+07 5.29E+07 9.40E+07 6.47E+07 
Sulfolactate 2.43E+07 2.81E+07 1.57E+06 1.01E+08 3.13E+06 
Glycerone phosphate 5.92E+06 1.95E+06 4.98E+06 1.28E+07 5.29E+06 
Arginine 6.83E+07 3.51E+07 4.26E+07 4.27E+07 6.21E+07 
Citrulline 1.70E+09 3.12E+08 2.97E+07 7.82E+07 1.26E+08 
Ascorbate 8.22E+04 2.56E+06 3.16E+05 6.61E+05 4.75E+05 
N-Carbamoyl-L-aspartate 9.89E+05 7.25E+07 5.17E+07 9.03E+06 1.35E+08 
Allantoate 1.81E+07 7.93E+08 3.62E+08 1.55E+09 2.36E+08 
2-Isopropylmalate 6.95E+08 1.84E+09 2.89E+09 2.29E+09 3.32E+09 
Glucosamine 3.20E+06 7.28E+06 5.84E+06 2.62E+07 6.55E+06 
myo-Inositol 2.02E+07 1.82E+07 2.58E+07 1.40E+07 3.33E+07 
Tyrosine 1.34E+09 2.16E+08 2.07E+08 8.53E+07 4.18E+08 
Homovanillic acid (HVA) 8.03E+08 2.03E+08 4.09E+07 2.90E+07 4.95E+07 
Homocysteic acid 0.00E+00 5.94E+06 2.60E+05 8.81E+07 8.17E+04 
4-Pyridoxate 1.00E+07 3.94E+07 2.49E+08 4.74E+08 2.94E+08 
N-Acetylglutamine 1.01E+08 1.80E+08 4.97E+07 4.70E+07 7.60E+07 
Citrate/isocitrate 5.86E+08 2.66E+09 2.00E+10 2.30E+10 1.73E+10 
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Table 25. Continued. 
Metabolite 6 Days-1 6 Days-2 6 Days-3 6 Days-4 6 Days-5 
D-Gluconate 7.35E+08 5.57E+08 5.70E+08 7.00E+08 6.78E+08 
N-N Dimethylarginine 2.32E+05 4.40E+06 7.80E+05 2.67E+06 2.63E+06 
Tryptophan 1.15E+09 1.90E+08 2.97E+08 2.39E+08 5.45E+08 
Xanthurenic acid 2.24E+07 8.07E+06 8.91E+06 1.25E+07 1.14E+08 
D-Glucarate 6.81E+09 2.62E+09 1.54E+09 4.92E+09 9.23E+08 
Pantothenate 1.57E+09 1.98E+09 1.33E+09 2.89E+09 2.87E+09 
Cystathionine 2.36E+04 1.06E+07 1.02E+07 1.80E+07 5.52E+06 
Cystine 1.93E+04 5.72E+03 5.20E+05 1.93E+05 2.64E+05 
Uridine 9.21E+07 1.84E+08 4.94E+07 6.76E+06 1.70E+08 
Biotin 1.54E+06 6.90E+05 4.75E+05 2.25E+05 9.20E+05 
Deoxyinosine 2.20E+05 3.72E+06 2.85E+06 8.03E+06 9.89E+06 
Glucose 6-phosphate 9.01E+06 3.46E+07 2.87E+07 6.85E+07 3.15E+07 
S-Ribosyl-L-homocysteine 1.75E+04 4.15E+06 3.01E+05 1.52E+05 1.12E+04 
6-Phospho-D-gluconate 5.39E+06 2.44E+07 1.17E+07 1.86E+07 3.62E+07 
Guanosine 3.18E+07 3.61E+06 1.53E+07 8.32E+06 2.47E+07 
Xanthosine 4.15E+07 1.61E+06 3.03E+06 1.50E+07 4.37E+06 
Glycinamide ribotide (GAR) 0.00E+00 6.28E+05 8.52E+05 4.35E+06 5.12E+04 
Ophthalmate 2.24E+08 1.34E+07 4.56E+06 8.01E+07 2.16E+07 
Glutathione 3.12E+07 9.78E+07 3.70E+07 1.64E+08 5.72E+07 
UMP 1.21E+06 1.06E+08 2.09E+08 4.07E+08 3.07E+08 
AICAR 1.30E+04 6.23E+05 7.80E+05 1.60E+06 7.51E+05 
Trehalose/Sucrose/Cellobiose 5.28E+05 1.52E+07 1.52E+07 2.93E+07 1.68E+07 
AMP/dGMP 1.60E+07 2.41E+08 5.19E+08 4.28E+08 7.29E+08 
IMP 2.14E+04 4.43E+06 9.93E+06 9.71E+06 2.51E+07 
  
116 
Table 25. Continued. 
Metabolite 6 Days-1 6 Days-2 6 Days-3 6 Days-4 6 Days-5 
GMP 1.13E+06 4.34E+07 2.26E+08 1.55E+08 3.20E+08 
Xanthosine 5--phosphate 4.55E+06 5.29E+06 1.10E+06 6.03E+05 7.18E+06 
Riboflavin 5.32E+06 2.11E+06 7.88E+06 1.41E+06 6.91E+06 
S-Adenosyl-L-homocysteine 0.00E+00 3.11E+05 2.95E+05 5.35E+05 2.91E+05 
ADP 1.04E+07 2.29E+08 7.47E+07 3.24E+08 1.22E+08 
Folate 4.52E+04 2.75E+04 1.49E+06 7.29E+05 1.81E+06 
CDP-ethanolamine 0.00E+00 1.21E+06 1.79E+06 4.36E+06 3.23E+06 
FMN 5.42E+06 4.79E+06 6.22E+06 8.51E+06 1.17E+07 
UDP-glucose 8.64E+05 8.62E+07 8.69E+07 2.07E+08 2.04E+08 
NAD+ 1.54E+07 1.39E+07 3.57E+06 3.81E+07 1.12E+07 
NADH 1.76E+05 1.50E+05 1.02E+04 1.36E+05 1.90E+05 
Dephospho-CoA 2.75E+05 1.15E+06 2.46E+06 1.64E+06 3.31E+06 
NADP+ 3.18E+07 6.12E+06 2.41E+06 1.75E+07 8.77E+06 
FAD 6.57E+06 2.24E+06 3.82E+06 3.57E+06 8.24E+06 
N-Acetylglutamate 5.13E+08 1.30E+09 9.31E+08 5.71E+08 1.64E+09 




Table 26. Intensities of G. mellonella replicates in 8 days post infection group. 
Metabolite 8 Days-1 8 Days-2 8 Days-3 8 Days-4 8 Days-5 
Glyoxylate 0.00E+00 1.14E+04 1.09E+07 0.00E+00 7.89E+07 
Glycine 1.92E+05 3.69E+04 8.06E+08 0.00E+00 1.69E+08 
Pyruvate 2.59E+07 1.38E+08 1.01E+08 2.41E+08 5.80E+07 
Alanine/Sarcosine 9.66E+09 5.99E+08 8.88E+08 5.95E+08 5.14E+08 
Lactate 7.62E+08 4.86E+08 6.34E+08 4.19E+08 1.05E+09 
Dimethylglycine 4.92E+08 7.12E+07 1.50E+08 7.79E+07 7.07E+07 
Serine 5.35E+06 5.34E+07 3.98E+07 7.18E+07 7.30E+07 
Histamine 1.08E+06 1.64E+06 1.27E+06 1.79E+06 1.22E+05 
Uracil 2.66E+09 9.49E+08 1.37E+09 2.09E+09 1.22E+09 
Creatinine 7.04E+04 5.84E+05 2.10E+05 5.91E+05 2.25E+04 
Proline 1.27E+10 4.28E+09 6.22E+09 6.31E+09 1.57E+09 
Fumarate 2.10E+06 4.26E+07 3.36E+07 7.06E+07 2.35E+07 
2-Oxoisovalerate 1.28E+07 3.04E+07 7.89E+07 7.36E+07 1.51E+07 
Indole 1.12E+07 5.68E+05 6.54E+05 1.07E+06 3.94E+05 
Valine 8.80E+09 2.01E+08 3.89E+08 5.13E+08 1.62E+08 
3-Hydroxyisovaleric acid 3.52E+08 7.41E+07 9.64E+07 1.46E+08 1.71E+07 
Homoserine/Threonine 2.45E+09 1.89E+08 1.88E+08 4.03E+08 1.58E+08 
3-Methylthiopropionate 1.10E+07 2.82E+05 5.23E+05 1.15E+06 2.23E+05 
Cysteine 1.34E+05 1.51E+06 7.13E+05 3.82E+06 3.77E+05 
Nicotinate 1.27E+08 1.80E+08 2.00E+08 2.90E+08 3.17E+07 
Taurine 4.20E+06 4.33E+05 2.32E+05 4.61E+05 3.38E+05 
Thymine 7.35E+08 1.92E+09 1.60E+09 4.56E+09 2.19E+09 
Hydroxyproline 7.28E+06 9.16E+06 6.42E+06 1.75E+07 6.35E+06 
  
118 
Table 26. Continued. 
Metabolite 8 Days-1 8 Days-2 8 Days-3 8 Days-4 8 Days-5 
N-Acetyl-beta-alanine 1.92E+09 9.08E+07 6.63E+07 3.95E+08 3.82E+07 
Leucine/Isoleucine 2.99E+10 7.90E+08 1.41E+09 2.03E+09 5.05E+08 
Glutaric acid 1.34E+08 4.48E+08 4.39E+08 4.20E+08 3.81E+08 
Asparagine 1.50E+07 1.55E+08 3.42E+08 1.04E+08 1.95E+08 
Hydroxyisocaproic acid 3.76E+09 2.58E+08 3.25E+08 6.67E+08 7.97E+07 
Ornithine 1.31E+09 5.04E+07 6.94E+07 2.77E+07 1.68E+07 
Salicylate 2.60E+07 3.29E+07 1.04E+07 6.43E+08 2.56E+07 
Hydroxybenzoate 7.38E+06 3.08E+07 8.76E+07 9.91E+07 8.14E+06 
Histidinol 1.71E+05 4.21E+06 2.00E+06 8.28E+06 3.51E+05 
2-Oxoglutaric acid 7.61E+06 1.56E+08 1.31E+08 4.03E+08 1.20E+08 
Glutamine 1.19E+09 4.81E+08 5.93E+08 5.38E+08 3.64E+08 
2-hydroxyglutarate 1.35E+10 8.76E+08 4.02E+08 1.55E+09 3.49E+08 
2-Hydroxy-2-methylsuccinate 1.35E+10 8.78E+08 4.02E+08 1.55E+09 3.49E+08 
L-Methionine 5.94E+08 3.53E+07 3.30E+07 6.49E+07 2.15E+07 
Guanine 1.21E+08 3.11E+06 3.24E+06 8.01E+06 7.03E+06 
3-Methylphenylacetic acid 7.98E+08 1.34E+06 1.28E+06 3.94E+06 8.10E+06 
Hydroxyphenylacetate 2.48E+06 6.42E+08 2.71E+08 1.70E+09 2.18E+07 
Xylitol 3.55E+08 3.14E+07 5.06E+07 1.56E+08 6.18E+07 
Dopamine 4.44E+08 1.19E+06 2.55E+06 1.41E+06 1.73E+06 
2_3-Dihydroxybenzoate 9.49E+05 2.89E+06 3.75E+06 3.97E+08 6.16E+07 
Histidine 1.51E+09 4.39E+07 5.48E+07 7.54E+07 3.31E+07 
Orotate 6.04E+07 1.03E+08 6.05E+08 2.44E+08 2.74E+08 
Dihydroorotate 1.82E+06 1.65E+06 5.52E+06 6.49E+06 3.58E+07 
Allantoin 9.41E+06 3.51E+08 5.51E+08 4.07E+08 7.14E+07 
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Table 26. Continued. 
Metabolite 8 Days-1 8 Days-2 8 Days-3 8 Days-4 8 Days-5 
Indole-3-carboxylate 4.83E+06 6.05E+07 3.30E+07 8.36E+07 9.92E+06 
Phenylpyruvate 5.75E+06 6.15E+07 1.08E+08 7.79E+07 4.94E+06 
Phenylalanine 1.65E+10 6.26E+08 5.70E+08 1.30E+09 4.59E+08 
Phenyllactic acid 3.07E+08 9.10E+08 7.48E+08 1.84E+09 1.46E+07 
Quinolinate 9.88E+05 1.29E+08 5.80E+07 5.20E+08 5.22E+07 
Phosphoenolpyruvate 5.36E+06 3.48E+07 3.44E+07 1.54E+08 5.30E+07 
Uric acid 3.56E+07 1.31E+08 6.04E+08 1.11E+08 1.64E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 6.71E+06 1.96E+07 6.92E+07 3.75E+07 6.05E+06 
Sulfolactate 1.04E+07 3.38E+06 2.49E+07 1.92E+07 8.88E+06 
Glycerone phosphate 2.51E+06 8.17E+06 5.39E+05 2.33E+07 1.44E+05 
Arginine 9.87E+06 5.13E+07 4.43E+07 5.35E+07 3.40E+07 
Citrulline 1.00E+09 9.13E+07 1.00E+08 3.28E+07 4.13E+07 
Ascorbate 9.12E+04 1.93E+05 5.31E+05 6.39E+05 2.95E+05 
N-Carbamoyl-L-aspartate 3.72E+05 3.08E+07 1.17E+08 4.52E+07 2.02E+08 
Allantoate 2.40E+06 7.66E+07 1.37E+09 1.38E+08 1.03E+07 
2-Isopropylmalate 2.20E+08 3.09E+09 2.53E+09 4.72E+09 1.32E+08 
Glucosamine 2.86E+06 1.93E+07 9.45E+06 1.65E+07 5.22E+07 
myo-Inositol 1.93E+07 1.47E+07 1.80E+07 4.08E+07 2.92E+07 
Tyrosine 2.21E+08 2.72E+08 1.41E+08 4.92E+08 1.57E+08 
Homovanillic acid (HVA) 4.73E+07 3.27E+07 9.99E+07 6.74E+07 3.09E+06 
Homocysteic acid 5.51E+03 3.87E+05 2.82E+06 8.64E+05 1.91E+05 
4-Pyridoxate 1.36E+07 2.96E+08 1.76E+08 8.47E+08 3.75E+08 
N-Acetylglutamine 1.21E+09 4.34E+07 3.81E+07 4.27E+07 4.34E+07 
Citrate/isocitrate 1.62E+09 2.62E+09 5.38E+09 5.97E+09 4.29E+09 
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Table 26. Continued. 
Metabolite 8 Days-1 8 Days-2 8 Days-3 8 Days-4 8 Days-5 
D-Gluconate 4.86E+08 4.97E+08 4.54E+08 1.35E+09 4.74E+08 
N-N Dimethylarginine 2.64E+06 5.68E+05 2.87E+06 4.25E+05 4.47E+05 
Tryptophan 2.56E+09 1.89E+08 2.36E+08 3.52E+08 1.44E+08 
Xanthurenic acid 8.13E+05 4.38E+07 6.09E+07 2.78E+07 8.22E+07 
D-Glucarate 2.24E+09 1.57E+09 1.29E+09 3.66E+09 7.07E+07 
Pantothenate 4.49E+08 2.18E+09 1.85E+09 6.61E+08 3.82E+08 
Cystathionine 2.65E+06 1.91E+07 1.44E+07 4.81E+06 7.67E+06 
Cystine 8.24E+03 1.07E+06 2.85E+05 9.26E+05 2.09E+05 
Uridine 3.65E+08 1.26E+07 1.99E+07 3.63E+07 1.50E+07 
Biotin 3.63E+06 6.47E+05 9.07E+05 7.35E+05 5.06E+05 
Deoxyinosine 8.30E+05 2.61E+06 1.78E+06 1.03E+07 3.08E+06 
Glucose 6-phosphate 2.27E+07 1.28E+07 2.09E+07 4.99E+07 4.88E+07 
S-Ribosyl-L-homocysteine 1.10E+06 6.54E+05 6.96E+04 8.22E+05 5.35E+03 
6-Phospho-D-gluconate 1.06E+06 4.15E+06 1.44E+07 1.19E+07 2.82E+07 
Guanosine 8.48E+06 9.72E+07 1.65E+07 1.44E+08 1.27E+07 
Xanthosine 2.32E+07 2.43E+06 3.70E+06 4.89E+06 6.91E+06 
Glycinamide ribotide (GAR) 0.00E+00 9.38E+05 5.64E+06 1.78E+06 7.03E+04 
Ophthalmate 1.03E+08 1.19E+07 1.29E+07 2.84E+07 1.82E+07 
Glutathione 3.02E+07 2.55E+07 2.45E+07 7.57E+07 6.61E+06 
UMP 3.29E+06 2.32E+08 2.58E+08 5.89E+08 1.36E+08 
AICAR 0.00E+00 4.86E+05 1.06E+06 6.91E+05 1.20E+05 
Trehalose/Sucrose/Cellobiose 2.94E+04 1.71E+07 1.65E+07 3.36E+07 1.36E+07 
AMP/dGMP 6.36E+07 1.09E+09 8.68E+08 2.18E+09 3.01E+08 
IMP 2.42E+05 9.33E+06 6.27E+06 2.38E+07 5.82E+06 
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Table 26. Continued. 
Metabolite 8 Days-1 8 Days-2 8 Days-3 8 Days-4 8 Days-5 
GMP 1.75E+06 4.51E+08 4.55E+08 1.42E+09 6.51E+07 
Xanthosine 5--phosphate 5.28E+04 6.38E+05 7.91E+05 1.62E+06 1.83E+05 
Riboflavin 4.62E+06 2.51E+06 3.66E+06 8.34E+06 2.66E+07 
S-Adenosyl-L-homocysteine 0.00E+00 3.88E+05 3.74E+05 6.86E+05 4.90E+05 
ADP 6.12E+07 1.23E+08 2.48E+08 2.70E+08 3.46E+07 
Folate 2.09E+04 2.13E+06 1.12E+06 4.89E+06 5.72E+06 
CDP-ethanolamine 0.00E+00 1.38E+06 1.50E+06 3.70E+06 1.71E+06 
FMN 8.86E+06 6.73E+06 5.28E+06 1.12E+07 1.71E+07 
UDP-glucose 1.38E+06 5.54E+07 7.17E+07 2.72E+08 1.17E+08 
NAD+ 1.47E+07 9.65E+06 1.00E+07 1.16E+07 1.01E+06 
NADH 1.18E+06 1.85E+04 1.72E+04 2.19E+04 3.82E+04 
Dephospho-CoA 3.15E+05 1.20E+06 1.13E+06 5.16E+06 1.15E+06 
NADP+ 5.62E+06 7.75E+06 5.04E+06 1.11E+07 5.08E+05 
FAD 1.32E+06 2.45E+06 1.75E+06 7.64E+06 6.93E+06 
N-Acetylglutamate 9.57E+08 7.96E+08 4.05E+08 1.06E+09 3.92E+08 





Table 27. Intensities of G. mellonella replicates in 10 days post infection group. 
Metabolite 10 Days-1 10 Days-2 10 Days-3 10 Days-4 10 Days-5 
Glyoxylate 1.35E+04 4.15E+03 9.16E+06 0.00E+00 0.00E+00 
Glycine 2.74E+04 1.01E+05 1.47E+09 1.84E+04 1.30E+06 
Pyruvate 9.47E+07 7.35E+07 1.12E+08 1.78E+08 2.20E+08 
Alanine/Sarcosine 3.85E+08 5.45E+08 1.10E+09 3.33E+08 4.14E+09 
Lactate 1.42E+09 4.82E+08 5.45E+08 4.27E+08 1.83E+09 
Dimethylglycine 1.03E+08 7.98E+07 7.63E+08 4.10E+07 2.14E+08 
Serine 6.34E+07 8.00E+07 5.31E+07 8.67E+07 5.05E+07 
Histamine 4.22E+06 1.37E+06 3.35E+06 1.33E+06 4.24E+06 
Uracil 2.54E+09 1.77E+09 2.33E+09 8.49E+08 2.24E+09 
Creatinine 6.47E+04 6.78E+05 3.66E+05 1.92E+06 1.10E+05 
Proline 3.50E+09 9.81E+09 8.90E+09 5.16E+09 1.32E+10 
Fumarate 1.70E+07 2.84E+07 1.49E+07 5.47E+07 5.99E+07 
2-Oxoisovalerate 5.01E+07 2.08E+08 5.95E+08 3.03E+07 2.51E+08 
Indole 2.24E+05 3.57E+05 3.59E+05 1.16E+06 3.65E+06 
Valine 2.30E+08 2.98E+08 5.27E+08 2.42E+08 5.07E+09 
3-Hydroxyisovaleric acid 7.00E+08 1.10E+08 4.04E+08 8.35E+07 7.35E+08 
Homoserine/Threonine 1.88E+08 2.28E+08 1.80E+08 2.40E+08 6.96E+08 
3-Methylthiopropionate 9.58E+05 5.78E+06 5.61E+06 2.55E+05 1.51E+08 
Cysteine 8.61E+05 1.42E+06 2.09E+05 1.76E+06 2.58E+05 
Nicotinate 1.29E+07 2.51E+07 1.51E+08 1.58E+08 1.03E+08 
Taurine 3.41E+05 9.01E+05 2.54E+05 6.94E+05 3.79E+06 
Thymine 2.98E+09 1.52E+09 2.29E+09 1.49E+09 1.27E+09 
Hydroxyproline 3.89E+07 3.04E+07 1.30E+07 7.78E+07 2.11E+07 
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Table 27. Continued. 
Metabolite 10 Days-1 10 Days-2 10 Days-3 10 Days-4 10 Days-5 
N-Acetyl-beta-alanine 3.82E+08 2.12E+08 2.33E+08 1.29E+08 2.63E+08 
Leucine/Isoleucine 5.41E+08 9.59E+08 1.14E+09 1.17E+09 1.59E+10 
Glutaric acid 2.82E+09 7.96E+08 1.26E+09 8.31E+07 5.57E+08 
Asparagine 4.24E+08 7.09E+08 2.98E+08 1.53E+08 1.19E+08 
Hydroxyisocaproic acid 3.14E+09 5.25E+08 1.15E+09 5.60E+08 3.07E+09 
Ornithine 1.13E+07 2.86E+07 4.15E+07 4.15E+07 5.49E+08 
Salicylate 3.51E+08 5.80E+07 5.14E+07 3.57E+07 2.09E+07 
Hydroxybenzoate 5.40E+08 5.10E+08 4.57E+08 4.75E+07 1.27E+08 
Histidinol 5.27E+05 9.61E+05 3.06E+05 1.33E+07 7.00E+05 
2-Oxoglutaric acid 7.30E+07 4.20E+07 5.72E+07 1.71E+08 1.16E+08 
Glutamine 5.19E+08 7.62E+08 4.35E+08 4.26E+08 3.03E+08 
2-hydroxyglutarate 1.57E+09 1.83E+09 6.51E+08 7.68E+08 1.03E+09 
2-Hydroxy-2-methylsuccinate 1.58E+09 1.83E+09 6.50E+08 7.71E+08 1.03E+09 
L-Methionine 1.85E+07 3.15E+07 2.88E+07 3.68E+07 4.12E+08 
Guanine 5.83E+06 5.27E+06 4.99E+06 2.99E+06 3.40E+06 
3-Methylphenylacetic acid 1.37E+09 3.11E+06 9.68E+05 1.56E+06 1.10E+07 
Hydroxyphenylacetate 6.43E+08 1.01E+09 3.97E+08 1.16E+09 1.66E+07 
Xylitol 6.62E+07 9.00E+07 7.76E+07 1.13E+08 8.66E+07 
Dopamine 5.22E+06 7.09E+05 1.25E+06 7.83E+05 9.59E+06 
2_3-Dihydroxybenzoate 5.26E+07 3.33E+07 3.55E+06 6.87E+07 7.21E+06 
Histidine 3.45E+07 8.19E+07 6.06E+07 7.79E+07 2.62E+08 
Orotate 6.64E+08 5.92E+08 1.31E+09 1.97E+07 1.48E+09 
Dihydroorotate 3.83E+06 3.91E+06 1.51E+07 1.64E+06 9.90E+06 
Allantoin 3.68E+08 4.72E+08 4.76E+08 1.36E+08 7.05E+08 
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Table 27. Continued. 
Metabolite 10 Days-1 10 Days-2 10 Days-3 10 Days-4 10 Days-5 
Indole-3-carboxylate 1.13E+08 1.47E+08 1.28E+08 7.30E+07 1.03E+08 
Phenylpyruvate 8.62E+08 4.53E+08 1.57E+09 9.09E+07 2.76E+08 
Phenylalanine 2.74E+08 4.52E+08 6.77E+08 7.17E+08 6.57E+09 
Phenyllactic acid 3.91E+08 4.07E+08 2.38E+08 1.27E+09 8.77E+08 
Quinolinate 2.42E+08 1.30E+09 4.88E+08 6.06E+08 8.96E+07 
Phosphoenolpyruvate 1.47E+08 3.51E+07 7.96E+07 5.37E+07 4.14E+08 
Uric acid 4.95E+08 7.71E+08 6.18E+08 1.06E+07 1.34E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 1.97E+08 1.85E+08 1.90E+08 4.07E+07 2.94E+08 
Sulfolactate 2.89E+07 1.28E+08 6.58E+07 2.72E+06 5.86E+07 
Glycerone phosphate 6.31E+06 8.11E+06 7.16E+06 9.15E+06 6.71E+05 
Arginine 1.80E+07 4.53E+07 3.55E+07 5.27E+07 3.55E+07 
Citrulline 7.90E+07 3.83E+07 3.34E+07 3.37E+07 8.86E+08 
Ascorbate 1.09E+06 2.76E+05 1.74E+06 7.69E+05 3.96E+05 
N-Carbamoyl-L-aspartate 3.39E+07 4.53E+07 2.99E+08 1.01E+07 8.99E+08 
Allantoate 3.13E+08 1.40E+09 1.05E+09 4.98E+07 8.16E+07 
2-Isopropylmalate 1.03E+10 1.15E+10 9.14E+09 3.17E+09 5.00E+08 
Glucosamine 1.45E+07 1.56E+07 6.82E+06 2.62E+07 6.54E+06 
myo-Inositol 5.00E+07 4.24E+07 2.80E+07 3.28E+07 2.52E+07 
Tyrosine 9.70E+07 1.75E+08 9.48E+07 4.27E+08 2.41E+08 
Homovanillic acid (HVA) 1.05E+08 3.74E+07 3.96E+07 1.35E+07 9.99E+07 
Homocysteic acid 6.44E+05 1.00E+07 1.28E+06 2.38E+05 9.43E+06 
4-Pyridoxate 5.32E+08 5.78E+08 1.65E+08 7.70E+08 5.41E+07 
N-Acetylglutamine 8.53E+07 3.78E+07 6.97E+07 4.73E+07 1.40E+08 
Citrate/isocitrate 6.30E+09 5.14E+09 3.54E+09 3.62E+09 3.06E+09 
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Table 27. Continued. 
Metabolite 10 Days-1 10 Days-2 10 Days-3 10 Days-4 10 Days-5 
D-Gluconate 6.62E+08 9.10E+08 6.44E+08 1.41E+09 5.57E+08 
N-N Dimethylarginine 3.20E+05 8.07E+05 5.98E+05 5.52E+05 3.30E+06 
Tryptophan 9.54E+07 1.53E+08 1.48E+08 3.84E+08 1.09E+09 
Xanthurenic acid 6.05E+07 4.11E+07 1.96E+07 3.87E+07 1.70E+05 
D-Glucarate 4.07E+09 1.75E+09 5.22E+09 2.36E+09 4.61E+09 
Pantothenate 4.06E+09 3.41E+09 3.94E+09 2.18E+08 1.39E+09 
Cystathionine 6.94E+06 6.44E+06 4.64E+06 3.77E+06 9.00E+06 
Cystine 0.00E+00 7.23E+04 1.85E+04 1.24E+06 1.36E+05 
Uridine 4.96E+07 7.21E+06 8.75E+07 5.41E+06 1.02E+08 
Biotin 1.70E+06 2.06E+06 1.61E+06 3.01E+05 1.56E+06 
Deoxyinosine 6.90E+06 2.47E+06 2.23E+06 2.14E+06 1.45E+06 
Glucose 6-phosphate 3.32E+07 1.72E+07 2.75E+07 1.48E+07 3.43E+07 
S-Ribosyl-L-homocysteine 1.14E+05 8.73E+05 2.82E+06 1.30E+05 0.00E+00 
6-Phospho-D-gluconate 2.93E+07 1.24E+07 2.15E+07 2.35E+06 3.51E+07 
Guanosine 1.51E+07 6.16E+06 5.21E+07 5.57E+07 1.15E+07 
Xanthosine 1.54E+07 1.20E+06 2.23E+06 2.93E+06 1.42E+07 
Glycinamide ribotide (GAR) 1.34E+06 4.33E+05 8.40E+05 2.85E+05 4.09E+04 
Ophthalmate 4.69E+07 2.68E+07 2.31E+07 2.11E+07 1.20E+07 
Glutathione 1.08E+08 1.91E+08 4.06E+07 2.40E+07 7.23E+06 
UMP 1.37E+08 2.65E+08 1.57E+08 3.51E+08 7.39E+07 
AICAR 2.56E+05 7.40E+05 3.89E+05 1.05E+05 1.61E+05 
Trehalose/Sucrose/Cellobiose 1.27E+07 2.81E+07 1.63E+07 3.18E+07 3.84E+06 
AMP/dGMP 4.60E+08 7.65E+08 7.41E+08 1.80E+09 2.07E+08 
IMP 3.43E+06 3.49E+06 2.92E+06 2.13E+07 3.23E+06 
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Table 27. Continued. 
Metabolite 10 Days-1 10 Days-2 10 Days-3 10 Days-4 10 Days-5 
GMP 1.38E+08 3.16E+08 3.11E+08 8.36E+08 8.49E+07 
Xanthosine 5--phosphate 5.37E+06 1.64E+06 2.59E+06 7.38E+05 3.79E+07 
Riboflavin 7.30E+06 8.50E+06 1.02E+07 3.57E+06 9.74E+05 
S-Adenosyl-L-homocysteine 2.72E+04 1.67E+05 4.25E+05 2.80E+05 3.89E+04 
ADP 3.31E+08 1.83E+08 3.16E+08 1.22E+08 6.66E+07 
Folate 4.41E+05 1.19E+06 1.13E+06 1.95E+06 1.77E+04 
CDP-ethanolamine 1.13E+06 9.43E+05 5.94E+05 1.33E+06 2.77E+05 
FMN 6.07E+06 2.77E+06 6.21E+06 7.12E+06 3.24E+06 
UDP-glucose 1.25E+08 9.57E+07 1.07E+08 1.97E+08 1.91E+07 
NAD+ 1.04E+07 1.03E+07 1.24E+07 1.22E+07 4.48E+06 
NADH 4.89E+04 0.00E+00 6.69E+03 0.00E+00 0.00E+00 
Dephospho-CoA 7.53E+05 9.77E+05 3.59E+05 2.36E+06 2.37E+05 
NADP+ 9.52E+06 3.19E+06 7.87E+06 1.41E+07 5.22E+06 
FAD 3.92E+06 2.27E+06 3.40E+06 4.12E+06 1.59E+06 
N-Acetylglutamate 1.61E+09 3.43E+08 1.48E+08 1.43E+09 1.66E+09 





Table 28. Intensities of G. mellonella replicates in 12 days post infection group. 
Metabolite 12 Day-3 12 Days-1 12 Days-2 12 Days-4 12 Days-5 
Glyoxylate 5.87E+06 4.74E+07 1.58E+07 1.88E+04 7.46E+06 
Glycine 2.21E+09 2.56E+08 4.03E+07 5.89E+05 1.42E+09 
Pyruvate 6.83E+07 9.72E+07 6.38E+07 7.90E+07 5.37E+07 
Alanine/Sarcosine 6.22E+09 6.52E+08 1.08E+08 8.56E+08 8.53E+08 
Lactate 6.79E+10 4.68E+08 3.83E+08 9.20E+08 1.50E+09 
Dimethylglycine 1.30E+08 1.09E+08 1.69E+07 2.27E+08 1.33E+09 
Serine 1.65E+06 5.00E+06 3.72E+07 2.68E+07 7.52E+07 
Histamine 8.64E+05 1.63E+05 1.99E+06 4.63E+06 6.49E+06 
Uracil 4.74E+08 9.47E+08 4.14E+08 2.93E+09 1.79E+09 
Creatinine 0.00E+00 1.77E+04 5.35E+05 6.19E+04 4.42E+05 
Proline 1.08E+10 5.08E+08 1.22E+09 2.73E+09 2.42E+09 
Fumarate 8.69E+05 1.37E+07 1.93E+07 1.74E+07 8.56E+06 
2-Oxoisovalerate 6.87E+06 2.16E+07 1.73E+07 5.25E+07 8.34E+08 
Indole 6.19E+06 7.68E+05 4.20E+05 1.75E+06 1.61E+05 
Valine 5.69E+09 1.39E+09 1.01E+08 1.00E+09 6.36E+08 
3-Hydroxyisovaleric acid 2.06E+08 5.82E+08 4.53E+07 1.13E+09 2.76E+09 
Homoserine/Threonine 1.66E+09 2.49E+08 6.67E+07 2.47E+08 1.60E+08 
3-Methylthiopropionate 5.15E+06 5.97E+06 1.12E+06 3.41E+07 1.19E+08 
Cysteine 6.99E+04 5.95E+04 1.16E+06 7.43E+05 2.12E+05 
Nicotinate 1.37E+08 4.26E+07 6.51E+06 5.36E+08 1.03E+08 
Taurine 1.22E+06 0.00E+00 3.00E+05 6.79E+03 2.54E+06 
Thymine 2.96E+08 9.80E+08 1.69E+08 3.58E+09 1.08E+09 
Hydroxyproline 5.19E+06 3.24E+06 6.95E+06 8.69E+06 1.95E+07 
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Table 28. Continued. 
Metabolite 12 Day-3 12 Days-1 12 Days-2 12 Days-4 12 Days-5 
N-Acetyl-beta-alanine 9.15E+08 4.27E+07 8.19E+07 2.32E+08 9.74E+07 
Leucine/Isoleucine 2.05E+10 5.96E+09 3.71E+08 1.93E+09 8.97E+08 
Glutaric acid 6.76E+07 2.24E+08 2.83E+08 1.74E+09 3.24E+08 
Asparagine 8.52E+08 1.56E+06 2.88E+08 2.86E+07 1.29E+08 
Hydroxyisocaproic acid 3.32E+09 2.19E+09 1.17E+08 2.34E+09 1.28E+10 
Ornithine 4.84E+08 2.99E+08 2.02E+07 4.41E+08 4.67E+07 
Salicylate 1.00E+08 7.27E+06 7.21E+06 1.67E+08 2.51E+07 
Hydroxybenzoate 4.97E+06 1.83E+07 1.18E+08 2.54E+07 5.47E+08 
Histidinol 7.23E+04 1.51E+06 1.76E+06 3.79E+06 3.97E+05 
2-Oxoglutaric acid 9.64E+06 2.53E+07 3.82E+07 6.80E+07 4.52E+07 
Glutamine 2.22E+09 4.96E+06 2.18E+08 1.03E+08 3.04E+08 
2-hydroxyglutarate 1.16E+10 1.73E+08 5.17E+08 7.63E+08 4.72E+08 
2-Hydroxy-2-methylsuccinate 1.16E+10 1.73E+08 5.17E+08 7.64E+08 4.71E+08 
L-Methionine 9.17E+08 1.33E+08 1.20E+07 1.81E+08 1.40E+07 
Guanine 4.87E+04 1.52E+06 1.24E+06 8.92E+05 1.37E+07 
3-Methylphenylacetic acid 1.51E+06 2.18E+09 7.03E+05 2.44E+06 1.39E+06 
Hydroxyphenylacetate 2.81E+06 9.85E+07 1.52E+08 6.50E+08 3.46E+08 
Xylitol 1.92E+08 5.41E+07 1.61E+07 4.17E+07 4.46E+07 
Dopamine 8.65E+08 9.91E+06 5.91E+05 7.17E+06 1.51E+06 
2_3-Dihydroxybenzoate 2.21E+06 8.26E+07 2.84E+06 1.11E+08 2.16E+06 
Histidine 7.73E+08 1.18E+08 5.66E+07 3.20E+07 3.98E+07 
Orotate 1.72E+07 2.09E+06 3.33E+07 2.28E+09 9.31E+08 
Dihydroorotate 1.91E+06 1.60E+06 1.76E+06 1.08E+08 2.99E+06 
Allantoin 3.42E+07 1.14E+06 3.22E+08 2.94E+07 5.37E+08 
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Table 28. Continued. 
Metabolite 12 Day-3 12 Days-1 12 Days-2 12 Days-4 12 Days-5 
Indole-3-carboxylate 1.47E+06 5.06E+07 3.98E+07 1.42E+08 9.24E+07 
Phenylpyruvate 4.51E+06 2.57E+07 7.53E+07 5.24E+07 1.27E+09 
Phenylalanine 9.49E+09 3.75E+09 2.00E+08 1.48E+09 4.61E+08 
Phenyllactic acid 4.49E+08 4.17E+08 3.51E+07 1.12E+09 1.39E+09 
Quinolinate 2.40E+05 4.73E+06 3.91E+08 5.43E+07 3.41E+08 
Phosphoenolpyruvate 1.04E+06 2.12E+07 3.68E+07 5.99E+07 3.09E+08 
Uric acid 1.56E+06 1.90E+08 1.53E+08 4.37E+08 2.75E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 2.83E+06 3.22E+07 4.97E+07 6.06E+07 2.79E+08 
Sulfolactate 2.77E+06 7.45E+07 8.00E+07 2.51E+07 7.97E+07 
Glycerone phosphate 2.13E+06 6.01E+04 5.63E+06 2.76E+06 3.42E+04 
Arginine 7.48E+05 9.23E+05 3.56E+07 1.35E+07 2.53E+07 
Citrulline 1.55E+08 5.35E+08 3.53E+06 1.53E+09 3.68E+07 
Ascorbate 2.45E+05 1.28E+05 9.96E+05 9.48E+05 2.43E+06 
N-Carbamoyl-L-aspartate 4.51E+06 1.60E+06 2.17E+07 9.01E+08 4.04E+07 
Allantoate 2.00E+06 4.11E+05 7.90E+08 7.66E+06 1.46E+09 
2-Isopropylmalate 1.78E+07 1.02E+09 6.53E+09 2.59E+09 3.62E+09 
Glucosamine 4.28E+05 2.08E+07 7.23E+06 8.31E+06 6.37E+06 
myo-Inositol 8.12E+08 4.39E+07 4.39E+07 5.52E+07 2.02E+07 
Tyrosine 4.02E+07 1.24E+09 1.58E+08 5.99E+08 5.73E+07 
Homovanillic acid (HVA) 4.26E+07 7.72E+08 3.13E+07 5.89E+07 8.76E+07 
Homocysteic acid 0.00E+00 1.51E+05 9.48E+05 1.05E+07 1.30E+06 
4-Pyridoxate 1.22E+07 3.85E+07 2.85E+08 1.55E+08 4.63E+07 
N-Acetylglutamine 1.46E+09 2.23E+07 1.99E+07 2.28E+07 5.73E+07 
Citrate/isocitrate 6.22E+07 4.78E+08 1.15E+09 1.80E+09 1.34E+09 
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Table 28. Continued. 
Metabolite 12 Day-3 12 Days-1 12 Days-2 12 Days-4 12 Days-5 
D-Gluconate 2.29E+08 1.37E+08 6.65E+08 4.73E+08 6.26E+08 
N-N Dimethylarginine 1.47E+06 1.29E+06 5.83E+05 2.04E+06 1.02E+06 
Tryptophan 1.94E+09 2.66E+08 1.56E+08 5.84E+08 7.18E+07 
Xanthurenic acid 3.69E+05 1.24E+07 8.46E+06 4.49E+06 4.82E+05 
D-Glucarate 2.88E+09 2.47E+07 1.10E+09 1.83E+08 4.04E+09 
Pantothenate 1.15E+09 1.01E+09 1.75E+09 2.28E+09 4.48E+09 
Cystathionine 6.44E+06 3.69E+05 6.30E+06 2.50E+06 8.49E+06 
Cystine 0.00E+00 1.07E+05 1.21E+06 1.28E+05 8.94E+04 
Uridine 3.43E+07 2.44E+08 1.16E+06 5.48E+07 1.21E+08 
Biotin 2.45E+06 1.84E+06 6.10E+05 2.52E+06 1.01E+06 
Deoxyinosine 1.10E+05 1.05E+06 2.96E+04 5.10E+06 7.87E+05 
Glucose 6-phosphate 2.43E+07 2.20E+06 1.01E+07 3.68E+07 2.27E+07 
S-Ribosyl-L-homocysteine 1.62E+06 1.50E+06 4.31E+05 2.03E+06 8.63E+04 
6-Phospho-D-gluconate 1.73E+05 1.73E+06 3.33E+06 3.26E+07 1.83E+07 
Guanosine 2.05E+06 2.17E+06 6.48E+06 1.02E+06 1.76E+07 
Xanthosine 4.24E+06 7.80E+06 3.58E+05 2.81E+06 2.83E+06 
Glycinamide ribotide (GAR) 0.00E+00 0.00E+00 2.71E+04 0.00E+00 1.49E+04 
Ophthalmate 8.67E+05 1.04E+07 3.60E+06 5.78E+06 7.99E+06 
Glutathione 2.87E+06 1.68E+06 3.69E+07 8.44E+06 1.64E+07 
UMP 2.25E+06 1.03E+06 1.64E+08 9.76E+07 3.33E+07 
AICAR 0.00E+00 0.00E+00 6.72E+03 4.21E+04 3.63E+04 
Trehalose/Sucrose/Cellobiose 3.90E+05 8.91E+05 2.78E+07 6.20E+06 9.60E+06 
AMP/dGMP 1.21E+07 8.60E+06 1.11E+09 2.94E+08 1.51E+08 
IMP 1.29E+05 3.05E+04 1.06E+07 5.81E+06 1.26E+06 
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Table 28. Continued. 
Metabolite 12 Day-3 12 Days-1 12 Days-2 12 Days-4 12 Days-5 
GMP 8.53E+05 3.58E+05 3.36E+08 8.00E+07 2.71E+07 
Xanthosine 5--phosphate 1.00E+04 1.21E+05 1.64E+06 1.36E+07 1.09E+07 
Riboflavin 1.76E+06 1.30E+07 5.71E+06 1.15E+07 4.95E+06 
S-Adenosyl-L-homocysteine 0.00E+00 0.00E+00 7.71E+04 1.69E+05 4.39E+04 
ADP 1.38E+06 7.80E+06 7.71E+07 7.37E+07 4.89E+07 
Folate 3.07E+04 2.47E+06 9.46E+05 2.45E+06 1.65E+05 
CDP-ethanolamine 2.13E+04 0.00E+00 4.68E+05 3.95E+05 1.06E+05 
FMN 5.28E+06 2.26E+07 2.80E+06 1.22E+07 6.00E+06 
UDP-glucose 7.32E+05 2.77E+06 8.90E+07 5.33E+07 4.75E+07 
NAD+ 2.55E+06 5.72E+06 2.93E+06 2.25E+06 7.09E+06 
NADH 1.90E+05 3.13E+05 0.00E+00 2.43E+05 1.25E+04 
Dephospho-CoA 7.72E+03 2.78E+05 1.13E+06 6.47E+05 2.08E+05 
NADP+ 2.54E+06 1.18E+07 3.68E+06 1.78E+06 7.60E+06 
FAD 3.53E+06 2.41E+07 2.47E+06 6.85E+06 3.58E+06 
N-Acetylglutamate 1.13E+09 4.31E+08 2.27E+08 4.47E+08 6.19E+07 





Table 29. Intensities of G. mellonella replicates in 16 days post infection group. 
Metabolite 16 Days-1 16 Days-2 16 Days-3 16 Days-4 16 Days-5 
Glyoxylate 0.00E+00 0.00E+00 0.00E+00 5.55E+08 7.39E+06 
Glycine 1.49E+04 1.02E+04 7.47E+04 2.27E+07 2.48E+08 
Pyruvate 2.79E+07 1.42E+08 3.43E+08 4.33E+07 4.77E+07 
Alanine/Sarcosine 4.36E+07 2.69E+08 1.88E+09 3.54E+07 4.21E+08 
Lactate 3.44E+08 7.95E+08 4.92E+08 2.10E+08 8.65E+08 
Dimethylglycine 8.86E+06 3.23E+08 3.09E+08 7.70E+06 4.56E+08 
Serine 1.93E+07 7.62E+07 1.14E+08 1.59E+07 4.89E+07 
Histamine 2.76E+04 2.17E+06 4.78E+06 0.00E+00 1.82E+06 
Uracil 7.69E+06 6.72E+08 2.85E+09 7.02E+07 6.62E+08 
Creatinine 3.24E+05 5.76E+05 9.70E+04 5.27E+04 7.04E+05 
Proline 2.60E+08 3.36E+09 5.64E+09 1.45E+08 7.57E+09 
Fumarate 6.86E+06 3.64E+07 3.90E+07 3.53E+06 8.20E+06 
2-Oxoisovalerate 1.10E+07 1.76E+07 1.47E+08 1.11E+07 1.11E+07 
Indole 2.09E+05 4.40E+05 1.24E+06 2.21E+04 3.66E+05 
Valine 2.18E+07 1.78E+08 2.06E+09 8.45E+07 1.43E+08 
3-Hydroxyisovaleric acid 1.79E+07 1.21E+08 1.01E+09 1.40E+07 9.53E+07 
Homoserine/Threonine 1.81E+07 1.26E+08 7.79E+08 4.63E+07 1.07E+08 
3-Methylthiopropionate 1.69E+07 1.04E+06 8.89E+07 4.01E+07 1.44E+06 
Cysteine 3.68E+05 1.38E+06 1.43E+06 2.51E+05 5.36E+05 
Nicotinate 1.28E+07 2.53E+08 8.67E+07 3.81E+07 3.15E+08 
Taurine 1.35E+06 2.61E+06 1.09E+06 1.47E+05 1.99E+06 
Thymine 1.20E+07 2.52E+08 1.73E+09 3.21E+07 4.17E+08 
Hydroxyproline 2.86E+06 1.23E+07 2.25E+07 2.57E+06 2.84E+07 
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Table 29. Continued. 
Metabolite 16 Days-1 16 Days-2 16 Days-3 16 Days-4 16 Days-5 
N-Acetyl-beta-alanine 7.54E+06 2.73E+08 2.15E+08 1.69E+07 3.38E+08 
Leucine/Isoleucine 1.02E+08 6.13E+08 7.08E+09 3.23E+08 3.94E+08 
Glutaric acid 1.88E+07 7.91E+08 8.70E+08 4.36E+07 4.82E+08 
Asparagine 4.54E+08 3.73E+08 1.35E+08 8.03E+06 2.48E+08 
Hydroxyisocaproic acid 3.96E+07 3.00E+08 3.40E+09 8.90E+07 3.13E+08 
Ornithine 6.47E+06 2.48E+07 1.09E+08 2.33E+07 4.17E+07 
Salicylate 3.63E+06 6.82E+07 3.56E+07 5.25E+07 3.23E+07 
Hydroxybenzoate 6.93E+06 5.75E+08 3.34E+08 1.50E+07 3.14E+08 
Histidinol 1.85E+05 1.10E+06 1.54E+06 9.53E+04 2.25E+06 
2-Oxoglutaric acid 1.34E+07 5.71E+07 1.11E+08 2.91E+07 1.97E+07 
Glutamine 2.13E+08 3.45E+08 5.00E+08 2.31E+07 4.24E+08 
2-hydroxyglutarate 5.53E+07 1.65E+09 7.22E+08 1.68E+08 1.09E+09 
2-Hydroxy-2-methylsuccinate 5.51E+07 1.66E+09 7.27E+08 1.68E+08 1.09E+09 
L-Methionine 1.09E+07 1.89E+07 2.29E+08 1.49E+07 1.99E+07 
Guanine 3.18E+06 1.08E+07 1.21E+06 3.03E+05 2.89E+06 
3-Methylphenylacetic acid 1.41E+06 1.98E+06 2.18E+06 3.66E+06 1.77E+06 
Hydroxyphenylacetate 4.42E+07 6.22E+08 6.49E+08 1.91E+07 6.17E+08 
Xylitol 1.91E+08 6.75E+07 1.86E+08 6.65E+07 1.08E+08 
Dopamine 4.51E+05 6.14E+05 6.50E+06 7.27E+05 1.48E+06 
2_3-Dihydroxybenzoate 2.41E+07 1.45E+06 6.80E+06 1.36E+08 2.11E+07 
Histidine 5.91E+07 7.43E+07 3.52E+07 3.74E+06 5.15E+07 
Orotate 9.58E+06 8.34E+07 2.44E+09 6.52E+07 5.08E+08 
Dihydroorotate 5.40E+06 3.04E+06 1.27E+07 3.39E+07 2.27E+06 
Allantoin 3.96E+06 6.86E+08 1.67E+08 4.05E+06 5.73E+08 
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Table 29. Continued. 
Metabolite 16 Days-1 16 Days-2 16 Days-3 16 Days-4 16 Days-5 
Indole-3-carboxylate 1.76E+07 6.05E+07 8.96E+07 1.46E+07 4.99E+07 
Phenylpyruvate 1.32E+07 1.57E+08 1.98E+08 4.61E+07 1.04E+08 
Phenylalanine 6.51E+07 2.97E+08 3.84E+09 2.52E+08 3.16E+08 
Phenyllactic acid 1.07E+07 2.50E+07 4.66E+08 8.55E+07 3.07E+07 
Quinolinate 4.72E+08 1.65E+09 2.01E+08 5.50E+07 9.53E+08 
Phosphoenolpyruvate 7.43E+06 9.33E+07 8.54E+07 5.21E+07 5.71E+07 
Uric acid 7.58E+06 3.61E+08 5.59E+08 2.95E+07 3.81E+08 
3_4-Dihydroxyphenylacetate (DOPAC) 1.42E+07 2.19E+08 1.13E+08 3.86E+06 1.35E+08 
Sulfolactate 4.42E+07 1.63E+08 4.82E+07 1.01E+08 1.04E+08 
Glycerone phosphate 5.52E+06 1.17E+07 1.11E+07 6.19E+04 1.96E+05 
Arginine 2.72E+07 3.02E+07 5.70E+07 2.10E+06 2.69E+07 
Citrulline 8.46E+05 1.27E+07 3.61E+08 8.96E+07 4.34E+07 
Ascorbate 2.34E+05 3.31E+05 5.32E+05 5.05E+05 7.22E+05 
N-Carbamoyl-L-aspartate 7.00E+06 9.42E+07 1.21E+09 9.77E+07 2.88E+07 
Allantoate 2.01E+06 1.57E+09 4.46E+08 3.99E+06 9.79E+08 
2-Isopropylmalate 4.36E+08 1.16E+10 4.35E+09 2.88E+08 5.85E+09 
Glucosamine 1.07E+07 1.63E+07 1.12E+07 4.59E+07 1.67E+07 
myo-Inositol 5.89E+07 1.26E+08 4.83E+07 1.34E+08 5.28E+07 
Tyrosine 1.21E+08 8.75E+07 1.12E+09 1.93E+08 8.70E+07 
Homovanillic acid (HVA) 1.22E+06 2.63E+07 8.73E+07 2.40E+07 3.24E+07 
Homocysteic acid 4.17E+06 1.42E+06 2.49E+07 4.42E+04 4.99E+06 
4-Pyridoxate 6.93E+07 5.83E+08 1.38E+08 3.32E+08 4.07E+08 
N-Acetylglutamine 6.61E+06 5.33E+07 1.03E+08 1.64E+07 4.23E+07 
Citrate/isocitrate 1.78E+09 2.11E+09 3.10E+09 9.71E+08 1.71E+09 
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Table 29. Continued. 
Metabolite 16 Days-1 16 Days-2 16 Days-3 16 Days-4 16 Days-5 
D-Gluconate 2.18E+08 1.14E+09 7.00E+08 2.95E+08 8.78E+08 
N-N Dimethylarginine 3.18E+05 1.29E+06 3.30E+06 2.02E+05 7.20E+05 
Tryptophan 9.45E+07 1.70E+08 4.24E+08 2.71E+07 1.44E+08 
Xanthurenic acid 3.18E+07 1.50E+07 2.63E+06 3.27E+06 1.35E+07 
D-Glucarate 1.44E+08 4.02E+09 4.13E+09 1.10E+08 2.25E+09 
Pantothenate 1.99E+08 3.28E+09 3.05E+09 5.93E+07 1.27E+09 
Cystathionine 1.55E+06 3.22E+06 7.09E+06 9.10E+05 5.11E+06 
Cystine 2.23E+05 7.24E+05 2.20E+06 2.42E+05 4.01E+05 
Uridine 2.83E+05 1.13E+07 1.39E+07 4.82E+06 1.17E+07 
Biotin 7.35E+05 1.48E+06 2.22E+06 1.56E+06 1.57E+06 
Deoxyinosine 3.77E+03 2.67E+05 3.29E+06 1.80E+03 6.54E+04 
Glucose 6-phosphate 8.20E+06 2.17E+07 8.73E+06 1.20E+07 1.55E+07 
S-Ribosyl-L-homocysteine 2.36E+05 1.15E+06 5.10E+06 5.65E+05 3.33E+05 
6-Phospho-D-gluconate 3.66E+06 1.42E+07 1.48E+07 1.04E+07 2.00E+07 
Guanosine 2.46E+06 1.43E+07 4.59E+06 2.07E+06 2.22E+07 
Xanthosine 1.41E+05 5.53E+05 1.03E+07 1.09E+06 7.23E+05 
Glycinamide ribotide (GAR) 7.33E+03 5.27E+03 1.19E+05 1.24E+04 2.28E+04 
Ophthalmate 1.34E+06 1.59E+07 5.84E+06 1.89E+06 1.56E+07 
Glutathione 5.36E+07 1.68E+07 4.65E+06 5.42E+05 3.28E+07 
UMP 8.02E+07 1.50E+08 3.15E+07 2.92E+07 1.80E+08 
AICAR 0.00E+00 3.92E+04 1.41E+04 8.22E+03 2.33E+05 
Trehalose/Sucrose/Cellobiose 3.18E+07 2.33E+07 5.59E+06 4.73E+06 2.50E+07 
AMP/dGMP 5.28E+08 9.04E+08 1.53E+08 8.60E+07 1.05E+09 
IMP 5.25E+05 1.56E+07 1.42E+06 1.91E+05 4.51E+06 
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Table 29. Continued. 
Metabolite 16 Days-1 16 Days-2 16 Days-3 16 Days-4 16 Days-5 
GMP 8.12E+07 3.26E+08 3.70E+07 8.79E+06 4.46E+08 
Xanthosine 5--phosphate 0.00E+00 1.18E+07 3.45E+06 2.41E+05 1.03E+07 
Riboflavin 2.62E+06 9.31E+06 2.80E+06 2.82E+07 8.37E+06 
S-Adenosyl-L-homocysteine 6.67E+03 6.12E+04 1.07E+05 2.51E+04 2.50E+05 
ADP 2.64E+08 1.40E+08 2.97E+07 1.97E+06 2.54E+08 
Folate 8.18E+05 1.79E+06 2.38E+05 6.81E+06 1.81E+06 
CDP-ethanolamine 5.15E+05 3.67E+05 1.75E+05 4.06E+04 5.58E+05 
FMN 1.95E+06 3.99E+06 1.42E+06 2.57E+07 2.82E+06 
UDP-glucose 3.83E+07 6.72E+07 1.42E+07 3.36E+07 9.74E+07 
NAD+ 7.00E+06 4.88E+06 2.16E+06 2.05E+06 6.63E+06 
NADH 1.04E+05 0.00E+00 7.34E+03 2.72E+04 1.27E+04 
Dephospho-CoA 5.49E+05 5.18E+05 5.80E+04 5.27E+03 5.62E+05 
NADP+ 1.63E+06 6.46E+06 1.15E+06 8.76E+05 5.53E+06 
FAD 1.46E+06 2.73E+06 1.47E+06 1.09E+07 2.47E+06 
N-Acetylglutamate 1.34E+07 1.59E+08 3.18E+08 5.04E+08 1.66E+08 





Table 30. Intensities of nematode replicates in infection model. 
Metabolite Nematode-1 Nematode-2 Nematode-3 Nematode-4 
Glyoxylate 0.00E+00 0.00E+00 0.00E+00 2.11E+03 
Glycine 8.45E+03 2.63E+03 1.10E+03 1.14E+04 
Pyruvate 2.55E+07 2.56E+07 2.19E+07 1.89E+07 
Alanine/Sarcosine 7.59E+07 6.14E+07 4.80E+07 3.78E+07 
Lactate 4.29E+08 4.07E+08 3.92E+08 2.57E+08 
Dimethylglycine 8.66E+06 8.29E+06 8.21E+06 8.08E+06 
Serine 1.08E+07 9.06E+06 5.14E+06 3.26E+06 
Histamine 1.07E+04 6.28E+03 0.00E+00 1.00E+03 
Uracil 4.45E+06 2.73E+06 2.12E+06 1.82E+06 
Creatinine 3.69E+04 6.33E+04 1.49E+05 6.89E+04 
Proline 7.86E+07 5.58E+07 6.75E+07 5.13E+07 
Fumarate 4.11E+06 3.07E+06 1.28E+06 8.10E+05 
2-Oxoisovalerate 8.37E+06 8.25E+06 8.41E+06 7.05E+06 
Indole 3.56E+03 0.00E+00 0.00E+00 0.00E+00 
Valine 7.27E+06 4.09E+06 3.63E+06 3.83E+06 
3-Hydroxyisovaleric acid 1.75E+07 1.56E+07 1.56E+07 1.34E+07 
Homoserine/Threonine 1.76E+07 7.70E+06 6.16E+06 4.36E+06 
3-Methylthiopropionate 2.62E+05 1.80E+05 1.33E+05 9.13E+04 
Cysteine 6.34E+04 7.01E+04 1.37E+03 3.75E+03 
Nicotinate 1.88E+06 1.44E+06 1.23E+06 1.06E+06 
Taurine 1.05E+05 8.81E+04 3.29E+04 1.11E+04 
Thymine 9.08E+06 8.12E+06 8.36E+06 7.85E+06 
Hydroxyproline 2.65E+06 2.13E+06 1.04E+06 5.32E+05 
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Table 30. Continued. 
Metabolite Nematode-1 Nematode-2 Nematode-3 Nematode-4 
N-Acetyl-beta-alanine 6.90E+06 5.88E+06 5.56E+06 4.97E+06 
Leucine/Isoleucine 1.54E+07 8.44E+06 5.67E+06 8.35E+06 
Glutaric acid 5.37E+06 5.70E+06 5.07E+06 3.24E+06 
Asparagine 2.07E+08 1.71E+08 5.80E+07 2.08E+07 
Hydroxyisocaproic acid 4.23E+07 2.79E+07 2.71E+07 2.10E+07 
Ornithine 1.46E+07 1.31E+07 5.06E+06 3.36E+06 
Salicylate 2.05E+06 2.14E+06 2.08E+06 1.39E+06 
Hydroxybenzoate 8.72E+05 1.19E+06 7.96E+05 6.48E+05 
Histidinol 1.53E+04 3.64E+04 2.02E+04 2.30E+04 
2-Oxoglutaric acid 1.04E+06 8.01E+05 5.68E+05 5.00E+05 
Glutamine 5.13E+07 4.19E+07 1.79E+07 1.34E+07 
2-hydroxyglutarate 4.91E+06 2.55E+06 1.70E+06 1.29E+06 
2-Hydroxy-2-methylsuccinate 4.86E+06 2.53E+06 1.69E+06 1.30E+06 
L-Methionine 2.49E+06 1.49E+06 8.75E+05 5.53E+05 
Guanine 1.54E+06 1.10E+06 2.11E+05 1.14E+04 
3-Methylphenylacetic acid 3.88E+06 2.41E+06 2.09E+06 1.69E+06 
Hydroxyphenylacetate 7.79E+05 6.93E+05 7.17E+05 6.28E+05 
Xylitol 4.24E+06 3.92E+06 4.76E+06 4.27E+06 
Dopamine 8.77E+05 4.93E+05 3.52E+05 3.66E+05 
2_3-Dihydroxybenzoate 1.06E+05 8.83E+04 7.05E+04 6.37E+04 
Histidine 5.03E+07 3.60E+07 8.34E+06 4.36E+06 
Orotate 7.56E+04 1.03E+04 2.40E+04 0.00E+00 
Dihydroorotate 3.79E+04 4.01E+04 2.30E+04 9.02E+04 
Allantoin 8.15E+05 5.67E+05 3.62E+05 2.30E+05 
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Table 30. Continued. 
Metabolite Nematode-1 Nematode-2 Nematode-3 Nematode-4 
Indole-3-carboxylate 5.49E+05 3.30E+05 3.30E+05 3.39E+05 
Phenylpyruvate 8.86E+05 5.77E+05 5.16E+05 4.90E+05 
Phenylalanine 1.01E+08 5.17E+07 4.16E+07 3.42E+07 
Phenyllactic acid 1.28E+06 8.29E+05 1.20E+06 9.12E+05 
Quinolinate 6.34E+05 4.31E+05 3.91E+05 2.95E+05 
Phosphoenolpyruvate 2.54E+05 1.74E+05 3.02E+04 9.17E+03 
Uric acid 3.93E+07 3.14E+07 6.08E+06 1.01E+06 
3_4-Dihydroxyphenylacetate (DOPAC) 1.38E+05 1.36E+05 8.90E+04 9.02E+04 
Sulfolactate 4.60E+05 3.64E+05 1.64E+05 7.11E+04 
Glycerone phosphate 8.32E+04 1.17E+05 3.03E+04 1.48E+04 
Arginine 3.02E+07 2.37E+07 6.67E+06 3.65E+06 
Citrulline 3.00E+05 2.06E+05 5.86E+05 2.90E+05 
Ascorbate 3.75E+06 2.64E+06 6.34E+03 3.68E+04 
N-Carbamoyl-L-aspartate 1.18E+05 7.93E+04 8.31E+04 6.62E+04 
Allantoate 2.82E+05 5.74E+03 1.90E+05 7.14E+03 
2-Isopropylmalate 2.60E+06 1.96E+06 1.85E+06 1.55E+06 
Glucosamine 4.82E+05 4.52E+05 2.66E+05 2.03E+05 
myo-Inositol 4.51E+06 3.98E+06 3.54E+06 2.18E+06 
Tyrosine 1.41E+07 9.96E+06 3.15E+06 1.87E+06 
Homovanillic acid (HVA) 3.70E+05 3.01E+05 3.06E+05 2.46E+05 
Homocysteic acid 1.92E+03 5.80E+03 0.00E+00 0.00E+00 
4-Pyridoxate 4.06E+06 3.80E+06 3.49E+06 3.17E+06 
N-Acetylglutamine 1.02E+06 8.92E+05 8.54E+05 5.14E+05 
Citrate/isocitrate 4.75E+08 3.11E+08 2.22E+08 1.34E+08 
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Table 30. Continued. 
Metabolite Nematode-1 Nematode-2 Nematode-3 Nematode-4 
D-Gluconate 1.73E+07 1.25E+07 2.66E+06 1.00E+06 
N-N Dimethylarginine 3.09E+05 3.02E+05 3.16E+05 2.80E+05 
Tryptophan 1.71E+07 1.07E+07 5.95E+06 3.99E+06 
Xanthurenic acid 1.24E+05 4.28E+04 1.45E+05 1.09E+05 
D-Glucarate 4.27E+06 1.98E+06 1.93E+06 1.40E+06 
Pantothenate 6.57E+07 5.67E+07 3.30E+07 3.22E+07 
Cystathionine 9.74E+04 6.30E+04 1.12E+04 4.10E+03 
Cystine 7.30E+03 9.91E+03 3.51E+04 6.41E+04 
Uridine 3.91E+04 1.50E+04 3.23E+04 1.69E+04 
Biotin 0.00E+00 0.00E+00 0.00E+00 1.84E+03 
Deoxyinosine 2.07E+03 1.69E+03 5.00E+03 8.86E+03 
Glucose 6-phosphate 4.12E+06 2.96E+06 5.01E+05 9.16E+04 
S-Ribosyl-L-homocysteine 2.39E+04 1.40E+04 1.20E+03 0.00E+00 
6-Phospho-D-gluconate 2.04E+05 1.03E+05 7.23E+04 0.00E+00 
Guanosine 1.37E+05 9.38E+04 4.93E+04 9.59E+03 
Xanthosine 1.43E+04 1.26E+04 0.00E+00 0.00E+00 
Glycinamide ribotide (GAR) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Ophthalmate 1.98E+04 1.35E+04 5.13E+03 0.00E+00 
Glutathione 1.63E+07 1.17E+07 1.23E+05 6.59E+05 
UMP 1.07E+06 7.84E+05 5.35E+05 1.41E+05 
AICAR 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Trehalose/Sucrose/Cellobiose 6.70E+06 5.70E+06 2.33E+06 9.77E+05 
AMP/dGMP 2.17E+07 1.60E+07 1.16E+07 3.29E+06 
IMP 3.02E+05 1.37E+05 3.70E+04 9.25E+04 
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Table 30. Continued. 
Metabolite Nematode-1 Nematode-2 Nematode-3 Nematode-4 
GMP 8.39E+05 5.33E+05 5.15E+05 4.29E+04 
Xanthosine 5--phosphate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Riboflavin 1.90E+05 7.92E+04 8.57E+03 0.00E+00 
S-Adenosyl-L-homocysteine 3.39E+03 0.00E+00 0.00E+00 0.00E+00 
ADP 3.84E+07 2.09E+07 1.61E+07 3.51E+06 
Folate 2.24E+05 1.46E+05 3.93E+03 0.00E+00 
CDP-ethanolamine 7.57E+04 5.68E+04 2.10E+03 0.00E+00 
FMN 6.48E+05 2.33E+05 1.54E+04 0.00E+00 
UDP-glucose 3.83E+06 2.74E+06 2.33E+06 1.47E+05 
NAD+ 1.29E+06 8.88E+05 2.72E+05 6.46E+04 
NADH 3.44E+05 2.05E+05 0.00E+00 0.00E+00 
Dephospho-CoA 7.96E+04 2.37E+04 1.10E+04 5.39E+03 
NADP+ 3.97E+04 1.99E+04 8.53E+04 0.00E+00 
FAD 1.22E+05 6.00E+04 4.15E+04 0.00E+00 
N-Acetylglutamate 4.01E+05 2.68E+05 2.50E+05 1.79E+05 





Table 31. Intensities of X. nematophila whole cell replicates. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
Alanine/Sarcosine 1.97E+07 2.84E+07 3.79E+07 4.36E+07 2.93E+07 4.03E+07 
Uracil 8.04E+07 1.08E+08 1.38E+08 1.45E+08 1.21E+08 1.60E+08 
Valine 1.67E+08 2.78E+08 3.13E+08 3.24E+08 2.43E+08 2.69E+08 
Succinate/Methylmalonate 3.97E+09 4.07E+09 2.65E+09 2.34E+09 2.18E+09 2.09E+09 
Homoserine/Threonine 6.23E+06 8.68E+06 8.47E+06 8.81E+06 6.70E+06 8.82E+06 
Thymine 7.33E+06 7.89E+06 1.02E+07 9.09E+06 7.28E+06 1.40E+07 
Leucine/Isoleucine 5.56E+07 9.22E+07 8.82E+07 1.02E+08 8.80E+07 9.40E+07 
Ornithine 5.42E+05 1.36E+06 1.28E+06 1.44E+06 1.11E+06 2.84E+06 
Acetylphosphate 1.57E+08 1.47E+08 1.44E+08 6.83E+07 1.48E+08 9.82E+07 
Histidinol 7.73E+05 1.30E+06 2.55E+06 3.93E+06 2.31E+06 3.11E+06 
alpha-Ketoglutarate 1.04E+07 1.88E+07 1.29E+07 1.52E+07 8.75E+06 1.28E+07 
Lysine 9.01E+05 1.43E+06 1.71E+06 2.38E+06 1.92E+06 1.78E+06 
O-Acetyl-L-serine 1.77E+08 1.34E+08 1.07E+08 1.79E+08 9.48E+07 2.83E+08 
2-Hydroxy-2-methylsuccinate 4.00E+08 3.71E+08 2.17E+08 1.83E+08 1.43E+08 2.19E+08 
Methionine 3.40E+06 5.54E+06 5.74E+06 7.08E+06 6.32E+06 6.91E+06 
Guanine 2.01E+07 2.17E+07 2.12E+07 2.89E+07 2.34E+07 2.55E+07 
Histidine 2.34E+06 2.75E+06 2.79E+06 3.71E+06 3.18E+06 2.53E+06 
Orotate 1.02E+05 1.44E+05 2.58E+05 7.59E+04 4.69E+05 1.53E+05 
Allantoin 1.52E+05 2.46E+05 2.83E+05 2.66E+05 2.82E+05 3.92E+05 
2-Aminoadipate 6.60E+06 1.21E+07 1.00E+07 1.01E+07 7.34E+06 1.16E+07 
Phenylpyruvate 1.10E+07 2.51E+07 1.81E+07 1.64E+07 1.98E+07 1.30E+07 
Phenylalanine 1.03E+08 1.37E+08 1.20E+08 1.46E+08 1.40E+08 1.47E+08 
Phenyllactic acid 2.13E+08 2.40E+08 2.34E+08 2.19E+08 2.18E+08 1.88E+08 
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Table 31. Continued. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
Aconitate 7.79E+07 5.26E+07 1.54E+08 1.22E+08 1.24E+08 1.98E+08 
N-Acetylornithine 3.05E+05 6.51E+05 5.47E+05 3.96E+05 4.01E+05 9.74E+05 
Citrulline 3.17E+06 5.12E+06 5.42E+06 6.36E+06 5.18E+06 1.05E+07 
N-Carbamoyl-L-aspartate 7.84E+05 1.21E+06 1.26E+06 1.60E+06 1.72E+06 9.04E+05 
2-Isopropylmalate 2.70E+09 4.03E+09 3.95E+09 4.88E+09 5.35E+09 3.08E+09 
Tyrosine 1.81E+07 2.43E+07 2.32E+07 2.92E+07 2.44E+07 2.75E+07 
3-Phosphoglycerate 1.04E+09 9.20E+08 9.19E+08 1.18E+09 9.13E+08 2.85E+09 
N-Acetylglutamate 6.75E+07 8.11E+07 5.68E+07 5.66E+07 5.42E+07 9.34E+07 
5-Hydroxyindoleacetic acid (5-HIAA) 1.43E+04 5.14E+03 1.22E+04 4.81E+03 4.81E+03 1.72E+04 
2-Dehydro-D-gluconate 2.10E+07 4.14E+07 2.84E+07 2.57E+07 1.94E+07 3.34E+07 
D-Gluconate 4.26E+08 4.77E+08 4.62E+08 5.58E+08 5.81E+08 3.97E+08 
Tryptophan 2.54E+07 3.52E+07 4.41E+07 5.44E+07 4.82E+07 5.64E+07 
Lipoate 8.48E+08 8.60E+08 6.01E+08 5.88E+08 5.56E+08 6.56E+08 
Deoxyribose phosphate 7.98E+07 8.87E+07 9.50E+07 1.07E+08 9.42E+07 1.08E+08 
Ribose phosphate 9.79E+08 1.16E+09 1.07E+09 1.09E+09 1.21E+09 1.30E+09 
Xylitol 5-phosphate 1.65E+08 2.31E+08 2.05E+08 1.85E+08 2.21E+08 1.54E+08 
Cystine 8.12E+06 8.36E+06 1.52E+07 1.34E+07 9.51E+06 2.58E+07 
Uridine 1.10E+07 1.39E+07 1.55E+07 1.92E+07 1.40E+07 1.76E+07 
Glucosamine phosphate 3.47E+06 5.46E+06 5.87E+06 9.18E+06 9.03E+06 8.42E+06 
S-Ribosyl-L-homocysteine 8.86E+05 6.01E+05 1.20E+06 9.27E+05 8.56E+05 1.52E+06 
Adenosine 9.61E+06 1.08E+07 1.39E+07 1.36E+07 1.28E+07 1.40E+07 
Homocystine 1.60E+04 3.44E+04 2.07E+05 2.94E+05 2.25E+05 1.70E+05 
Inosine 7.55E+07 8.94E+07 8.92E+07 9.43E+07 9.02E+07 7.39E+07 
6-Phospho-D-gluconate 6.06E+08 5.97E+08 4.08E+08 6.76E+08 5.67E+08 3.61E+08 
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Table 31. Continued. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
Guanosine 1.71E+07 1.83E+07 3.96E+07 5.64E+07 4.54E+07 4.81E+07 
Xanthosine 1.12E+07 1.61E+07 1.83E+07 2.67E+07 2.58E+07 2.89E+07 
Glycinamide ribotide (GAR) 2.01E+04 1.50E+05 2.66E+04 4.94E+04 6.97E+04 3.68E+04 
Aminoimidazole ribotide (AIR) 1.25E+04 5.86E+04 1.23E+05 6.27E+04 1.73E+05 8.16E+05 
N-Acetylglucosamine 1/6-phosphate 7.99E+06 9.86E+06 1.23E+07 1.50E+07 1.59E+07 1.79E+07 
Octulose 8/1P 6.02E+06 7.76E+06 7.81E+06 6.98E+06 8.80E+06 7.50E+06 
CMP 4.24E+06 4.09E+06 5.17E+06 6.28E+06 5.46E+06 7.61E+06 
UMP 6.29E+06 3.72E+06 5.79E+06 9.09E+06 7.04E+06 9.95E+06 
AICAR 3.73E+07 3.68E+07 4.33E+07 5.24E+07 4.83E+07 5.66E+07 
Fructose 1_6-bisphosphate 1.93E+10 2.52E+10 2.29E+10 2.48E+10 2.41E+10 2.20E+10 
Trehalose/Sucrose/Cellobiose 4.67E+06 4.92E+06 4.25E+06 4.39E+06 4.26E+06 5.61E+06 
AMP/dGMP 1.91E+07 1.48E+07 1.54E+07 1.75E+07 1.32E+07 2.37E+07 
IMP 1.01E+06 9.44E+05 8.07E+05 9.55E+05 7.28E+05 2.18E+06 
S-Adenosyl-L-methioninamine 9.64E+05 1.41E+06 1.83E+06 2.21E+06 1.92E+06 4.60E+06 
Sedoheptoluse bisphosphate 8.09E+08 1.06E+09 8.77E+08 1.03E+09 1.02E+09 9.20E+08 
dTDP 3.14E+06 2.96E+06 2.12E+06 1.67E+06 1.43E+06 1.86E+06 
UDP 1.51E+07 2.61E+08 3.51E+08 3.38E+08 3.29E+08 3.20E+08 
FMN 4.96E+07 5.45E+07 4.30E+07 4.52E+07 4.20E+07 3.71E+07 
UDP-glucose 4.25E+08 2.76E+08 3.15E+08 3.68E+08 2.37E+08 4.71E+08 
UDP-glucuronate 1.12E+06 3.63E+07 3.68E+08 7.12E+08 5.76E+08 5.03E+08 
UDP-N-acetylglucosamine 6.28E+07 4.37E+07 7.12E+07 8.12E+07 6.39E+07 1.07E+08 
NAD+ 4.91E+07 3.63E+07 3.71E+07 4.22E+07 3.12E+07 7.22E+07 
NADH 1.15E+07 1.81E+07 9.03E+06 9.42E+06 7.38E+06 6.59E+06 
Dephospho-CoA 5.69E+06 4.83E+06 5.16E+06 7.05E+06 5.27E+06 5.14E+06 
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Table 31. Continued. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
NADP+ 2.70E+08 1.70E+08 1.80E+08 1.56E+08 1.58E+08 2.18E+08 
FAD 4.32E+07 4.14E+07 3.15E+07 2.98E+07 2.91E+07 2.80E+07 
Pyruvate 2.29E+09 2.44E+09 2.96E+08 2.09E+09 3.30E+08 3.91E+08 
Fumarate 4.82E+08 5.89E+08 5.98E+08 6.08E+08 5.40E+08 5.24E+08 
Cysteine 7.67E+04 9.11E+04 2.03E+05 1.15E+05 9.48E+04 2.79E+05 
Nicotinate 2.84E+09 3.24E+09 2.87E+09 2.87E+09 2.90E+09 3.11E+09 
Malate 1.06E+10 1.16E+10 1.27E+10 1.25E+10 1.17E+10 1.14E+10 
Hypoxanthine 7.14E+07 8.19E+07 8.21E+07 8.96E+07 7.43E+07 6.85E+07 
Indole-3-carboxylate 2.30E+04 9.16E+03 5.59E+03 1.22E+04 3.40E+03 1.03E+04 
Phosphoenolpyruvate 2.47E+08 3.74E+08 2.82E+08 3.60E+08 3.11E+08 1.29E+09 
Glycerone phosphate 1.29E+09 1.46E+09 1.47E+09 1.54E+09 1.62E+09 1.43E+09 
sn-Glycerol 3-phosphate 1.43E+08 1.33E+08 1.42E+08 1.46E+08 1.42E+08 2.34E+08 
Citrate/isocitrate 3.86E+09 3.92E+09 9.28E+09 9.35E+09 9.70E+09 1.16E+10 





Table 32. Intensities of X. nematophila supernatant replicates. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
Alanine/Sarcosine 1.30E+06 1.66E+06 6.54E+05 4.31E+05 1.54E+05 1.11E+05 
Uracil 4.26E+06 6.34E+06 9.93E+06 2.66E+07 2.50E+07 4.83E+07 
Valine 3.45E+07 4.33E+07 3.58E+07 3.58E+07 3.95E+07 2.16E+07 
Succinate/Methylmalonate 9.93E+05 1.21E+06 1.44E+06 1.10E+06 1.41E+06 8.50E+05 
Homoserine/Threonine 9.61E+06 1.48E+07 1.23E+07 1.34E+07 1.18E+07 1.52E+07 
Thymine 1.85E+06 2.16E+06 2.58E+06 6.19E+06 4.91E+06 9.83E+06 
Leucine/Isoleucine 1.35E+05 1.45E+05 1.92E+05 1.69E+05 2.32E+05 2.28E+05 
Ornithine 7.02E+05 5.56E+05 4.45E+05 5.58E+05 5.48E+05 7.90E+05 
Acetylphosphate 5.95E+05 3.47E+05 4.22E+05 4.23E+05 2.93E+05 3.09E+05 
Histidinol 8.14E+07 7.80E+07 6.84E+07 7.52E+07 6.10E+07 8.19E+07 
alpha-Ketoglutarate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Lysine 7.86E+07 9.05E+07 8.80E+07 1.10E+08 1.04E+08 1.41E+08 
O-Acetyl-L-serine 1.45E+08 1.53E+08 1.36E+08 1.46E+08 1.35E+08 1.56E+08 
2-Hydroxy-2-methylsuccinate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Methionine 5.39E+05 1.02E+06 3.69E+05 4.80E+05 4.18E+05 3.79E+05 
Guanine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.74E+03 0.00E+00 
Histidine 1.10E+07 1.21E+07 8.73E+06 1.04E+07 1.01E+07 1.34E+07 
Orotate 8.03E+04 9.05E+04 4.87E+04 1.09E+05 5.21E+04 1.09E+04 
Allantoin 3.99E+07 4.45E+07 3.39E+07 4.11E+07 3.72E+07 4.88E+07 
2-Aminoadipate 4.17E+06 5.49E+06 4.00E+06 5.65E+06 4.83E+06 6.88E+06 
Phenylpyruvate 1.96E+06 2.39E+06 2.11E+06 4.36E+06 3.02E+06 2.73E+06 
Phenylalanine 5.66E+07 6.65E+07 4.75E+07 6.46E+07 5.78E+07 7.51E+07 
Phenyllactic acid 7.16E+07 7.14E+07 5.56E+07 6.58E+07 5.74E+07 9.15E+07 
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Table 32. Continued. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
Aconitate 2.12E+05 1.71E+05 2.62E+05 1.45E+05 2.27E+05 1.80E+05 
N-Acetylornithine 1.91E+06 1.78E+06 2.16E+06 2.22E+06 2.35E+06 2.54E+06 
Citrulline 8.22E+04 1.20E+05 8.08E+04 1.20E+05 7.92E+04 1.49E+05 
N-Carbamoyl-L-aspartate 6.83E+08 8.10E+08 6.27E+08 7.77E+08 6.87E+08 1.00E+09 
2-Isopropylmalate 1.33E+04 5.98E+04 6.41E+03 1.84E+04 0.00E+00 0.00E+00 
Tyrosine 9.54E+07 3.50E+07 1.33E+07 1.39E+07 1.26E+07 1.53E+07 
3-Phosphoglycerate 3.75E+06 2.85E+06 3.20E+06 2.58E+06 2.66E+06 2.05E+06 
N-Acetylglutamate 4.61E+05 4.44E+05 3.16E+05 5.41E+05 2.83E+05 5.03E+05 
5-Hydroxyindoleacetic acid (5-HIAA) 2.57E+07 2.95E+07 2.60E+07 3.31E+07 3.01E+07 3.88E+07 
2-Dehydro-D-gluconate 1.26E+07 1.66E+07 1.45E+07 1.81E+07 1.66E+07 2.02E+07 
D-Gluconate 6.38E+05 8.11E+05 6.17E+05 1.10E+06 9.44E+05 1.68E+06 
Tryptophan 2.28E+08 2.51E+08 2.70E+08 2.92E+08 2.47E+08 2.51E+08 
Lipoate 4.10E+06 5.18E+06 4.51E+06 5.86E+06 5.72E+06 6.79E+06 
Deoxyribose phosphate 7.36E+07 8.75E+07 7.12E+07 9.09E+07 8.75E+07 1.27E+08 
Ribose phosphate 1.22E+07 1.34E+07 1.06E+07 1.36E+07 1.30E+07 2.07E+07 
Xylitol 5-phosphate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.92E+03 0.00E+00 
Cystine 0.00E+00 3.01E+05 1.14E+06 3.63E+05 1.81E+05 5.82E+04 
Uridine 4.64E+05 3.08E+05 3.56E+05 4.98E+05 3.11E+05 4.48E+05 
Glucosamine phosphate 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
S-Ribosyl-L-homocysteine 3.07E+05 1.56E+04 2.12E+04 0.00E+00 3.80E+03 4.86E+03 
Adenosine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Homocystine 3.52E+06 4.52E+06 5.20E+06 5.77E+06 6.58E+06 6.42E+06 
Inosine 9.00E+06 5.09E+06 3.05E+06 2.18E+06 1.21E+06 2.25E+06 
6-Phospho-D-gluconate 9.45E+04 1.03E+05 1.58E+05 1.34E+05 2.10E+05 1.89E+05 
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Table 32. Continued. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
Guanosine 2.50E+06 2.98E+06 1.84E+06 2.43E+06 2.36E+06 2.66E+06 
Xanthosine 0.00E+00 0.00E+00 0.00E+00 0.00E+00 6.78E+03 0.00E+00 
Glycinamide ribotide (GAR) 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Aminoimidazole ribotide (AIR) 3.08E+04 2.66E+04 3.49E+04 3.34E+04 4.90E+04 2.45E+04 
N-Acetylglucosamine 1/6-phosphate 1.65E+04 8.84E+04 4.05E+04 8.97E+04 1.14E+05 7.06E+04 
Octulose 8/1P 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
CMP 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
UMP 0.00E+00 2.16E+03 1.62E+04 1.37E+04 9.20E+03 1.05E+04 
AICAR 3.47E+09 4.00E+08 5.90E+07 1.57E+07 5.99E+06 3.57E+06 
Fructose 1_6-bisphosphate 7.44E+06 8.84E+06 9.56E+06 1.03E+07 9.01E+06 8.39E+06 
Trehalose/Sucrose/Cellobiose 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
AMP/dGMP 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
IMP 6.33E+05 4.09E+05 6.41E+05 6.52E+05 6.23E+05 9.51E+05 
S-Adenosyl-L-methioninamine 1.37E+08 1.02E+07 1.55E+05 1.82E+04 1.31E+04 0.00E+00 
Sedoheptoluse bisphosphate 0.00E+00 3.49E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
dTDP 2.96E+08 1.68E+07 2.13E+06 1.27E+04 3.00E+03 3.50E+03 
UDP 1.90E+06 5.55E+05 3.40E+05 3.02E+05 2.87E+05 4.93E+05 
FMN 3.90E+05 3.85E+05 5.22E+03 0.00E+00 0.00E+00 0.00E+00 
UDP-glucose 4.70E+08 2.82E+07 2.22E+07 5.03E+06 7.57E+05 7.64E+05 
UDP-glucuronate 5.86E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
UDP-N-acetylglucosamine 0.00E+00 0.00E+00 0.00E+00 4.25E+03 0.00E+00 0.00E+00 
NAD+ 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
NADH 1.53E+05 4.86E+03 3.93E+03 9.68E+03 0.00E+00 0.00E+00 
Dephospho-CoA 3.41E+06 0.00E+00 6.01E+03 7.64E+03 4.23E+03 0.00E+00 
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Table 32. Continued. 
Metabolite 1495-1 1495-2 1495-3 1496-1 1496-2 1496-3 
NADP+ 1.50E+05 1.03E+05 5.29E+04 6.69E+04 5.69E+04 2.13E+05 
FAD 3.38E+07 4.82E+07 4.44E+07 4.92E+07 5.08E+07 5.40E+07 
Pyruvate 5.90E+06 4.37E+06 4.46E+06 3.35E+06 4.06E+06 2.23E+06 
Fumarate 2.82E+03 0.00E+00 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
Cysteine 4.85E+09 5.64E+09 4.65E+09 5.87E+09 5.80E+09 7.53E+09 
Nicotinate 1.47E+08 9.05E+07 9.42E+07 7.50E+07 8.46E+07 5.76E+07 
Malate 1.23E+05 4.20E+05 7.00E+05 7.30E+05 8.52E+05 7.52E+05 
Hypoxanthine 4.48E+05 4.24E+05 3.48E+05 4.65E+05 3.58E+05 4.94E+05 
Indole-3-carboxylate 7.53E+07 3.28E+07 2.75E+07 1.51E+07 8.62E+06 6.51E+06 
Phosphoenolpyruvate 1.86E+07 1.45E+07 1.10E+07 1.32E+07 1.12E+07 1.57E+07 
Glycerone phosphate 9.20E+06 1.09E+07 8.68E+06 1.03E+07 1.07E+07 1.05E+07 
sn-Glycerol 3-phosphate 5.16E+09 2.56E+09 2.06E+09 1.65E+09 1.33E+09 1.28E+09 
Citrate/isocitrate 8.53E+06 1.18E+07 7.87E+06 9.57E+06 7.29E+06 8.34E+06 
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